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were not worth knowing, life would not be worth living.”
Jules Henri Poincare (1854-1912)
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“The scientist does not study nature because it is useful; he studies it 
because he delights in it, and he delights in it because it is beautiful. If 
nature were not beautiful, it would not be worth knowing, and if nature
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A bstract
i
Mammalian pyruvate dehydrogenase multi-enzyme complex (PDC) is a key 
metabolic assembly responsible for the maintenance of glucose homeostasis. PDC 
comprises a central pentagonal dodecahedral core of 60 dihydrolipoamide 
acetyltransferase (E2) and 12 E3 binding protein (E3BP) molecules. E2 is thought 
to form the edges of the icosahedral core structure while a single E3BP molecule is 
thought to occupy each of the 12 pentagonal faces. Both E2 and E3BP have a 
modular multi-domain organisation and are responsible for the attachment of up to 
30 pyruvate decarboxylase (El) heterotetramers and 6-12 dihydrolipoamide 
dehydrogenase (E3) homodimers, respectively. The formation of highly specific 
E2/E1 and E3BP/E3 subcomplexes is characteristic of PDC from eukaryotes and 
critical for normal complex function.
This thesis describes the large-scale purification of tagged, recombinant human 
PDC proteins E2, E3 and E3BP as well as several truncated E2 and E3BP 
constructs. Due to the limited solubility of recombinant human E l, the protein was 
obtained by purification from native bovine PDC. The ability to purify relatively 
large amounts of proteins enabled the characterisation of the individual proteins as 
well as their subcomplexes using a variety of biochemical and biophysical 
techniques.
Truncated E3BP, full-length E3 and their resultant subcomplex were analysed in 
solution by analytical ultracentrifugation (AUC). The stoichiometry of interaction 
was determined to be 2:1 (E3BP:E3) using native polyacrylamide gel
_____________________________________________________Abstract
electrophoresis (PAGE), AUC, isothermal titration calorimetry (TTC) and small 
angle x-ray scattering (SAXS), thus implying the existence of a network of E3 
“cross-bridges” linking pahs of E3BP molecules across the surface of the E2 core 
assembly. A low resolution structure for E3 obtained by SAXS shows significant 
differences to the crystal structures obtained previously for human and yeast E3s. 
The low resolution structure determined for the truncated E3BP/E3 subcomplex 
was surprisingly anisometric, indicating the asymmetric distribution of lipoyl 
domains within the subcomplex. Rigid-body modelling with homology models of 
E3 and the individual E3BP domains resulted in a structure in which only one of 
the E3BP lipoyl domains was docked into the E3 active site. This new level of 
architectural complexity in mammalian PDC has important implications for the 
catalytic mechanism, overall complex efficiency and regulation by its intrinsic 
PDC kinase.
Analogous to the E3BP/E3 subcomplex, initial investigations of the interaction of 
truncated E2 with E l using AUC also seem to indicate the formation of 2:1 
subcomplexes, cross-linking neighbouring E2 molecules on the PDC core surface. 
However, the relatively low stability of bovine E l -  as revealed by AUC -  has 
hampered the investigation of E2/E1 subcomplex formation.
Until recently, mammalian PDC core was thought to consist of 60 E2 and 12 E3BP 
molecules (the “addition” model). The relatively recent publication of an 
alternative, “substitution” model by Hiromasa and colleagues (2004), where E3BP 
replaces 12 E2 molecules, resulting in a 48:12 (E2:E3BP) core structure, initiated 
the search for experimental approaches able to distinguish between the PDC core 
models. SAXS data, even in conjunction with ab initio reconstruction techniques 
were deemed insufficient for this purpose, while small angle neutron scattering 
(SANS) in combination with contrast matching of selectively deuterated 
components gave promising initial results and could be used in future for the 
resolution of this fundamental problem in PDC subunit organisation.
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Introduction to pyruvate dehydrogenase 
complex structure and function
1.1 Multi-enzyme complexes
Multi-enzyme complexes combine two or more enzymatic activities within a single assembly.
Direct consequences of the evolution of these multi-component complexes are the 
concomitant development of substrate channelling and active site coupling: products from one 
reaction can be shuttled effectively from one active site to the next, greatly reducing diffusion 
times and thus increasing enzyme efficiency, as well as protecting (possibly unstable) 
intermediates from outside influence.
The 2-oxoacid dehydrogenase complexes are a prime example of multi-subunit, high 
molecular weight assemblies that consist of thiee different enzymes (El, E2 and E3). The 
lipoamide cofactor associated with the central E2 moiety is required to visit the active sites of 
all three enzymes via its so-called “swinging arm”. Therefore, these complexes serve as 
excellent models for the investigation of protein-protein interactions within multi-enzyme 
complexes, enzyme cooperativity, active site coupling, and any associated regulatory 
advantages. This chapter will provide insights into the metabolic role and importance of 2- 
oxoacid dehydrogenase complexes, as well as their structural organisation, with particular 
emphasis on the eukaryotic pyruvate dehydrogenase complex.
1.2 2-oxoacid dehydrodgenase complexes
1.2 2-oxoacid dehydrogenase complexes
The family of 2-oxoacid dehydrogenase complexes consists of thiee different members, all of 
which play important metabolic roles: pyruvate dehydrogenase complex (PDC) links 
glycolysis with the tiicarboxylic acid (TCA) cycle (Fig. 1.1) by catalysing the 
decarboxylation of pyruvate and concomitant generation of acetyl-CoA. As no net production 
of carbohydrates is possible from acetyl-CoA, PDC is the main regulator of glucose 
homeostasis in mammals (Sugden & Holness, 2003). Analogously, 2-oxoglutarate 
dehydrogenase (OGDC) decarboxylates its substrate 2-oxoglutarate, an important 
intermediate of the TCA cycle, and forms succinyl-CoA (Sheu & Blass, 1999). Finally, the 
branched-chain 2-oxoacid dehydrogenase complex (BCDC) catalyses the irreversible step in 
the catabolism of branched chain amino acids, such as leucine, isoleucine and valine (Patel & 
Harris, 1995).
Branched chain 
amino acid
Branched chain  
2-oxoacid
Glucose
IIIII
Pyruvate
Branched chain 2-cawKicid 
dehydrogenase
Pyruvate
dehydrogenase
B ïa ïic îied  cliaiii. acyl-CoA  »
i : ----------------------“ A cetoacetate
A cetyl-C oA
TCA cycle
2-oxog lu tarate
Propionyl-CoA ► Sncciiiyl-CoA/ 2-oxoglutaratedehydrogenase
Figure 1.1 Involvement of 2-oxoacid dehydrogenases in cellular metabolism
Enzymes are shown in blue and their products in green.
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1.4 PDC component structural information
1.3 Reaction mechanism of PDC
PDC catalyses the conversion o f pyruvate to o f  acetyl-CoA and N A D H  in three distinct 
enzymatic steps (Fig. 1.2). Initially, pyruvate is decarboxylated by the thiamine diphosphate 
(ThDP)-dependent enzyme pyruvate decarboxylase (E l, EC 1.2.4.1) which also catalyses the 
subsequent transfer o f the resulting acetyl group from ThDP onto the lipoamide moiety o f  
dihydrolipoamide acetyltransferase (E2, EC 2.3.1.1) in a reductive acétylation step. This 
generates a stable transition state where the acetyl group is initially covalently bound to the S* 
position o f the lipoamide group (Yang & Frey, 1986). In the presence o f  CoASH, the latter 
also interacts with E2 which then catalyses the transacetylation reaction to form acetyl-CoA. 
Otherwise, the acetyl groups remain bound to the lipoamide cofactor. In the final step the E2 
dihydrolipoamide is reoxidised by dihydrolipoamide dehydrogenase (E3, EC 1.8.1.4). E3 
transfers electrons via a redox-active pair o f cysteines to the isoalloxazine ring o f FAD and 
onto the terminal electron acceptor NAD^. The overall reaction can be summarised as 
Pyruvate + CoASH + NAD"  ^ acetyl-CoA + CO2 + N A D H  + H^
C0 A8 H
RCCOOH ThDP
FAD
OH E3CO, NADH + HRC ThOP
FAD
SH8H NAD
Figure 1.2 PDC reaction scheme
Adapted from Milne et al. (2002).
1.4 PDC component structural information
1.4.1 B asic core organisation
All three 2-oxoacid com plexes display a similar mode o f quasi-symmetric organisation o f  
their subunits E l ,  E2 and E3 into high molecular weight assem blies o f  4-11 MDa. Apart from 
playing a role in the catalytic mechanism, E2 also forms a central 24-meric or 60-meric core.
1.4 PDC component structural information
consistent with octahedral (432) or icosahedral (532) symmetry, respectively (Fig. 1.3) 
(Oliver & Reed, 1982; Wagenknecht et al., 1990). For OGDC and BCDC, as well as PDC 
from Gram-negative bacteria, the E2 core is assembled as an octahedron. Only in Gram- 
positive bacteria and eukaryotes does the PDC core assume an icosahedral morphology. The 
E2 core also provides the framework for the interaction with the other two enzymes, E l and 
E3 (Patel & Roche, 1990; Perham, 2000). Furthermore, eukaryotic PDC contains an 
additional protein, E3 binding protein (E3BP, previously designated protein X ) which is 
associated with the E2 core (De Marcucci & Lindsay, 1985; Jilka et al., 1986) and is 
responsible for binding E3, as suggested by its name.
Figure 1.3 E2 core formation in 2-oxoacid dehydrogenase complexes
The octahedral core of Azotobacter vinelandii PDC (PDB ID lEAA) is shown with different views 
along the two- (A), three- (B) and four-fold (C) axes of symmetry. Similarly, the icosahedral core of 
Bacillus stearothermophilus PDC (PDB ID 1B5S) is depicted with representations along the two- (D), 
three- (E) and five-fold (F) axes of symmetry. All E2 molecules are coloured identically (N-terminus 
to C-terniinus).
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1.4.2 D ihydrolipoylacetyltransferase (E2)
E2 (and E3BP) exhibit a similar, modular, multi-domain structure (Fig. 1.4) (Borges et al., 
1990): the N-terminal arm visits all three active sites in turn and contains one to three lipoyl 
domains (LD) -  the exact number varies from organism to organism (Reed & Hackert, 1990; 
Perham, 1991) -  and is follow ed by the peripheral subunit binding domain (SBD ) necessary 
for association with E l and/or E3 (Packman & Perham, 1986; Hipps et al., 1994; Lessard & 
Perham, 1995; Westphal et al., 1995). A  large C-terminal domain (CTD) o f approximately 
250 residues is responsible for self-association (Reed & Hackert, 1990; Perham, 1991) and 
also contains the acetyltransferase active site. All domains are interconnected by long, 
extended linker regions o f  ca. 30 residues in length, resulting in a flexible, yet extended 
ensem ble that radiates outwards from the core and confers the large conformational flexibility 
associated with the N-terminal “swinging arm”.
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Figure 1.4 Domain structure of E2 and E3BP
Schematic representation of the domain structure of E2 (A) and E3BP (B). The number of lipoyl 
domains (L) varies from one to three for different organisms. Lipoyl groups are indicated by a star. The 
subunit binding (SBD) and C-terminal domains (CTD) are also shown.
1.4.2.1 The lipoyl domain
Due to its small size (ca. 80 residues) and ability to fold independently the lipoyl domain was 
amenable to structure determination using NMR spectroscopy. The three-dimensional
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structures o f E2-LD from B. stearotherm ophilus PDC (Dardel et al., 1993), E. colt PDC and 
OGDC (Green et al, 1995; Ricaud et al., 1996), A. vinelandii PDC and OGDC (Berg et al., 
1995; 1996; 1997) as well as human PDC (Howard et al., 1998) have been solved. All 
solution structures are very similar to each other even when the sequence identity between 
different lipoyl domains is rather low, e.g. between E2-LD o f  A. vinelandii PDC and OGDC  
(25%) (Berg et al., 1997). Similarly, no significant differences were recorded in the NMR  
spectra for lipoylated and non-lipoylated protein (Dardel et al., 1991; Berg et al., 1994).
The LD folds into a flattened p-barrel comprising two four-stranded, antiparallel y9-sheets with 
a two-fold quasi-symmetry axis (Fig. 1.5). The lysine residue to be lipoylated is situated 
within a conserved DKA m otif at the tip o f a type 1 p-tum. Lipoylation can only occur if  the 
lysine residue is present at the tip o f  the turn; movement o f the lysine by a single residue 
towards the N- or C-terminus abolishes lipoylation (W allis & Perham, 1994). Mutagenesis 
studies have also established that neither the aspartate nor the alanine within the DKA m otif 
are required for lipoylation. However, both residues are necessary to support reductive 
acétylation at wild-type levels (W allis & Perham, 1994; Jones et al., 20(X)).
Figure 1.5 Structure of the human inner E2 lipoyl domain
Two views of the NMR structure solved for non-lipoylated human E2-LD (PDB ID IFYC) are shown. 
The two P-sheets are depicted in green (strands 1, 3, 6, 8) and blue (strands 2, 4, 5, 7). The lysine 
residue that becomes lipoylated is drawn in stick representation. The surface loop involved in 
determining El-specific binding is coloured cyan, while the equivalent loop in the other “half’ of the 
domain is drawn in yellow.
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Despite the large structural similarities between different LDs, they are nevertheless very 
specific with regard to interactions with their cognate E l enzymes. Discrimination of different 
E l proteins is possible due to a variable surface loop connecting strands 1 and 2. Deletion of 
this loop in the E2-LD of B. stearothermophilus PDC results in non-recognition of the LD by 
E l and concomitantly abrogates reductive acétylation completely (Wallis et al., 1996).
In E. coli covalent modification of the apodomain with exogenous lipoate is catalysed by 
LplA lipoate protein ligase using a two-step reaction mechanism (Morris et al., 1994). When 
no free lipoic acid is available from the growth medium, protein lipoylation proceeds via a 
second, relatively poorly understood pathway using endogenously synthesised lipoate: Lipoyl 
groups are formed by sulfur insertion into octanoyl entities catalysed by Lip A (Miller et al., 
2000), while LipB -  a lipoyl (octanoyl) transferase -  is responsible for attachment of the 
lipoyl (octanoyl) group to the apoprotein (Morris et al., 1995; Jordan & Cronin, 1997; 2003). 
In contrast, protein lipoylation in mammals is catalysed by two separate enzymes acting in 
concert: The ATP-dependent lipoate-activating enzyme promotes formation of lipoyl-AMP, 
which is subsequently transferred onto the apoprotein by lipoyl-AMP :N^-lys lipoyitransferase 
(Fujiwara et al., 1994; 1996).
1.4.2.2 The subunit binding domain
With approximately 35-50 amino acids, the subunit binding domain (SBD) is one of the 
smallest known protein domains capable of independent folding without the stabilising effects 
of disulphide bridges, ligands or cofactors (Perham, 1991; Spector et al., 1998; 1999a). As its 
name suggests, the SBD is required for interaction with the E l and E3 enzymes: in B. 
stearothermophilus the E2-SBD is capable of binding both E l and E3, while in mammalian 
PDC E2-SBD only mediates interaction with E l whereas E3 binds to the related E3BP-SBD.
The structure of B. stearothermophilus SBD has been determined independently in solution 
(Fig. 1.6) (Kalia et al., 1993) as well as in association with either E l (Frank et al., 2005) or E3 
(Mande et al., 1996). Very recently, the crystal structure of human E3BP-SBD complexed 
with E3 has also been published (Ciszak et al., 2006). The B. stearothermophilus and human 
SBD structures superimpose quite well with a rms deviation of 1-1.4 Â (Ciszak et al., 2006). 
SBD consists of two short, parallel a-helices connected to a very short 3^^-helix by two loops.
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When superimposing the B. stearotherm ophilus solution and crystal structures (the human 
crystal structure was not available in the PDB data bank at the time o f  writing), differences in 
structure are mainly observed in loop L2 and may represent conformational changes upon E3 
binding or the innate flexibility o f the loop itself. The SBD structure is stabilised mainly by 
hydrophobic interactions between the two parallel helices HI and H2. A second hydrophobic 
core is formed by loops LI and L2, although a network o f hydrogen bonds around a highly 
conserved aspartate at position 34 also contributes to domain stability (Kalia et al., 1993; 
Mande et al., 1996). Indeed, if  Asp34 is replaced by asparagine the domain is still able to 
fold, but is much less stable (Spector et al. 1998), while replacement by a hydrophobic 
residue such as valine prevents protein folding entirely (Spector et al. 1999b).
Figure 1.6 Structure of the E2 subunit binding domain from B. stearothermophilus
The solution structure of E2-SBD from B. stearothermophilus was solved by NMR (PDB ID 2PDD) 
(Kalia et al., 1993). The two a-helices (HI & 2) are joined to a short 3‘®-helix by two loops (LI & 2).
1.4.2.3 The C-terminal domain
The C-terminal domain (CTD) o f E2 is capable o f self-aggregation and forms the central PDC 
core by association into trimers which are located at each vertex. Eight trimers are necessary 
for octahedral core formation in A. vinelandii (Mattevi et al., 1992a; 1993b), while 20 trimers 
associate into the icosahedral cores o f B. stearotherm ophilus (Izard et al., 1999; Milne et al., 
2002), yeast (Stoops et al., 1992; 1997) and bovine PDC (Behai et al., 1994; Zhou et al., 
2001b). The trimers are fairly loosely associated via bridges, 20 Â in length, along the two­
fold axes, creating highly dynamic structures. Cryo-electron microscopy (cryo-EM) studies 
have shown that size variabilities o f  up to 20% exist between individual molecules which
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equates to a difference in diameter of up to 40 Â and first introduced the concept of PDC core 
“breathing” (Zhou et al., 2001a; Kong et a l, 2003). These inherent, concerted movements are 
thought to be important for complex function.
Structures obtained for core particles from protein crystallography and cryo-EM represent the 
PDC core as a hollow and highly solvated particle (Fig. 1.3). The crystal structure solved for 
the octahedral core of A. vinelandii shows that the cube has an outer diameter of ca. 125 Â, 
while the inner diameter is approximately 46 Â and the “window” on each of the six faces 
measures 30 Â (Mattevi et a l, 1992a). For the crystal structure of the icosahedral core of B. 
stearothermophilus these measurements increase to 237 Â and 118 Â for the outer and inner 
diameters, respectively, while each of the 12 windows is 52 Â across (Izard et a l, 1999). 
These dimensions agree roughly with those determined for bovine (Zhou et a l, 2001b) and 
Saccharomyces cerevisiae E2 cores (Stoops et a l, 1992) using cryo-EM although both 
particles seem to be somewhat larger than suggested from the B. stearothermophilus atomic 
structure, representing the natural size variability of PDC core and/or crystal packing forces.
Interestingly, E2 amino acid sequences fi'om organisms that form either octahedral or 
icosahedral cores align reasonably well Even though the final particle shape is very different, 
only small changes in the subunit interfaces are thought to be sufficient for a change in 
symmetry. Izard and co-workers (1999) found that the formation of octahedral and 
icosahedral cores is the result of only a few differences in the mode of E2 interaction: two 
truly equivalent and several quasi-equivalent contacts were ascertained from a comparison of 
A. vinelandii and B. stearothermophilus cores. Differences in the E2 primary sequence could 
not be used to predict symmetry. These observations are further underlined by the fact that 
even though E2 core symmetry is roughly divided between Gram-negative bacteria, and 
Gram-positive bacteria and eukaryotes, respectively, exceptions do exist: for example, PDC 
from Zymomonas mobilis, a Gram-negative bacterium, is organised around an icosahedral 
core, as is that of another Gram-negative bacterium, Thiobacillus ferrooxidans (Neveling et 
a l, 1998a; 1998b).
The acetyltransferase active site is located in a 30 Â long channel at the E2-CTD subunit 
interface and runs across the trimer. A conserved sequence motif, DHRXXDG, is thought to 
accommodate the histidine and aspartate necessary for catalysis (Radford et a l, 1987).
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Interestingly, it is evident from the crystal structure that the two substrates for 
transacetylation, CoASH and the acetylated LD have to approach the E2 active site from 
opposite directions (Izard et al., 1999): CoASH binds to the inside of the E2 core, while 
acetyl-LD interacts with the outside (Mattevi et al., 1992a; 1993b; 1993c).
1.4.2.4 The linker regions
The lipoyl and subunit binding domains of E2 (and E3BP) are separated from the core and 
each other by a set of linker regions of 30-50 amino acids in length. The linkers are rich in 
alanine, proline and charged amino acid residues. Analogous domains often adopt an a-helical 
secondary structure, but NMR spectra confirmed that the linkers are solvent-exposed and 
disordered although they do not form random coils (Radford et al., 1989a): in particular,
1.4.3 E3 b in d in g  p rotein
E3BP is an integral component of the PDC core in eukaryotes. However, its position within 
the core with respect to E2 has not been completely resolved. E3BP (protein X) was initially 
identified as a contaminant of bovine PDC preparations and thought to be an E2 proteolytic 
product. Its separate role was only established when western blotting with anti-sera raised 
against individual components of the PDC failed to elicit a reaction (De Marcucci & Lindsay,
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Îalmost all Ala-Pro peptide bonds (> 95%) adopted the trans configuration as opposed to a 
value of ca. 80% expected for random coils. This feature results in a more rigid and extended 
structure (Texter et al., 1988; Radford et a l, 1989a; Green et a l, 1992).
The linker regions are essential for PDC function as it is due to their inherent flexibility that 
the LD can visit the three different active sites within the PDC complex (Perham et a l, 1981; 
Green et a l, 1992). Indeed, binding of specific antibody fragments to the linker regions in E. 
coli E2 abolished active site-coupling and critically diminished overall PDC activity while 
individual enzyme activities were unaffected (Radford et a l, 1989b). Analysis of deletion 
mutants has furthermore shown that the number of residues present in the outer linker can be 
halved before PDC activity is severely compromised (Miles et a l, 1988), indicating that 
overall linker length can be accommodated to some degree.
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1985; Jilka et al., 1986) and peptide-mapping and radiolabelling confirmed E3BP as a fourth 
PDC component (De Mai'cucci et al., 1986; Hodgson et al., 1986; Jilka et al., 1986; Neagle et 
al., 1989). Homology between E3BP and E2 was finally established when the Pdxl gene 
encoding 5. cerevisiae E3BP was cloned and analysed (Behai et al., 1989). The human gene 
was cloned subsequently (Hams et al., 1997) and confirmed the high similaiity between the 
two proteins: interestingly, the N-terminus encoding the lipoyl and subunit binding domains 
displays relatively high sequence identity with the equivalent E2 domains (46% and 38%) in 
both human and yeast PDC. Similarly, the human E3BP C-terminal domain is highly 
homologous when compared to E2 (50%), while the E3BP-CTD from yeast is quite different 
(Harris et al., 1997). The histidine within the E2 active site motif DHRXXDD associated with 
acetyltransferase activity is replaced by serine in human E3BP, while it is completely absent 
in the yeast protein (Harris et al., 1997) and E3BP is therefore unable to sustain enzyme 
activity.
To ascertain E3BP function was more difficult, in part because the protein is tightly 
associated with E2 and could not be separated unless very harsh, denaturing conditions were 
used. Protection of E3BP from proteolysis in the presence of E3 first suggested its 
involvement in binding (Rahmatullah et al., 1989a). Subsequently, selective proteolysis of 
E3BP within the bovine PDC using ArgC (Neagle & Lindsay, 1991) as well as disruption of 
the yeast Pdxl gene (Lawson et al., 1991a) demonstrated the important role of E3BP in 
mediating high-affinity binding of E3. These observations were later confirmed by in vitro 
binding studies (McCartney et al., 1997). Whether E3BP performs other tasks during the PDC 
catalytic cycle is still unclear: the E3BP-LD can be reductively acetylated by E l (De 
Marcucci et al., 1986; Jilka et al., 1986; Rahmatullah & Roche, 1987). Also, deletion or 
selective removal of E2-LD in yeast and bovine PDC resulted in a reduction of PDC activity 
to 10-15% of that of the wild-type complex (Rahmatullah et al., 1990; Lawson et al., 1991b), 
indicating that E3BP is able to interact with all PDC active sites. In a reverse experiment 
selective removal of E3BP-LD also caused a loss of PDC activity (Gopalakrishnan et al., 
1989; Powers-Greenwood et al., 1989), but this was later shown to be primarily due to 
reduced E3 binding (Sanderson et al., 1996a). More recent cell culture experiments did not 
reveal any change in complex activity using an E3BP mutant that cannot be lipoylated and is 
therefore unable to accept acety 1-groups from E l (Seyda & Robinson, 2000). Given the 
central metabolic role of PDC, it is reasonable to hypothesise that E2 and E3BP lipoyl
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domains may serve a somewhat redundant function, representing a fail-safe mechanism. 
Whether preferred routes of interaction exist in the native complex between the LD of E3BP 
and E3, and E2-LD and E l, respectively, may therefore be difficult to answer in the future.
The number of E3BP molecules present per core was established as 12 for bovine (Sanderson 
et al., 1996b) and yeast PDC (Maeng et al., 1994) and are thought to be associated with each 
of the icosahedral faces (Fig. 1.7A). Stoops and co-workers (1997) obtained cryo-EM 
reconstructions of the S. cerevisiae E2 C-terminal domain, as well as complexes formed 
between E2-CTD and E3BP-CTD, E2-CTD and E3BP, and E2-CTD and E3BP/E3, 
respectively. They located E3BP on the inside of the E2 core, apparently associated with the 
tips of E2 trimers, while E3 was also anchored on the inside of the core. However, the 
organisation of yeast and mammalian cores cannot be compared directly, as it has been shown 
previously that E3BP can be integrated into established yeast E2 cores (Maeng et al., 1994) 
while co-expression of the mammalian proteins is critical for correct E2/E3BP core formation 
(Li et al., 1992; Behai et ai., 1994; McCartney et al., 1997). Also, the CTD from yeast E3BP 
is considerably smaller (28 kDa) than its mammalian counterpart (35 kDa) and displays less 
sequence similarity to its cognate E2 than the human protein, which may account for 
differences in behaviour.
r
Figure 1.7 Models of PDC 
core formation
The addition (A) and substitution (B) 
models for E3BP core integration. In the 
addition model 12 E3BP molecules are 
thought to bind to the 12 faces of the 60- 
meric E2 core, while they are envisaged 
to replace 12 E2 molecules in the 
substitution model, the core being formed 
from 48 E2 and 12 E3BP molecules. 
Diagrams were adapted from Reed 
(2001) and Hiromasa et al. (2004).
More recently, Hiromasa and colleagues (2(X)4) proposed an alternative model for human 
PDC core organisation based on analytical ultracentrifugation (AUC) and small angle x-ray 
scattering (SAXS). They proposed that 12 E3BP molecules replace an equivalent number of
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A number of crystal structures have been published over the last few years including PDC El 
from E. coli (Arjunan et al., 2002) and humans (Ciszak et al., 2001; 2003), as well as 2- 
oxoisovalerate dehydrogenase from Pseudomonas putida (Ævarsson et al., 1999) and human 
BCDC E l (Ævarsson et al., 2000). Comparison of these and structures available for other 
ThDP-dependent enzymes such as transketolase (Fiedler et al., 2002) and benzylformate 
decarboxylase (Hasson et al., 1998) emphasise their similarities with respect to structure and 
function (Hawkins et al., 1989; Muller et al., 1993; Schellenberger, 1998).
E l a  and p subunits are airanged tetrahedrally and related by a non-crystallographic two-fold 
symmetry axis (Fig. 1.8). The active sites, each of which is associated with one ThDP 
molecule, are located at the interface of the a- and P-subunits at the bottom of a 20 Â funnel- 
shaped tunnel and accessible to the E2 lipoyl-lysine moiety which must be fully extended 
(Ævarsson et al., 1999). This structural feature also explains why free lipoamide is not a good 
substrate for E l (Liu et al., 2001) and why mutation of the amino acids suiTounding the
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E2 molecules (Fig. 1.7B), rather than add to the 60-meric E2 core. More experiments are 
required to firmly establish which, if either, model is correct.
I
1.4,4 P yruvate decarboxylase (E l)
El is a substrate-specific and ThDP-dependent decarboxylase that catalyses the first rate- 
limiting and irreversible step in the PDC catalytic cycle (Danson et al., 1978; Cate et al.
1980; Berg et a l, 1998). The reaction proceeds via a two-step mechanism of initial pyruvate 
decarboxylation and subsequent transfer of the ThDP-bound acetyl group (2-a- 
hydroxyethylidene-ThDP) onto E2-lipoamide in a reductive acétylation step (Kern et al, 
1997; Pan & Jordan, 1968). E l occurs as an az homodimer in all 2-oxoacid complexes with 
octahedral cores or as an azpz heterotetramer in organisms with icosahedral core symmetry -  
mammalian BCDC E l is an exception as it is also present as a heterotetramer. However, in 
both cases E l has two chemically equivalent active sites, each of which is associated with a 
ThDP cofactor and Mg ion necessary for catalysis.
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lipoyl-lysine cause a drop in the acétylation rate as these residues must be in transient contact 
with E l (W allis & Perham, 1994).
Two-fold axis
Figure 1.8 Structure of human pyruvate decarboxylase
Front (A) and side (B) views of the crystal structure solved for the human E l heterotetramer (PDB ID 
1NI4). The two a subunits are shown in light and dark blue, the P subunits are coloured red and green. 
The two-fold axis is indicated.
The formation o f E l tetramers proceeds via association o f two aP heterodimers. Interaction o f  
the a  and P subunits is promoted mainly by hydrophobic contacts. In particular, both the a  
and P subunit each contain a helix with a G<1)XXG m otif (where O is usually a p-branched 
chain amino acid). These helices are thought to tightly pack against each other in order to 
form a fairly rigid dimer interface, implicated in the concerted movement o f each ap 
heterodimer with respect to the other within the E l heterotetramer (Kleiger et al., 2001; 
Ciszak et al., 2003). However, it has also been speculated that three E l residues (Glu59, 
G ly l3 6 , V a il38) are able to detect the catalytic state o f the cofactors and to coordinate E l  
catalytic action via movement o f  the pair o f helices interconnected by the GOXXG m otif 
(Ciszak et al., 2003). Although both active sites are chem ically equivalent, their dynamic non­
equivalence has been established in a series o f  kinetic, spectral and biochemical experiments 
on pigeon E l and other ThDP-dependent enzym es (Khailova & Korochkina, 1985; 1990; Yi 
et al., 1996; Kovina & Kochetov, 1998; Sergienko et al., 20(X); 2002). Thus, one active site
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catalyses the decarboxylation step while the other one concurrently reductively acetylates E2- 
lipoamide. Similarly, access to ThDP is granted to either pyruvate or the lipoyl-lysine moiety 
at any given moment, resulting in a flip-flop enzymatic mechanism. It was proposed that the 
two ap heterodimers undergo a concerted shuttle-like motion causing a “push-and-pull” 
conformational change in both active sites (Ciszak et al., 2003). More recently however, 
Frank and colleagues (2004) highlighted the presence of a 20 Â tunnel lined with acidic 
residues connecting the two active sites. Binding of ThDP to apo-El is thought to abstract a 
single proton which subsequently serves as a means of communication between the two active 
sites by repeated shuttling through the tunnel, whereby the formation of activated ThDP 
provides the “molecular switch”. Convincing evidence for this type of active site 
communication is provided by mutants that had two tunnel residues far from the active site, 
Asp 180 and Glul83 replaced with alanines or asparagine and glutamine, respectively. The 
rate of E l decarboxylation was greatly reduced in both mutants (to 31% and 7%). Similarly, 
PDC function was severely affected when either mutant was used for the reconstitution of 
PDC from individual components. Overall activities were reduced to 12% and 3% for the 
D180R and E183Q E l mutants, respectively, indicating that reductive acétylation of E2 was 
seriously impaired (Frank et al., 2004).
1965; 1992; Wilkinson & Williams, 1981).
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1.4.5 D ihydrolipoam ide dehydrogenase (E3)
E3 is a flavoprotein and part of the family of pyridine nucleotide-disulphide oxidoreductases 
which catalyse electron transfer between pyridine nucleotides and disulphides. The E3 
component is identical in all 2-oxoacid dehydrogenase complexes with the exception of 
Pseudomonas putida where multiple genes encode three separate enzymes (Reed, 1974; 
Carothers et al., 1989; Bums et al., 1989). In PDC it catalyses the reoxidation of the E2 
dihydrolipoamide using a two step mechanism: first, two electrons are transferred from the 
reduced lipoamide group via a redox-active disulphide bridge onto FAD, forming a stable 
EHz intermediate. The electrons ai*e shared between the FAD and the reactive disulphide, 
resulting in a charge transfer complex formed between the thiolate anion and FAD cofactor 
which subsequently donates its electrons to NAD'*' during the second step (Williams,
II
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The three-dimensional structures o f  E3 from several different sources have been solved by x- 
ray crystallography (Fig. 1.9), including E3 from A. vinelandii (Schierbeek et al., 1989; 
Mattevi et al., 1991), Pseudom onas putida  (Mattevi et al., 1992b), P. fluorescens  (Mattevi et 
al., 1993a), B. stearotherm ophilus (Mande et al., 1996), S. cerevisiae  (Toyoda et al., 1998b) 
and most recently from humans (Brautigam et al., 2005). E3 tertiary structure is preserved in 
eukaryotic and prokaryotic E3 enzym es which align well despite a rather low overall amino 
acid sequence identity o f approximately 40%. Major discrepancies are apparent mainly in the 
loop regions. Similar to other members o f  the same family, such as glutathione reductase 
(Schulz et al., 1978; Thieme et al., 1981; Karplus & Schulz, 1987), thioredoxin reductase 
(Kuriyan, 1991) or trypanothione reductase (Kuriyan et al., 1991), E3 consists o f four 
different domains: the FAD domain (aa 1-150), the N AD domain (aa 151-208), the central 
domain (aa 281-350) and the interface domain (aa 351-474). E3 is an obligate homodimer that 
requires the presence o f  one non-covalently bound FAD per monomer for correct folding and 
dimérisation (Lindsay et al., 2000). Dimérisation occurs largely via contacts between the 
interface domains. The two monomers are related by a non-crystallographic two-fold axis. 
The FAD and N AD domains both display the characteristic paP Rossmann fold associated 
with proteins involved in nucleotide binding, while the central domain is responsible for 
binding to E2 or E3BP.
Tm>-fold axis
Figure 1.9 Crystal structure of human E3
Front (A) and top (B) views of human E3 crystallised in the presence of NAD'*' (white) (PDB ID 
IZMC). Both monomers are coloured identically (N-terminus to C-terminus) and the quasi- 
symmetric two-fold axis is indicated. FAD is shown in red.
The two active sites are located separately at the subunit interface near the FAD cofactors. A  
redox-active pair o f cysteines, Cys45 and C ys50 (residue numbering refers to the human
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protein) that forms the catalytically vital disulphide bridge, as well as the amino acid 
sequences requisite for FAD and NAD'*' binding are contributed from one subunit, while 
His452' and Glu457' are part of the other monomer. His452" is thought to act as a proton 
acceptor/donor during catalysis. Indeed, when the histidine is mutated to glutamine, E3 
activity is almost completely abolished to levels of 0.2% of the wild-type enzyme. Similarly, 
replacement of Glu457 which forms a strong hydrogen bond with His452, by glutamine 
causes a reduction in activity of 72% (Kim & Patel, 1992; Liu et al., 1995b). Mutation of 
these two residues in E3 from other organisms and even in glutathione reductase have the 
same effect and explain their high degree of conservation (Deonarain et al., 1989; Berry et a l,
1989; Williams et a l, 1989). i
During catalysis the lipoamide group has to enter either active site from a pocket on the Cys 
side of the flavin plane, approximately 15 A from the E3 surface and therefore deep enough to 
accommodate the lipoyl-lysine swinging arm. The nicotinamide moiety of NAD'*' associates
. '1with a pocket on the other, re side of FAD (Mattevi et a l, 1991; 1992b; 1993a; Toyoda et a l, 1998b).
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1.5 Association of El and E3 with the PDC core
In eukaryotes the E2/E3BP core of PDC provides the structural and mechanistic framework 
for the tight but non-covalent association of E l and E3. The stability and overall subunit
:organisation of the complex is governed by specific and tight protein-protein interactions 
between E2-SBD and E l, and E3BP-SBD and E3, respectively (Fig. 1.10). However, in
Gram-positive bacteria such as B. stearothermophilus E l and E3 both associate with E2 (Fig. 
1.11), as E3BP is a purely eukaryotic feature. Consequently, E l and E3 have to compete for 
overlapping binding sites on E2; interaction of E2 with either E l or E3 prevents complex 
formation with the other. Interestingly, PDC-deficient patients who totally lack the E3BP 
subunit possess partial complex activity (10-20% of controls) (Ling et a l, 1998), apparently 
because the SBD of E2 has retained a limited ability to mediate low affinity E3 binding, in 
accordance with binding data obtained for human recombinant proteins in vitro using surface 
plasmon resonance (SPR) (Richards, 1999).
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1.5 Association of E l and E3 with the PDC core
Figure 1.10 Schematic representation of protein associations in eukaryotic PDC
El (blue) binds to E2 (green), while E3BP (X; magenta) associates with E3 (cyan). PDC kinase (PDK) 
and phosphatase (PRF/PDF) interact with the inner E2-LD. The core is based on a cryo-EM 
reconstruction (Reed, 2001).
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Figure 1.11 Subcomplex formation of E l and E3 with E2-SBD in B. stearothermophilus
(A) Complex of B. stearothermophilus E l (a, yellow/pink; p, green/purple) with E2-SBD (blue) (PDB 
ID 1W85). (B) Complex of B. stearothermophilus E3 (green/red) with E2-SBD (blue) (PDB ID 
lEBD).
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1.6 Substrate channelling and active site 
coupling
The ability of PDC to sustain substrate channelling and active site coupling is the basis for its 
efficient and tightly controlled function. Central to PDC substrate channelling is the presence 
of the lipoyl swinging arm within the E2 and E3BP lipoyl domains. Lipoamide incorporated 
into a LD is required for efficient interaiediate transfer in PDC. Free lipoate can sustain E2 
and E3 activity, but neither lipoate on its own nor lipoylated oligopeptides aie reductively 
acetylated by E l in an efficient manner (Graham et al., 1989; Berg et al., 1998; Liu et al., 
2001). Free LDs can support the reaction, albeit at a much reduced rate (ca. 60-fold) when 
compared to the tethered domain (Berg et al., 1998), indicating the strategic importance of 
limiting LD diffusion for substrate channelling.
The swinging arm originally referred to the lipoamide alone. Its conformational freedom has 
been established by spin-labelling studies (Ambrose & Perham, 1976; Grande et al, 1976) 
and was also observed by NMR (Roberts et a l, 1983; Dardel et a l, 1991; Berg et a l, 1994). 
However, it is the presence of the swinging aim incorporated into a “swinging lipoyl domain” 
that is required for substrate channelling since the lipoyl-lysine could only reach sites up to 28 
Â apart (Angelides & Hammes, 1979; De Kok et al, 1998). Fluorescence energy transfer 
studies revealed that the thiee different active sites have to be at least 40 Â apart since no 
energy transfer could be detected for A. vinelandii PDC (Shepherd & Hammes, 1977; Scouten
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In B, stearothermophilus PDC, E l and E3 both bind to the SBD of E2 with 1:1 
stoichiometries (Hipps et a l, 1994; Lessai'd et a l, 1998, Jung et a l, 2002a; 2002b). The 
crystal structures determined for the E3/E2-SBD as well as the E1/E2-SBD subcomplexes 
from B. stearothermophilus (Fig. 1.11) show unequivocally that association of a second 
molecule of E2-SBD to either E l or E3 is not possible. In the case of E l the binding site for 
E2-SBD is located across the two-fold axis (Frank et a l, 2005) whereas the binding site on E3 
is close to the two-fold axis of symmetry (Mande et a l, 1996). Occupation of both binding 
sites on E3 would result in steric clashes in one of the loop regions. A schematic 
representation of E l and E3 binding to the icosahedral core is shown in Fig. 1.10.
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et al., 1980). Cryo-EM reconstructions o f B. stearotherm ophilus and bovine PDC indicate 
even larger distances. Milne et al. (2002; 2005) have shown the existence o f  an annular gap o f  
ca. 90 Â between the E2 core and deposited E l, while that distance is somewhat smaller (~  75 
Â) between E2 and E3 (Fig. 1.12). The distances reported for bovine PDC are shorter with a 
space approximately 50 Â in length between the core and both E l and E3, respectively (Zhou 
et al., 2001b). The difference in spacing observed in Bacillus and bovine PDC remains 
unexplained: PDC organisation could be different in both organisms, but the different 
distribution o f E l and E3 within the outer shell may represent artefacts resulting from sample 
treatment. However, in both cases the distances between the active sites are too large to be 
accessible if  only the lipoyl-lysine group experienced flexibility (Zhou et al., 2001b). Taking 
the lipoyl domain and its linker into account, bridging the distances between active sites 
becom es straightforward, as gaps as large as 200 Â or more could be traversed (Perham et al., 
1981; 2000).
Figure 1.12 Active site coupling in B, 
stearothermophilus PDC
Three El (purple) and E3 (yellow) molecules 
of the outer shell are shown above the E2 core 
(grey). Individual E2 molecules are coloured 
red, green and yellow. Their SBDs are bound 
to El and E3 -  the trimeric distribution of El 
and E3 molecules is for simplified observation 
only and both enzymes are expected to be 
distributed randomly in native PDC. Possible 
conformations for the LD are depicted as they 
are expected to shuttle between the different 
active sites (white) and are long enough to 
interact with more than one trimer of the outer 
shell.
Adapted from Milne et al. (2005).
A side effect o f this arrangement is that a single lipoyl domain can service more than just one 
E l and/or E3 enzyme. Simultaneously, the formation o f a network o f  interacting LDs on the 
com plex surface also becomes possible (Grande et al., 1976; Berman et al., 1981; Hackert et.
20
1.7 Regulation of PDC activity
al., 1983; Sanderson et al., 1996b). Migration of acetyl groups between the S*^ and S® atoms of 
lipoamide has been documented (Frey et al., 1989) and experiments using labelled pyruvate 
have confirmed that acetyl groups and reducing equivalents can be shuttled between different 
LDs (Bates et al., 1977; Collins & Reed, 1977; Danson et al., 1978; Cate et al., 1980). The 
amount of lipoyl domain present per complex can be reduced by up to 50% using trypsin 
without significant adverse effects on PDC activity (Stepp et al., 1981). Mutagenesis of 
selected LDs in E. coli E2 in order to render them unlipoylatable similarly does not affect 
catalysis significantly (Allen et al., 1989), showing that different lipoyl domains can function 
independently of each other.
1.7 Regulation of PDC activity
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Given its central metabolic role, PDC regulation is of critical importance in balancing 
metabolism towards glucose or fatty acids and ketone bodies (Randle, 1986). Flux through 
PDC is dramatically reduced during starvation or diabetes in order to preserve carbohydrate 
reserves, while it is up-regulated after meals to fuel energy production and fatty acid 
biosynthesis. PDC regulation is achieved by intrinsic (e.g. metabolites) and extrinsic factors 
such as nutritional state and hormones.
I
The main short-term control mechanism of PDC activity is through de-Zphosphoiylation by a 
complex specific PDC phosphatase (PDP, EC 3.1,3.43) and kinase (PDK; EC 2.7.1.99). Both 
enzymes act on the rate-limiting E l component of PDC (Harris et al., 2002) by catalysing the 
ATP-dependent phosphorylation of El a at any one of three different serine residues (Ser264,
Ser271, Ser203 for human PDK), thus causing inactivation of the enzyme (Kolobova et al.,
2001; Bao et al., 2004a). Dephosphorylation by PDP results in PDC reactivation (Linn et al.,
1969; Wieland, 1983).
Interestingly, PDK is not significantly homologous to other eukaryotic serine protein kinases, 
but instead is similar to prokaryotic histidine protein kinases even though their catalytic 
mechanisms are different (Steussy et a l, 2001; Harris et a l, 2002). In mammals four 
isozymes of PDK (1-4) have been identified which can form both homo- and heterodimers
■
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(Boulatnikov & Popov, 2003). They are expressed in a tissue-specific manner and have 
different specific activities (Popov et ai., 1994; Gudi et al., 1995; Rowles et al., 1996; 
Bowker-Kinley et al., 1998); PDKl and 4 are mainly expressed in the liver and muscle 
tissues, while PDK3 is prevalent in the kidney, brain and testes and PDK2 is present in most 
tissues (Gudi et al., 1995; Bowker-Kinley et al., 1998). PDKl can phosphorylate all three Ser 
residues, while the other three isoforms can only act on sites 1 and 2 and do so with different 
affinities. Phosphorylation at a single site is sufficient for complete inactivation and is 
independent of the status of the two remaining sites (Yeaman et a l, 1978; Korotchkina &
Patel, 1995; 2001; Patel & Korotchkina, 2001; Kolobova, 2001).
PDK is tightly bound to the PDC; PDK 1-3 associate with the E2 inner lipoyl domain (ILD) 
while PDK4 preferentially interacts with the E3BP-LD (Roche et a l, 2003). The interaction
with the LD causes a conformational change in PDK and causes an increase in its activity; in 
the case of PDK3, the conformation of the ATP lid is affected, thus decreasing its affinity for 
ADP and stimulating kinase activity (Roche et a l, 2003; Bao et a l, 2004b; Kato et a l, 2005). 
Furthermore, reduced/acetylated LDs as well as NADH are thought to stimulate kinase
activity (Fig. 1.13) (Patel & Korotchkina, 2001; Roche et a l, 2003; Bao et a l, 2004b). Only a 
few molecules of kinase are known to be present per core (Yeaman, 1989) and they have been 
shown capable of quickly inactivating multiple E l enzymes present on the core surface (Yang 
et a l, 1998). Experiments using E2-LD fused to glutathione ^-transferase (GST) have shown 
high-affinity binding of PDK to the dimeric constructs, suggesting the formation of transient 
cross-links between adjacent pairs of E2 and resulting in a “hand-over-hand” mechanism of 
migration on the PDC surface (Liu et a l, 1995a).
Dephosphorylation and restoration of PDC activity is regulated by two PDP heterodimeric 
isozymes (1 & 2), consisting of a catalytic and regulatory subunit. Analogously to PDK, 
isozyme expression is tissue-specific: PDPl is associated with muscle tissue while PDP2 is 
predominantly associated with the liver and adipose tissue (Huang et a l, 1998). 
Dephosphorylation of E l by PDP is dependent on Mg^ "*" and further stimulated by Ca^  ^(Linn 
et a l, 1969; Denton et a l, 1972; Damuni & Reed, 1987; Reed et a l, 1996). In contrast to 
PDK, PDP is only loosely associated with PDC, although its catalytic efficiency is increased 
7 -16-fold by interaction with E2-LD. E2 binding is Ca^ '*' dependent and the presence of
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lipoamide has been shown to enhance enzyme activity (Pettit et ah, 1972; Chen et a l, 1996). 
PDP activity is also stimulated by spermine and other polyamines, probably by reversing the 
effects of its regulatory subunit (Damuni et a l, 1984).
Feedback inhibition is also used for short-teim regulation of PDC activity: E l uses pyruvate 
as a positive and acetyl-CoA as a negative effector. Simultaneously, acetyl-CoA also inhibits 
E2 activity, while high NADH levels reduce E3 activity (Wieland, 1983). A diagram 
summarising short-term regulation of PDC is shown in Fig. 1.13.
pyruvate 
CoA - 
NAD"
acetyl-CoA
NADH
PDHC ‘••TOP.
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ATP
PDH 
kinases 
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‘AÙP
e e epolyamines
PDHC
inactive
Figure 1.13 Short-term regulation of PDC activity
Activators and inhibitors of pyruvate dehydrogenase complex (PDHC) and its regulatory enzymes are 
shown.
Adapted from Strumilo (2005).
Long-term regulation of PDC in response to hormonal or dietary changes is accomplished at 
transcriptional level by controlling gene expression of PDC constituent and regulatory 
enzymes (Patel et a l, 1995; 2003). PDC activity in rats that were fed a high-sucrose diet, for 
instance, increased up to 4-fold with concomitant changes in the amount of PDC present. 
Similarly, hypoactive thyroid glands in rats resulted in the loss of ca. 30% of total PDC
23
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activity and a similar reduction of E l protein present (other PDC proteins were not 
quantified) (Da Silva et al., 1993; Patel et al., 1996). However, a major determinant for PDC 
activity under different physiological conditions is the amount of PDK. In response to 
starvation, for example, expression of PDK2 and PDK4 is up-regulated in many tissues. 
Diabetes also increases PDK4 expression in rats, but the effect can be reversed by treatment 
with insulin (Harris et al., 2001).
1.8 PDC and disease
1.8.1 G enetic d isorders
Aerobic glucose oxidation is of critical importance in nervous tissues like the brain, which are 
dependent on this pathway for energy generation. Hence, defects in PDC cause 
developmental problems and/or degenerative changes that are associated with a wide variety 
of abnormalities, ranging from mild ataxia, lethargy and feeding difficulties to developmental 
delay, blindness, severe neurological disorders and even death (Robinson et al., 1987; Brown 
et al., 1989a; Di Mauro & De Vivo, 1996; De Vivo, 1998). Besides reduced energy 
generation due to a decrease in the production of acetyl-CoA, the accumulation of lactate as a 
result of anaerobic glucose oxidation causes lactic acidosis. Most patients display either 
severe and often fatal lactic acidosis or chronic neurodegenerative disease with extensive 
neuropathology (Brown et al., 1994; Robinson, 1995). However, cases with PDC deficiency 
who present only mild symptoms and therefore survive into child- and adulthood keep being 
identified, thus continuously expanding the spectrum of clinical disease associated with PDC 
deficiency (Seyda et ai., 2000; Brown et al., 2002; Head et al., 2005). Current treatment 
strategies usually include the activation of residual PDC activity by dichloroacetate, an 
inhibitor of PDK (Morten et al,, 1999), the administration of cofactors like lipoic acid or 
ThDP (Byrd et al., 1989; Naito et al., 2002), and the prescription of a ketogenic diet (Wijburg 
et al., 1992; Wexler et al., 1997). However, all of the above treatments are applied with 
varying success.
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Over 90% of cases of PDC deficiency are caused by mutations in the PDHAl gene encoding 
the E la  subunit of PDC: more than 75 different mutations have been identified so far, roughly 
equally divided between missense/nonsense and insertion/deletion mutations (Fouque et al., 
1998; Lissens et al., 2000). The severity of clinical abnormalities due to E la  mutations varies 
and depends on the precise nature of the mutation itself. PDHAl is located on the short arm of 
the X chromosome (Brown et al., 1989b; Szabo et al., 1990; Dahl et al., 1992). Therefore, in 
women expression of E la  is mosaic, dictated by the pattern of X chiomosome inactivation 
which causes differences in the clinical symptoms observed. Men are usually more severely 
affected as only one X chromosome is present per cell. Therefore, all E la  will be mutated and 
residual PDC activity depends on the severity of gene defect (Lissens et al., 2000). A second 
gene coding for E la, PDHAl has been identified, but is expressed exclusively in the testes 
(Dahl et al., 1990). No mutation in PDHAl has been observed as yet (Dahl, 1995).
Missense mutations affecting the PDHB gene encoding E ip  have been identified in two 
patients only so far. In both cases a single amino acid substitution is thought to destabilise the 
E l heterotetramer and thus results in rapid protein turnover (Brown et al., 2004). Similarly, 
mutations in E2 are extremely rare and have also been reported only twice: a deletion within 
the E2 encoding DLAT gene removes a glutamic acid residue from the outer LD, while a 
missense mutation results in the replacement of a highly conserved phenylalanine by leucine 
in the E2 active site (Head et al., 2005). While the outer LD was shown to be dispensable for 
E. coli PDC activity in vitro (Guest et al., 1985) this may not be representative of the situation 
in human PDC and/or in vivo as isogenic E. coli strains with three lipoyl domains were able to 
outgrow those with just one (Guest et al., 1997).
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Nonsense mutations that result in premature termination of translation and deletions in the 
PDXI gene encoding E3BP have been identified in 12 patients (Marsac et al., 1993; Geoffrey 
et al., 1996; Aial et al., 1997; DeMeirleir et al., 1998; Ling et al,, 1998; Brown et al., 2002;
Dey et al., 2002; 2003; Ramadan et al., 2004). Patients therefore completely lack functional 
E3BP, but still display 10-20% of normal PDC activity, thus indicating that E2 retains a 
residual capacity to bind E3 (Marsac et al., 1993). These findings have also been confirmed in 
vitro where a 100-fold excess of E3 was able to restore PDC activity to ca. 25% of wild-type 
levels (McCartney et al., 1997). The symptoms presented by patients with mutations in genes
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encoding different PDC components cannot necessarily be distinguished readily. However, at 
least some cases of E3BP deficiency are associated with a milder form of the disease (Head et 
al., 2005).
More than 20 cases of E3 deficiency have been identified, with a disproportionate number 
affecting Ashkenazi Jews who are all affected by a single substitution of Glyl94 by cysteine 
in the NAD domain (Hong et al., 2003). Another 11 different mutations, most of them 
resulting in amino acid substitutions in the FAD, central and interface domains have been 
found, presumably affecting FAD binding, catalysis, core association and E3 dimérisation 
(Odievre et al., 2005). However, not only does E3 deficiency affect PDC activity, but OGDC 
and BCDC function is also impaired, resulting in elevated substrate levels in plasma and urine 
(Hong et al., 1997; Shany et al., 1999).
1.8.2 M etabolism  and A lzheim er’s d isease
Reduced activity of PDC and other metabolic enzymes such as OGDC and isocitrate 
dehydrogenase have been associated with the development and progression of Alzheimer’s 
disease (AD) (Sheu et al., 1994; Hoyer, 2004; Bubber et al., 2005). Reduction in brain 
metabolism always seems to accompany clinical AD, although it can precede overt clinical 
symptoms by years (Small et al., 1995; Reiman et al., 1996). Severe, prolonged impairment of 
brain glucose oxidation can cause substantial brain damage, including permanent dementia 
(Plum & Posner, 1980). In particular, decreases in OGDC activity seem to be highly 
correlated to the clinical dementia rating (Gibson et al., 2000), while treatment with glucose 
and insulin improves the memory function of AD patients at least temporarily (Craft et al., 
2000). However, the moleculai- mechanisms that link metabolic enzymes such as PDC and 
OGDC to AD are not clear*. Possibilities include inactivation by oxidative stress (Blass & 
Gibson, 1999; Sims et al., 2000), which in turn increases the generation of reactive oxygen 
species and reduces the brain’s ability to cope with added oxidants (Slii et al., 2005). Defects 
in PDC may also impair the production of acetylcholine due to a shortage in acetyl-CoA, 
while lower OGDC activity can promote the accumulation of glutamate, which acts as a 
neurotoxin at elevated levels (Blass & Gibson, 1991; Shoffner, 1997; Klivenyi et al., 2004).
26
I
:
.
1.8 PDC & disease
1.8.3 Prim ary b iliary  cirrhosis
Primary biliary cirrhosis (PBC) is a chronic autoimmune liver disease resulting in the 
inflammatory destruction of the biliary epithelial cells lining the intrahepatic bile ducts and 
leads to cirrhosis and liver failure. It is also the most prevalent autoimmune disease occurring 
in middle-aged women (Iwayama et al., 1992; Mackay et al., 2000). PBC is characterised by a 
high titre of anti-mitochondrial autoantibodies in affected individuals. They are primarily 
directed against the E2 component of PDC (> 95%) and can inhibit enzyme function (Yeaman 
et al., 1988; Van de Water et al., 1988a). Immunogenicity is mainly caused by the inner E2- 
LD (Van de Water et al., 1989b; Surh et al., 1990; Fussey et al., 1990), including the lipoate 
binding site. The presence of covalently bound lipoate also seems to be important for 
antibody recognition. However, cross-reactivities of sera from PBC patients have been 
detected for E2 from OGDC and BCDC (Fussey et al., 1988; Fussey et al., 1991), as well as 
PDC E3BP (Yeaman et al., 1988; Surh et al., 1989) and both PDC El subunits (Fussey et al., 
1989). E2 and E3BP antigens were subsequently found to be aberrantly expressed at the 
plasma membrane of biliary epithelial cells from PBC patients (Joplin et al., 1997; Joplin & 
Gershwin, 1997). The mechanism for this molecular process is unclear. However, as for most 
autoimmune diseases the exact aetiology of PBC and break-down of tolerance is unclear.
1.8.4 PDC and d iabetes
Type II diabetes is associated with problems in the balance between glucose and lipid 
metabolism. High fasting blood glucose levels, in excess of 10 mM, mainly result from 
excessive glucose production in the liver via gluconeogenesis (Randle et al., 1994; Boden et 
al., 2001). Increasing the rate of pyruvate oxidation in the peripheral tissues provides an 
attractive mechanism in order to remove the surplus of gluconeogenic substrates. Treatment 
of type II diabetics with dichloroacetate (DCA), an inhibitor of PDK, results in a fall of 
glucose concentrations (Stacpoole et al., 1978), but is unsuitable as a therapeutic agent due to 
its low potency, metabolism and toxicity (Stacpoole et al., 1998). However, it highlights PDK 
as an attractive drug target. Both PDK2 and PDK4 are suitable targets: PDK2 is expressed in 
all tissues and would be able to increase glucose uptake and decrease gluconeogenesis in both 
liver and peripheral tissues. PDK4 would provide the same service, but in the peripheral
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tissues only, although it would also prevent liponeogenesis in the liver as a result of increased 
acetyl-CoA production which could prove detrimental (Mayers et al., 2005). A series of 
inhibitors is currently being developed against PDK2 that seem to exhibit reasonable 
specificity, although PDKl is also inhibited, albeit at a much lower level, while PDK4 
activity is increased (Mayers et al., 2005). Furthermore, PDC activity was increased and 
glucose levels lowered in obese Zucker rats which are often used as a model system for type 
II diabetes (Morrell et al., 2003; Mayers et al., 2003), thus improving the prospects for a 
possible therapy for type II diabetes.
1.8.5 C hem ical m odification  o f PDC
Some research has also focused on the modification of 2-oxoacid dehydrogenase complexes 
by toxins and chemical additives found in food. 2-octynoic acid is one example of a 
widespread additive commonly found in perfumes, lipstick and food flavourings. Lipoylated 
E2-derived peptides that were tieated with 2-octynoic acid cross-reacted with sera obtained 
from PBC patients (Amano et al., 2005; Long et al., 2005). Experiments on guinea pigs 
suggest that lipoyl-E2 -  once it is xenobiotically modified -  can elicit an even stronger 
autoimmune response than the native protein and which is able to recognise both the modified 
and native forms of lipoyl-E2 (Amano et al., 2005).
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Another interesting example of chemical modification are arsenical compounds: they 
irreversibly modify the lipoate cofactor present in the E2 components of 2-oxoacid 
dehydrogenase complexes as well as transketolase, although susceptibility varies from 
organism to organism (Voet & Voet, 1995). For this reason and in the absence of better 
alternatives, arsenical compounds are still widely used for the treatment of trypanosomiasis 
and leishmaniasis: both diseases are caused by parasites who are slightly more sensitive to 
arsenical compounds than humans. Nevertheless, 50% of patients die because of treatment 
rather than the disease itself (Rosen, 1995; Dumas, 2000).
1.9 Project aims
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Another ongoing question in the PDC field is the location of E3BP within the eukaryotic, 
icosahedral core. Two main models have been published: a 60:12 (E2:E3BP) addition model 
based on cryo-EM and a 48:12 (E2:E3BP) substitution model proposed horn results obtained 
from AUC and SAXS. Chapter 7 describes initial SAXS and small angle neutron scattering 
(SANS) experiments in an attempt to develop an experimental strategy able to differentiate 
between these models.
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A lot of research has focused on the elucidation of individual enzyme structures and their 
modes of interaction in prokaryotic PDCs, in particular PDC from B. stearothermophilus and 
A. vinelandii. Structural information on enzymes from eukaryotic PDC has also been more 
forthcoming since the start of this project, as evidenced by the publication of atomic 
structures obtained for human E l (Ciszak et ah, 2001; 2003), E3 (Brautigam et al., 2005) and 
inner E2-LD (Howard et a l, 1998), as well as yeast E3 (Toyoda et a l, 1998b). Very recently, 
the crystal structure of human E3 complexed with the E3BP subunit binding domain (Ciszak 
et a l, 2006) has been solved. However, information about interactions of human E l and E3 
with their respective SBDs in solution has not been available until now. Preliminary 
microcalorimetry experiments in the laboratory of Prof. G. Lindsay, University of Glasgow 
indicated the formation of unexpected 2:1 stoichiometric complexes -  so-called “cross­
bridges” -  formed between a didomain construct of E3BP (XDD) and E3 (Brown, 2002), 
implying the existence of a new level of ultrastructure in human PDC that could revise our 
current understanding of eukaryotic PDC organisation and function.
The aim of this project was to investigate the formation of E3BP/E3 cross-bridges in vitro 
(Chapter 5) by a number of different biochemical and biophysical techniques, including
native polyacrylamide gel electrophoresis (PAGE), analytical ultracentrifugation (AUC) and 
isothermal titration calorimetry (ITC). Low-resolution stiuctures of the complex formed 
between XDD and E3 as well as free E3 were also obtained using small angle x-ray scattering 
(SAXS) in combination with molecular modelling approaches. Similarly, the possibility of 
similar cross-bridges formation between E2 and E l was also investigated (Chapter 6), 
although problems with protein stability and monodispersity meant that these data are, to 
some extent, preliminary.
1.9 Project aims
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Most biophysical studies (Chapter 2) require rather large amounts of pure, monodisperse 
protein. Large-scale protein purification is described in Chapter 4.
' I
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2.1 Introduction
This chapter summarises the biophysical techniques used to analyse PDC and its constituent 
proteins throughout this project: analytical ultracentrifugation (AUC), isothermal titration 
calorimetry (ITC) and small angle x-ray and neutron scattering (SAXS/SANS).
2.2 Analytical ultracentrifugation
During ultracentrifugation, solutes -  in this case proteins -  are spun at high speeds (typically 
3000-60000 rpm) resulting in movement of the particles through the solvent in the direction 
of the centrifugal force and sedimenting as a function of time. The sedimentation process is
dependent on mass, shape and charge of a particle and causes depletion of the solute from the 
meniscus and the formation of distinct solute/solvent boundaries. In analytical '
ultracentrifugation (AUC) the movement of the boundaries can be observed by monitoring the 
solute concentration using absorbance (Schachman et al., 1962; Hanlon et al., 1962; Giebeler,
1992), interference (Schachman, 1959; Yphantis et ah, 1994; Laue, 1994), schlieren
Ï
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(Svedberg & Pedersen, 1940) or fluorescence (Schmidt & Riesner, 1992; Laue et ah, 1997) 
optics (Fig. 2.1). Only absorbance and interference optics were used for work described in 
this thesis.
The fact that experiments are conducted in solution without the need for labelling or chemical 
modification, or interaction with a surface or supporting matrix represents a major advantage 
of the technique. In addition, the different optical systems used for data acquisition as well as 
different sample cell path lengths allow for experiments covering a laige range of sample 
concentrations. Furthermore, by adjusting the rotor speed, AUC can be used to analyse 
macromolecules over a very large moleculai' weight range (Lebowitz et ah, 2002).
AUC was used to determine the homogeneity, apparent molecular weight and stoichiometry 
of PDC and its constituent proteins. Apart from the stoichiometries of interactions, the 
thermodynamic binding constant(s) can be determined as well, provided that association 
reactions can be observed on the time-scale of the experiment. In addition, recent advances in 
the analysis of AUC data enable refined characterisation of heterogeneous systems.
2 .2.1 Sed im entation  velocity
In sedimentation velocity (SV) experiments the solute and solvent are placed in the separate 
channels of a two-channel centrepiece and subjected to centrifugation at high rotor speeds 
(40-60 krpm) where the exact rotor speed is dependent on the size of the macromolecule. 
During the experiment, proteins are separated as a result of their different rates of migration 
through the centrifugal field. The sedimentation process is monitored over time by a set of 
absorbance/interference profiles (Fig. 2.1). At the start of the experiment the solute is ■■I
distributed homogeneously throughout the radial range recorded. At later times sedimentation
profiles show movement of the solute boundary towards the bottom of the cell. The 
sedimentation coefficient of a macromolecule is obtained from its sedimentation profile and 
defined by the Svedberg equation (Svedberg & Pedersen, 1940; Lebowitz et al., 2002)
u _  M  (I ~~ v p )  _  MD(1  -  v p )  
 ^ co^r N J  RT
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Figure 2.1 Analytical ultracentrifugation
(A) Schematic diagram of the absorbance optical system in an XL-A analytical ultracentrifuge. (B) 
Typical sedimentation velocity profiles a{r,t) as a function of radial position r at different times, t. (C) 
Characteristic sedimentation equilibrium profile a(r) as a function of radial position r.
(A) was adapted from (Ralston, 1993).
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where u is the observed radial velocity of the boundary midpoint, co is the angulai' velocity, r 
is the radial position, M is the molar mass, v  is the partial specific volume, p  is the buffer 
density, Na is Avogadro’s num ber,/is the frictional coefficient, R is the gas constant and T is 
the temperature. The right-hand side of eq. 2.1 was derived from the relationship of the 
diffusion and frictional coefficients D -  RTf N^ f .  Sedimentation coefficients are reported in 
Svedberg units (S), equivalent to 10 s.
Assuming spherical symmetry the Stokes equation can be used to calculate the anhydrous 
frictional coefficient/ o .
/o = , (2.2)
where is the viscosity of the solvent and Rq is the radius of the sphere. By combining the
*20,IV -  **7.0(  Vt,b 1yV2Q,W J (2.4)
I
Î:Svedberg and Stokes equations and substituting all constants with the values for water at 
20°C, it is possible to define the sedimentation coefficient, s of an anhydrous spherical 
particle in terms only of M (g/mol), v  (ml/g) and p  (g/ml).
^  . (2.3)
Using eq. 2.3 the maximum sedimentation coefficients of spherical proteins in water at 20°C 
can be calculated since spherical particles have minimal surface area exposed for solvent 
interaction (hydration shell) and consequently have the lowest frictional coefficients, / , .  Any
asymmetry in particle shape increases interactions of protein surface residues with the solvent 
and causes the value of s to decrease as a consequence.
In order to be able to compare sedimentation coefficients obtained under different 
experimental conditions, s is corrected to standard conditions (in water at 20°C) using
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where the subscripts T and B refer to the temperature and buffer conditions used throughout 
the experiment, and 20,w indicates standard conditions.
_ 1 8 
dt r dr dr (2.5)
In the computer program SEDFIT sedimentation profiles are fitted with numerical finite 
element solutions of the Lamm equation. This process takes into account the entire 
sedimentation process and has the added advantages of being able to achieve a higher 
resolution than other methods as well as to model the sedimentation profiles of species for 
whom no separate boundary is visible in the actual data due to the effects of diffusion 
(Schuck, 2000; Lebowitz et al., 2002). Furthermore, this type of analysis is capable of 
handling very small species, e.g. salts as well as very large particles such as viral capsids. If 
more than one species is present in a sample, the user needs to specify a particular model for 
fitting the data, including, for example, ‘non-interacting’ (for n non-interacting species) and 
‘interacting’ (e.g. monomer-dimer association, etc.).
A method that requires no prior knowledge of the number of species present in a sample or 
their interaction(s) is sedimentation coefficient distribution, c(.s) developed by Schuck (2000). 
SV profiles are modelled with distributions of Lamm equation solutions
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2.2.1.1 SV data analysis
Numerous approaches have been developed for the analysis of SV data. Only the methods 
used throughout this thesis will be described, in particular the sedimentation coefficient 
distribution and finite element analyses as implemented in the program SEDFIT (Schuck,
2000; Schuck et al., 2002).
The generation of a macromolecular concentration distribution % as a function of time t and
:radial position r under the influence of sedimentation and diffusion processes in a sector­
shaped sample cell is described by the Lamm equation (Lamm, 1929);
2.2 Analytical ultracentrifugation
a{r,t)= ^c{s)z{s,D ,r,t)ds + e , (2.6)
where a{r,t) represents the recorded sedimentation data, c{s) is the concentration of species 
with sedimentation coefficients between s and s + ds, ;^;(5',D,r,0 denotes the solution of the
Lamm equation for a single species and g is a noise component. Simply put, sedimentation 
data are composed of several different populations, each of which has a different 
sedimentation, s and diffusion coefficient, D and therefore contributes to the radial- and time- 
dependent absorbance/interference signal a{r,t) in a manner proportional to the Lamm 
equation solution %(f,D,r,f) and its loading concentration. However, this approach does 
assume that none of the species interacts with another on the time-scale of the experiment. It 
can still be used to analyse mixtures of interacting proteins, but may lead to the observation of 
peaks in the c(.s) profile generated that do not correspond to any sedimenting macromolecule 
but instead represent the chemical interconversion of species (Gilbert & Jenkins, 1956; Dam 
et al., 2005). This case is best diagnosed by analysing different concentrations of the same 
protein mixture. Sedimentation coefficient distributions can be integrated to yield weight- 
average sedimentation coefficients.
c{s) analysis was always used as a first step in the analysis of SV data throughout this project 
in order to determine the number of species present in the experimental system and to provide 
initial estimates of their sedimentation coefficients and loading concentrations. In experiments 
with less than or equal to four different species the data were modelled subsequently using 
finite element analysis, employing either a non-interacting or appropriate association model to 
determine the true sedimentation coefficient for each species. SEDFIT does not have the 
capacity to model more than four separate species. In more extreme cases the program 
SEDPHAT (Schuck, 2003; Vistica et al., 2004) could be used to fit up to ten different species. 
To correct for the effects of concentration, sedimentation coefficients were extrapolated to 
infinite dilution to yield the value of s independent of concentration, •
*
a
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results in a straight line with a slope of —— — . The molecular mass can be obtained2RT
from the slope, provided the partial specific volume V is known. Ideality in thermodynamic 
terms refers to particles in solution that do not interact with each other.
When more than one species is present in the experimental system, the sedimentation profile 
as a function of its radial position, a{r), is the sum of the exponentials recorded for each 
species
exp -\-ô (2.8)
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In sedimentation equilibrium (SE) analytical ultracentrifugation macromolecules are
 ^ ' ... ■ subjected to a lower centrifugal field, i.e. experiments are run at lower rotor speeds. The
opposing forces of sedimentation and diffusion on macromolecules lead to the establishment
of a thermodynamic equilibrium with no net movement of molecules within the concentration
gradient. Within this gradient the distribution of each species is described by an exponential.
For a single, thermodynamically ideal macromolecule the sedimentation process can be
described by a combination of the Lamm and Svedberg equations:
91n(c) _ M {l-vp)cd^
where c is the macromolecular concentration. For a single ideal species plotting ln(c) versus
i
where n represents the number of species, c,,o denotes the molar concentration of species i at a 
reference position ; 6- is its molar extinction coefficient, d is the optical path length (12
mm or 3 mm) and S  represents the baseline offset which accounts for all non-sedimenting 
material as well as small imperfections in the cell assembly and data acquisition. When using 
interference optics the extinction coefficient in eq. 2.7 is replaced by a specific signal 
increment (2.75 fringes per mg/ml).
I
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The steepness of the concentration gradient is dependent on the square of the rotor speed and 
the buoyant molar mass = M (1 -  vp )  which corresponds to the mass of a macromolecule 
corrected by a buoyancy factor due to the amount of displaced solvent. In order to obtain 
optimum results from SE experiments, usually 2-3 different rotor speeds and 7-9 sample 
concentrations are used, resulting in the acquisition of 14-27 independent equilibrium 
profiles.
All other analyses were performed in SEDPHAT which enables the use of more complex 
fitting routines. SE data were generally analysed using SEDPHAT’s multispeed function 
which allows simultaneous fitting of data sets obtained from the same cell at different speeds 
and thereby improves consistency by fitting them with the same baseline. Cells were analysed 
individually to enable graphical determination of the concentration-independent molecular 
weight, M °, by plotting of the apparent molecular weight, M,v,app, versus protein 
concentration, c. Finally, data sets were also fitted globally to ensure reliability of the results 
obtained. Fitting routines available in SEDPHAT include a non-interacting discrete species 
model (up to four different macromolecules), a monomer n-mer self-association model and 
A -f B C hetero-association model.
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Analysis of SE data includes model-independent and model-dependent approaches: model- 
independent methods are very useful for the initial characterisation of samples as well as 
samples that prove too complex to be fitted using model-dependent approaches. By solving 
eq. 2.7 the weight-average molecular mass, is determined. This type of analysis was done 
using the Beckman XL-A/XL-I software implemented in MicroCal ORIGIN or using 
SEDPHAT (Schuck, 2003; Vistica et al., 2004). The Beckman XL-A/XL-I software was also 
used for the determination of the second virial coefficient, B, when analysing nonideal 
systems. I
I
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2.3 Isothermal titration calorimetry
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Isothermal titration calorimetry (ITC) is one of the most quantitative methods for analysing 
molecular interactions. Concentrated ligand is combined with the macromolecule under study 
in a series of discrete injections. ITC directly measures the amount of heat taken up or 
released upon complex formation and allows direct determination of the binding constant, K ,^ 
the stoichiometry of the interaction, n and the enthalpy of binding, The free energy of a 
reaction, AG° is calculated from AG° = -RTixiK„ while the entropy, AS° is derived from the 
standard thermodynamic expression AG° = AH^ -  TA5®. A typical experimental set-up is 
shown in Fig. 2.2. The heat of each injection is obtained from calculating the area under each 
peak. As the amount of uncomplexed protein in the reaction cell progressively decreases with
each injection, the peaks become smaller accordingly until complete saturation is achieved. 
Any further injections simply resemble peaks caused by dilution of the macromolecular 
solution and need to be subtracted prior to data analysis. For a macromolecule with i non­
interacting binding sites the amount of heat, Q, generated or absorbed upon ligand binding is 
described by
Î.*■
" = ^
where Vo is the volume of the ITC cell, [M]t is the total concentration of macromolecules 
(including bound and free fractions), n is the stoichiometry of interaction, AH is the enthalpy 
of binding per mole of ligand and [L] is the free ligand concentration.
The most significant limitation of ITC is its inability to characterise well very fast binding 
events, i.e. very high affinity interactions. When binding constants exceed a value of 10 -^10^
M'' saturation is achieved in only 1 - 2  injections, titrations loose their characteristic sigmoidal 
shape and therefore lack the information content necessary to determine the binding constant 
accurately.
Surface plasmon resonance (SPR) is also often used to determine the strength of molecular 
associations, but requires attachment of one interaction partner to a matrix which can be 
problematic.
I
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Figure 2.2 Isothermal titration calorimetry
(A) Schematic representation of an ITC instrument. Two cells are contained within an adiabatic jacket. 
A small continuous power is applied to the reference cell in the form of a heater and thermocouple 
detectors sense temperature differences between the reference and sample cells. Upon ligand binding 
heat is either generated or absorbed. In order to maintain equal temperature within the reference cell 
changes in the power supply occur via the feedback system. The heat supplied to the sample cell per 
unit time is measured by the instrument and results in the appearance of the characteristic peak pattern. 
(B+C) Sample ITC data. The raw data are shown in (B), while the integrated data and fit to the data are 
shown in (C).
(A) was adapted from Pierce et al. (1999).
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2.4 Small angle x-ray scattering
Small angle x-ray scattering (SAXS) is a technique used to obtain low resolution structural 
information, e.g. particle size and shape, for materials that can vary in size from ten to several
f ( i )  = JjO (r) e--“"-dV, , (2.10)
where f {s ) is the Fourier transform of the electron density distribution, s is the scattering 
vector and V,- is the volume of the sample. The scattering vector s resulting from the
thousand Angstroms such as proteins and viral capsids (Heller et al., 2004; Lee et al., 2004). ■
The technique is not limited to biological macromolecules and is used widely to characterise 
synthetic polymers, nanoparticles, porous materials, etc.. However, the following sections 
will focus on the aspects relevant to the work described in this thesis, i.e. the solution 
scattering of monodisperse systems of identical, non-interacting particles.
2.4.1 S catterin g  by an ideal m onodisperse so lu tion
X-rays interact with the electrons of a sample. In ideal solutions particles do not interact with 
each other. In a monodisperse system all particles have the same chemical composition 
(chemical monodispersity) and shape (shape monodispersity). In an ideal, monodisperse 
system all particles have the same scattering amplitude which is non-directional (isotropic). 
Furthermore, the recorded scattering intensity is the sum of the intensities of all individual 
particles and no interference is observed. It is the uniform particle distribution in solution and 
isotropic scattering in the absence of a crystal lattice that leads to spherical averaging of the 
single particle scattering, a one-dimensional scattering curve and low resolution compared to 
x-ray crystallography. Typically, SAXS experiments achieve a resolution of 10-20 Â, 
although it can be as high as 5 Â in exceptional circumstances (Petoukhov & Svergun, 2003).
Assuming a sample with an electron density p(r) at a point r  scatters x-rays with an incident 
wave vector, (|so| = 2 ;r/A, where À is the wavelength of the x-rays), then at distances 
much larger than the size of the particle the amplitude of the scattered radiation is defined by
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scattering of the incident beam by the sample can be calculated by 5  -  , where is the
wave vector of the scattered x-rays (Fig. 2.3).
X-rays Detector
Sample
Figure 2.3 Schematic representation of SAXS
For a given scattering angle of 20 and x-ray wavelength, X then
which is the modulus of the scattering vector.
The scattered intensity l{s) is defined as follows:
(2 .11)
(2.13)
where the integral runs over the particle volume V, r, and ^  are vectors inside the particle 
and A/? represents fluctuations in the electron density of the particle with respect to the 
solution.
The isotropic scattering intensity l{s) is often expressed in terms of the distance distribution 
functionp{r) as follows:
270'S (2. 14)
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For a monodisperse, ideal solution the p{r) function can be written as
y(r) = — fr5 /( 5 )sin 2 ;zr5 £/5'. 7Ï J (2.15)
The scattering intensity at zero angle /(O) can be derived from eq. 2.10 as
I (o) = JjAp(q )A/?(r2 )dV^dV2 ~ AnF -  m l , (2.16)
where m is the total number of electrons in the paiticle and mo is the number of solvent 
electrons displaced by the particle.
The scattered intensity can be expanded in powers of to give
l{s) = /(O) (2.17)
but close to the origin, i.e. at low angles, the expansion can be restricted to the first order term
l{s) ™ 7(0)exp (2.18)
%
1
f
7 :■iiî
i
where Rg is the particle radius of gyration which is defined by the following relationship 
(Guinier & Fournet, 1955):
^isp{r)r'^dV
^Kp{r)dV (2.19)
Eq. 2.16 is also known as the Guinier approximation which states that at very low scattering 
angles the scattering intensity can be modelled by a Gaussian distribution, the width of which
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is inversely proportional to the radius of gyration. The radius of gyration, Rg is a measure of 
particle (non)sphericity and can be detennined experimentally by plotting lnl(s) versus 
(Guinier plot). Using linear regression Rg can be detennined from the slope, while the 
intensity at zero angle, 7(0) is obtained by extrapolation to zero scattering angle. The Guinier 
region, i.e. the range of scattering angles, 5  over which the Guinier approximation is valid is 
usually defined as 0.2 < sRg< 1.3 although the exact values differ for asymmetric particles
where is the maximum particle dimension. Eq. 2.17 is identical to eq. 2.11 except that 
the integral is now delimited by The p(r) function has the same information content as 
I(s) and data processing can be done ‘indirectly’ by restoring the p(r). It also introduces an 
important constraint due to the ‘boundedness’ of the function provided by D,„ax. This indirect 
transform approach was used first by Glatter (1977) and also forms the basis of the computer
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/(Perkins, 1988). The Guinier approximation relies on the assumption of an ideal, 
monodisperse solution. Therefore, in the case of a polydisperse solution, e.g. due to aggregate 
formation, determination of the Rg becomes ambiguous and unreliable. In order to circumvent 
this problem the scattering from several sample concentrations is usually recorded.
s
I
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2.4.2.1 Data processing
Ideal single particle scattering intensities 7( )^ cannot be measured directly; instead, a discrete 
set of intensities 7exp(.s/) at i angles within the angular range <s < m^ax is recorded, fuifher 
compounded by the presence of statistical error and possible smearing effects from beam 
divergence, polychromaticity or detector resolution (Feigin & Svergun, 1987). It is vital, 
therefore, to restore the ideal scattering intensities 7(f) from the experimental set 7exp(f,) during 
data processing. For monodisperse solutions 7(f) is related to the particle distance distribution 
function p(r) by the Fourier transform
I(s) = 4 ^  f p{r)~ ^ dr, (2.20)
0
2
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program GNOM (Semenyuk & Svergun, 1991; Svergun, 1992) that was used for the 
processing of SAXS data throughout this project. Another important aspect of GNOM is the 
use of a régularisation parameter, a which enables the user to compensate for the quality of 
the data fit and the smoothness of the resulting p{r) function (Svergun, 1992), The choice of a 
is critical for the stability and validity of the solution: too small a value leads to unstable 
solutions, while too large a value results in systematic deviations from the experimental data.
,GNOM automatically performs a search for a, relying on a number of perceptual criteria like
max'
2.4.2.2 Direct modelling of the p(r) function
Historically, three-dimensional information from SAXS data was obtained by building 
relatively simple low resolution models on a trial-and-error basis. Models were made up from 
geometrical shapes such as spheres, cylinders or ellipsoids and their scattering curves and p{r)
discrepancy, systematic deviations, smoothness, positivity of the p{r) and stability of the 
solution to small changes in a to determine the outcome. Failure to find a good solution 
usually indicates that wrong assumptions were made about the experimental system, such as 
an incorrect value of D,„ax- Generally, is not known very accurately and several trial-and- 
error calculations have to be done for different values of D,
Using eq. 2.17 GNOM also automatically back-extrapolates l{s) beyond the measured s-range 
to zero angle and thus provides an estimate of /(O). It uses the p(r) function to determine the 
radius of gyration, Rg which proves to be less sensitive to residual interpaiticle interactions 
and even to small amounts of aggregate, as it uses the entire scattering curve for its 
calculation, rather than just the Guinier region.
As mentioned above, scattering curves and their corresponding p{r) functions share the same 
information content. Inspection of both also allows rudimentary estimation of particle shapes: 
as shown in Fig. 2.4 the scattering curves of a sphere and a rod, for example, are profoundly 
different as anisometric particles yield fairly featureless scattering profiles that decay much 
more slowly than those of globular particles.
45
2.4 Small angle x-ray scattering
JS
s
Disumc«
Figure 2.4 Scattering curves and distance distribution functions of geometrical bodies
Scattering curves and their corresponding p(r) functions were calculated for a sphere ( • ) ,  rod (▼), disc 
( ), hollow sphere (♦ )  and dumbbell (A).  All particles have the same Dmax- 
This figure was adapted from Svergun and Koch (2003).
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functions were calculated subsequently and compared to the experimental data (Kratky & 
Pils, 1972; Glatter, 1980; Glatter & Kratky, 1982).
A different approach to the evaluation of SAXS data focused on the calculation of theoretical 
scattering curves from high resolution structures obtained from x-ray crystallography or 
NMR. In order to be able to simulate scattering curves it is important not only to include the 
scattering atoms within the particle, but also to account for the effects of the particle excluded 
volume:
/(■s) = , (2 .2 1 )
where /?o is the average electron density of the buffer, and < >a represents the spherical 
average. The main problem in the calculation of scattering curves is the estimation of the 
excluded volume contribution (i.e. term 2 in eq. 2.18). Several methods have been developed 
to deal with this problem. Most recently, Lattman (1989) used spherical harmonics to 
calculate scattering intensities, an approach that was further improved by Svergun and co­
workers (1995) by inclusion of the hydration shell with a different electron density (p/,J to 
both that of the paiticle and the buffer (po):
I{s) = panicle (^) ~ PoFhtfffer (^) + ^ PdFhydshell (^)|  ^ ' (2 .2 2 )
h^ydsheiA )^ Is the Scattering amplitude o f the water layer bound to the particle, and ôpQ = -
Po- This method has been implemented in the computer program CRYSOL (Svergun et al.,
1995) which computes the scattering profile of any high or low resolution structure and is 
able to fit it to experimentally determined data sets. In order to improve these fits the electron 
density of the hydration shell and the average excluded solvent volume per atomic group are 
allowed to vary.
!
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2.4.2.S Ab in itio  modelling
The extraction of thi'ee-dimensional data from a one-dimensional scattering curve is a non­
trivial undertaking. In the past, shape information from SAXS data was obtained by building 
low resolution models on a trial-and-error basis, sometimes including information procured 
from other methods such as electron microscopy.
Over the last 35 years, however, several other methods have been developed that allow for 
more detailed three-dimensional information to be obtained from the analysis of SAXS data. 
The first ab initio approach, i.e. the shape restoration of a particle without the need of any 
prior knowledge about the system, was developed by Stuhrmann (1970) and relied on an 
angular envelope function described by a series of spherical harmonics to approximate 
particle shape. Svergun et al. have developed and implemented this approach in their 
computer program SASHA (Svergun & Stuhrmann, 1991; Svergun et al., 1997b). The low 
resolution shape is defined by a few parameters that fit the scattering data. For eiTor-free, 
theoretical data SASHA is able to generate unique solutions (Svergun et al., 1996), indicating 
that reconsbuctions for experimental data sets (including errors) are stable and independent of 
the starting approximation. The stability and/or resolution can be further improved if 
information on particle symmetry is available (Vachette & Svergun, 2000).
The use of envelopes for shape restoration is limited to relatively globular particles with fairly 
simple shapes and no internal cavities. More detailed ab initio models can be obtained from 
Monte Carlo searches. Svergun et al. have implemented this approach in their computer 
program DAMMIN (Svergun, 1999): a sphere of diameter is filled with closely packed 
dummy atoms on a hexagonal lattice. Each dummy atom is either part of the particle (‘1’) or 
the solvent (‘0’), thus generating a long binary string. Simulated annealing is used to 
determine the lowest energy configuration within the search space. The computer program 
CRYSOL (see above) is employed to determine the scattering of each configuration. Further ':;3'
constraints for DAMMIN reconstructions include compactness and connectivity. As with 
SASHA the user can specify particle symmetry if known. DAMMIN has been evaluated with 
several test cases (Svergun, 1999; Voikov & Svergun, 2003) and more than 100 papers 
featuring DAMMIN reconstructions have been published during the last few years (e.g.
Î
■ï‘;
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Sokolova et al., 2001; Ackerman et al., 2003; Petoukhov et al., 2003; Marquez et al., 2003; 
Nôllmann et al., 2004; Arita et al., 2004; Hough et al., 2004).
A similar approach was also used for the computer program DALAIGA (Chacon et al., 1998; 
Chacon et a l, 2000). Again, a sphere of diameter is filled with a large number of closely 
packed dummy atoms which are either part of the particle or the solvent. However, starting 
from a random configuration a genetic algorithm is used instead to search for a configuration
that adequately describes the data.
The most recent ab initio method developed by the Svergun group for the analysis of SAXS 
data is implemented in the program GASBOR (Svergun et a l, 2001; Petoukhov & Svergun, 
2003). Apart from particle and solvent beads it introduces a third kind corresponding to the 
particle hydration shell, although the water molecules bound form part of the primary 
hydration layer and SAXS is unable to account for a full hydration shell in a hydrodynamic 
sense. The macromolecule is not represented by hexagonally closely packed beads; instead, 
one dummy residue is placed per amino acid. GASBOR has encoded within it connectivity 
constraints that result in models in which the dummy residues form a protein-like fold. As 
with DAMMIN, simulated annealing is used for an exhaustive search of the configurational 
search space (a sphere with diameter D,„^). GASBOR uses data at higher scattering angles 
than DAMMIN (s < 0.5 A'^) and thus produces more detailed, i.e. higher resolution models. 
In some rare cases a resolution as high as 5 A has been achieved using GASBOR (Svergun et 
a l, 2 0 0 1 ), but more typically the resolution of resultant models lies between 10-15 A. A 
similar ab initio algorithm has been developed more recently by Heller et al. (2002; 2003).
2.4.2.4 Addition of loops and domains
Currently, it is not possible to incorporate data obtained with complementary methods in the 
ab initio modelling process. This limits the usefulness of the resultant models although a 
higher signal-to-noise ratio and/or an extended angular range maximise the likelihood of the 
restored structure representing the actual solution conformation. Some shapes, in particular 
very anisometric particles or those containing voids, can be difficult to reconstruct properly 
(Volkov & Svergun, 2003). In order to address this problem, several programs have been
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developed recently that allow inclusion of high resolution structures and/or homology models 
in the modelling process. For example, the programs CREDO and CHADD (Petoukhov et al, 
2 0 0 2 ) have been employed to add missing loops and domains to atomic structures, using a 
GASBOR-like approach to determine the position of the unknown amino acid residues. 
Neither algorithm, however, can take into account possible conformational changes, e.g. 
resulting from the comparison of a protein in solution with its crystal structure.
2.4.2.5 Rigid-body modelling
When dealing with multisubunit proteins or macromolecular complexes where high resolution 
structures or models are available, the use of rigid-body modelling in combination with ab 
initio analysis can be very effective. The first computer program available for rigid body 
modelling with SAXS (MASSHA; Konarev et al, 2001) operates mainly on an interactive 
basis and its automated fitting function accesses only a limited volume of search space.
More recently, Nôllmann et a l (2005) developed an algorithm implemented in the computer 
program Rayuela based on Monte Carlo simulated annealing for the rigid-body modelling of 
multisubunit proteins/complexes with reference to SAXS data. In addition, hydrodynamic 
parameters obtained from AUC and distances determined using fluorescence resonance 
energy transfer (FRET) can also be included in order to further increase the stringency of the 
analysis.
For modelling with Rayuela, a protein or complex is divided into a user-specified number of 
structural ‘domains’. Each domain can be moved by translations and rotations of its centre of 
mass, generating a large number of possible configurations. For each possible solution the 
scattering curve, sedimentation coefficient and FRET distances are calculated in silico and 
compared to the experimental data. A scoring function measures the discrepancy between the 
simulated and experimental data, and determines the lowest energy configuration. A similar 
approach for rigid-body modelling with SAXS data has also been developed by the Svergun 
group (Petoukhov et a l, 2002; Petoukhov & Svergun, 2005).
50
2.5 Small angle neutron scattering
2.5 Small angle neutron scattering
The underlying principles of the technique as well as the methods described in Section 2.4 
also apply for the treatment and analysis of small angle neutron scattering (SANS) data. 
However, additional information on macromolecular complex formation can be obtained from 
SANS experiments when compared to SAXS.
While x-rays interact with the particle electron cloud, neutrons are scattered by the nucleus. 
The efficiency of scattering by different isotopes of the same element, e.g. hydrogen and 
deuterium varies, resulting in pronounced differences in the scattering length. Molecules of 
identical chemical composition have the same physical and chemical properties, but differ in 
their interactions with neutrons. With scattering lengths of -0.374 x 10'^  ^cm and 0.667 x 10'^  ^
cm for hydrogen and deuterium, respectively, scattered intensities vary considerably 
depending on isotope incorporation into macromolecules.
2.5.1 C ontrast variation
The difference in scattering lengths between hydrogen and deuterium is exploited in contrast 
match experiments. When investigating molecular interactions it is possible to render one (or 
more) complex components virtually “invisible”. This can be achieved either by solvent 
exchange (H2O/D2O) (Ibel & Stuhrmann, 1975) or by selective deuteration (Engelman & 
Moore, 1972) methods. In both instances the scattering density of one complex component is 
exactly matched with that of the solvent by varying the buffer D2O content. Solvent exchange 
can only be used for analysing interactions between two different types of biological 
macromolecule, e.g. a protein-DNA complex, due to the different match points of protein (ca. 
40%) and DNA (ca. 60%) (Fig. 2.4). Using selective deuteration it is also possible to 
investigate protein-protein interactions as one complex component is overexpressed in 
deuterated media before being reconstituted with the remaining protonated constituent(s). The 
exact D2O/H2O ratio can vary considerably for deuterated proteins and depends on labelling 
efficiency.
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2,5 Small angle neutron scattering
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Figure 2.4 Neutron scattering length densities of biological macromolecules in 
solution
The scattering length density for H2O is close to -5 X lO^cm'^ while that for D2O is 64 X lO^cm' .^ 
Scattering length densities vary in a linear fashion and no scattering can be observed at approximately 
8% D2O.
Adapted from Zaccai (2000).
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C hapter 3
Materials & methods
3.1 Molecular biology
3.1.1 P lasm id  preparation
Plasmid DNA was extracted and purified from 5 ml overnight cultures using the Promega 
(USA) Wizard SV Miniprep DNA Purification System according to manufacturer’s 
instructions. DNA was eluted from spin columns in 100 pi TE buffer (10 mM Tris-HCl, 1 
mM EDTA, pH 7.5) unless stated otherwise and stored at -20®C. Plasmids used in this project 
are listed in Table 3.1.
3.1.2 A garose gel e lectrop h oresis
Agarose gel electrophoresis, as described by Maniatis et al. (1987a) was used to assess the 
efficiency and purity of plasmid preparations.
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3.1.3 DNA extraction  from  agarose gels
DNA bands visualised with ethidium bromide were excised and the DNA extracted using the 
QIAquick gel extraction kit (Qiagen, UK) according to manufacturer’s instructions. DNA 
was eluted in 30 |il TE and its quantity and quality assessed by agarose gel electrophoresis.
Plasmid name Vector Insert Source
PET14-E3 pET14b Human E3 
aa 36-509
A. Brown (2002)
pETll-E2 pETllb Human E2 
aa 53-613
A. Brown (2002)
pET14-E2DD pET14b Human E2 
aa 54-613
A. Brown (2002)
pET14-X pET14b Human E3BP 
aa 54-501
A. Brown (2002)
pET28-X pET28b Human E3BP 
aa 54-501
A. Brown (2002)
pET14-XDD pET14b Human E3BP 
aa 54-216
A. Brown (2002)
pGEX2-XLD pGEX2T Human E3BP 
aa 54-177
A. Brown (2002)
pET30-XSBD pET30a Human E3BP 
aa 166-230
M. Smolle
Table 3.1 Plasmids used throughout this project.
3.1.4 P olym erase chain  reaction
Oligonucleotides were synthesised by MWG (Germany). Reactions were set up using the 
Expand High Fidelity PCR System (Roche, USA) according to manufacturer’s instructions.
3.1.5 R estriction  d igests and plasm id liga tion
Restriction digests of PCR products and plasmids were performed using restriction enzymes 
obtained from Promega (USA) and NEB (USA) according to manufacturer’s instructions 
Ligation reactions were set up using the Rapid Ligation Kit from Promega (USA) according 
to manufacturer’s instructions.
iI
I
Îii:
I
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3.2.1 C om petent ce lls  and transform ations
Cells were made chemically competent using the calcium chloride protocol and transformed 
as described by Maniatis et al. (1987b).
II
3.2 Bacterial strains
Escherichia colt strain DH5a (Stratagene, USA) was used for plasmid propagation. E. colt 
BL21 DE3, E. colt BL21 DE3 pLysS and E. coll BL21 DE3 Star (all Invitrogen, UK) strains 
were used for recombinant protein overexpression (Table 3.2).
E, coll strain________Genotype____________________________________ __________
DH5a F  080 lacZ AM15 A(/«cZYA-ar^F)U169 recAl endhl hsdKll{x^
mjc’*') phoK supEAA thi-l gyrA96 relAl tonA 
BL21 (DE3) F' ompT hsdS^ (rsTuB') gal dcm (DE3)
BL21 (DE3) pLysS F" ompT hsdSB (rBmB) gal dcm (DE3) pLysS (Chl^)
BL21 (DE3) Star__________F" ompT hsdSB (rB'mg') gal dcm mgl31 (DE3)_______________
Table 3.2 Bacterial strains used
DE3 signifies that all BL21 strains contain the 1DE3 lysogen that canies the gene for T7 RNA
polymerase. All BL21 strains are deficient in Ion protease and the outer membrane protein OmpT. The
pLysS strain contains the pLysS plasmid which encodes T7 lysozyme and confers chloramphenicol 
(Chl*^ ) resistance.
:i
3.3 Protein methods
3.3.1 P rotein  overexpression  and so lub ility
Overnight cultures were set up by inoculating Luria-Bertani broth (LB; 10 g bacto-tryptone, 5 
g bacto-yeast extract, 5 g NaCl made up to 1 1 with de-ionised water) supplemented with the 
appropriate antibiotic(s) (Table 3.3) with a single bacterial colony obtained from 
transformation. For protein overexpression LB including antibiotics was inoculated at a ratio 
of 1:50 with overnight culture. Bacteria were grown at 37°C to an OD^ oo of 0.6-0.8 and 
induced with 1 luM IPTG for 3-5 hours at 30°C. At induction, XDD, XLD (see Chapter 5), 
E2DD (see Chapter 6 ) and E2/E3BP (see Chapter 7) cultures were supplemented with lipoic
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'
acid to a final concentration of 50 pg/ml in order to maximize lipoylation. Cells were 
harvested by centrifugation at 15300 g for 10 minutes and the cell pellets stored at -20°C.
3,3 Protein methods
Antibiotic Stock solution Selective conditions Plasmid
Ampicillin (Amp) 1 0 0  mg/ml in dHaO 1 0 0  pg/ml pETll,pET14,
pGEX2
Kanamycin (Kan) 25 mg/ml in dH2 0 25 pg/ml pET28, pET30
Chloramphenicol (Chi) 32.5 mg/ml in ethanol 32.5 pg/ml pLysS
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Table 3.3 Antibiotics and selective conditions used
Protein solubility was tested by lysing cells from a 50 ml culture in a final volume of 3 ml 
using a French press (750 psi) or chemical lysis (see below). Cell debris was removed from 
the soluble fraction by centrifugation at 15300 g for 20 minutes. The insoluble fraction was 
solubilised in SDS loading buffer and protein solubility assessed by SDS PAGE (see 3.3.5.1),
if
3.3.2 P r o te in  p u r if ic a t io n
Details of all buffers used during protein purifications described here can be found in Section 
4.2.3. I
3.3.2.1 Cell lysis
Frozen cells were resuspended in metal chelate binding buffer (10 ml/250 ml of bacterial 
culture) supplemented with Ix Bugbuster reagent (Novagen, UK) for chemical lysis. Cells 
were lysed in the presence of Complete® EDTA-free protease inhibitors (Roche, USA), 
benzonase (25 U/ml) and T7 lysozyme (4.5 U/ml) (both Novagen, UK) by rotation at room 
temperature for 30-90 minutes. Insoluble cell debris was removed by centrifugation at 15300
■g for 2 0  minutes and the lysate filtered prior to chromatography.
3.3.2.2 Metal chelate affinity chromatography
His-tagged proteins were first purified using metal chelate affinity chromatography on a 
BioCAD 700E workstation (Applied Biosystems, USA). A 20MC column (Applied
f
.'.îîî.
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#
Bound protein was eluted from the column in a 0-100% gradient of elution buffer and 
the eluate collected in 2  ml fractions.
The column was washed with 5 CV of dH%0 and 5 CV of elution buffer at 5 ml/min.
3
:
Biosystems, USA) was prepared at a flow rate of 10 ml/min unless mentioned otherwise as 
follows:
• The coluirm was initially washed with 5 column volumes (CV) of strip solution (50
,mM EDTA, IM NaCl) to remove any remaining metal ions from a previous 
purification, followed by 5 CV of de-ionised water (dH^O).
• Metal ions were loaded onto the column over 30 CV using 100 mM ZnCE or 100 
mM NiCh at 5 ml/min followed by another wash step with 5 CV of dHaO at 10 
ml/min.
• Unbound ions were removed with a wash step of 5 CV of 500 mM NaCl and the 
column equilibrated with 5 CV of elution buffer followed by 10 CV of binding 
buffer.
Sample was injected in 5 ml aliquots and each injection was followed by a wash step 
of binding buffer for 3 CV.
After the final injection the column was washed with 9 CVs of binding buffer.
Peak fractions were analysed by SDS PAGE and pure fractions were pooled and either 
subjected to further purification steps or dialysed and stored at 4®C.
t
S.3.2.3 HQ anion exchange chromatography
Peak fractions from metal chelate chromatography were pooled and buffer exchanged into 
binding buffer. A 20HQ column (Applied Biosystems, USA) was prepared as follows:
i
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Equilibration of the column was achieved using 10 CV of binding buffer at 10 
ml/min.
• The column was washed with 5 CV of dHgO and 5 CV of elution buffer at 5 ml/min.
• Equilibration of the column was achieved using 10 CV of binding buffer at 10 
ml/min.
• Protein was eluted from the column using a 0-100% gradient of elution buffer over 
15 CV, collecting 2 ml fractions.
Peak fractions were again analysed by SDS PAGE and pure fractions were pooled and 
concentrated for gel filtration.
i:
Following sample injection the column was washed with a further 10 CV of binding 
buffer in order for the absorbance at 280 nm (Aggo) to return to the baseline.
• Protein was eluted from the column using a 0-50% or 0-100% gradient of elution 
buffer over 30-100 CV, collecting 2 ml fractions. Details vary for different proteins.
Peak fractions were again analysed by SDS PAGE and pure fractions were pooled and 
concentrated for gel filtration.
I
3.S.2.4 S cation exchange chromatography
Peak fractions from anion exchange chromatography were pooled and buffer exchanged into 
binding buffer. A 20S column (Applied Biosystems, USA) was prepared as follows:
Following sample injection the column was washed with a further 10 CV of binding 
buffer in order for the A^ go to return to the baseline.
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•IS.3.2.5 GST purification of XLD
A 5 ml GST Trap FF column (Amersham, USA) was equilibrated with PBS (140 mM NaCl,
2.7 mM KCl, 10 mM Na2HP0 4 , 1.8 mM KH2PO4 , pH 7.3) at 2 ml/min. Sample was loaded at 
a rate of 0.5 ml/min. The column was then washed with more PBS until the baseline returned 
to zero. Bound protein was eluted in a single step with 50 mM Tris-HCl, 20 mM glutathione, 
pH 8.0 and collected in 1 ml fractions. Peak fractions were analysed by SDS PAGE and 
dialysed for further experiments.
■A
B.3.2.6 Gel filtration chromatography
A Sephacryl S-300 or S-100 column (Amersham, USA) was equilibrated with 2 CV of buffer 
at 1 ml/min. Fractions from previous purifications were pooled and concentrated to less than 
1 ml and injected onto the column. Protein was eluted over 1.2 CV of buffer run at 1 ml/min 
while collecting 2  ml fractions.
3.3.2.7 Purification of PDC from bovine heart
PDC from bovine heart was isolated as described by Stanley and Perham (1980), but with the 
following modifications: 600 g of bovine heart muscle were homogenised for 5 minutes in 
500 ml of extraction buffer (50 mM MOPS, pH 7.0, 2.7 mM EDTA, 3% (v/v) Triton X-100, 
100 pM DTT, 1 mM PMSF, 1 mM benzamidine, 0.2% (v/v) anti-foam A) and the final 
volume adjusted to 2 litres. Unbroken cells and cell nuclei were pelleted by centrifugation at 
10000 g for 20 minutes. The supernatant was pooled, its pH lowered to pH 6.45 with 10% 
(v/v) acetic acid and subjected to a first round of PEG precipitation by the addition of 0.12 
volumes of 35% (w/v) PEG 6000 and left stirring on ice for 30 minutes before centrifugation 
at 18000 g for 15 minutes. The pellets were resuspended in 200 ml homogenisation buffer (50 
mM MOPS, pH 7.0, 2.7 mM EDTA, 1% (v/v) Triton X-100, 1.5 pM leupeptin, 1 mM PMSF, 
ImM benzamidine) and clarified by centrifugation at 25000 g for 40 minutes. The 
supernatant was collected and filtered through 8  layers of muslin before the dropwise addition 
of 0.013 volumes of 1 M MgCE and 0.05 volumes of 1 M sodium phosphate, pH 6.3. The pH 
was not allowed to fall below pH 6 . 8  by adjustment with 0.5 M NaOH. The pH of the 
supernatant was then lowered to pH 6.45 with 10% (v/v) acetic acid before a second PEG
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precipitation with 0.12 volumes of 35% (w/v) PEG 6000 and was again left to stir for 30 
minutes on ice. The precipitate was collected by centrifugation at 25000 g for 10 minutes and 
the pellets resuspended in 160 ml of homogenisation buffer. The suspension was stored 
overnight at 4®C with added protease inhibitors (1 mM PMSF, 1 mM benzamidine, 1 pM 
leupeptin, 100 pM DTT). The next day the suspension was rehomogenised before 
clarification at 25000 g for 60 minutes. The third and final PEG precipitation was carried out 
as above by lowering the pH of the supernatant to pH 6.45 and the addition of 0.06 volumes 
of 35% (w/v) PEG 6000 which was left stirring on ice for 30 minutes. OGDC was pelleted by 
centrifugation at 25000 g for 10 minutes. The remaining supernatant contained PDC and was 
spun at 10000 g for 15 minutes to remove remaining OGDC contamination. PDC was 
pelleted by ultracentrifugation at 120000 g for 120 minutes. Storage buffer (50 mM 
potassium phosphate, pH 7.4, 2 mM EDTA, 0.02% (w/v) sodium azide, 1 mM benzamidine,
1 mM PMSF) was added to both OGDC and PDC pellets and stored at 4°C for 15-20 hours 
before homogenisation. The protein concentrations of OGDC and PDC were determined 
using BioRad assays (see 3.3.6) and preparations stored at a maximum concentration of 10 
mg/ml in 50% (v/v) glycerol at -20°C.
3.3.2.8 Sucrose gradient centrifugation
Discontinuous sucrose gradients were set up as described by Rahmatullah et al. (1989b), but 
with the following modifications: 4 ml of 20% (w/v) sucrose, 2 ml of 10% (w/v) sucrose and
2 ml of 5% (w/v) sucrose in 50 mM potassium phosphate, 2 M NaCl, 2 mM EDTA, 0.02% 
(w/v) sodium azide, pH 7.4 were layered on top of each other. The gradient was overlayed 
with 5-8 ml of sample and spun at 50000 rpm at 4°C for two hours. 1 ml fractions were 
collected following removal from the top using a peristaltic pump.
I
3.3.3 R em oval o f H is-tags
His-tags were removed from E3 by thrombin cleavage. Purified E3 was buffer exchanged 
into PBS buffer by concentration. Approximately 10 U of thrombin (Amersham, USA) were 
added per mg of protein and incubated at room temperature overnight. Thrombin and the 
cleaved tags were removed from E3 preparations by a subsequent gel filtration step.
I
■I
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3.3.4 D ia lysis
In order to match buffers for biophysical experiments, proteins were dialysed against 5 1 of 
buffer overnight at 4°C. For salt removal between different chromatography steps, brief 
dialysis steps for 2-3 hours at room temperature were used. Dialysis membrane was obtained 
from Visking (UK) and prepared as described by Bollag et al. (1996a). Alternatively, 
SnakeSkin dialysis tubing and dialysis cassettes from Pierce (USA) were used according to 
manufacturers’ instructions.
3.3.5 P olyacrylam ide gel e lectrop h oresis
3.3.5.1 SDS polyacrylamide gel electrophoresis (SDS PAGE)
SDS PAGE was used to assay the purity and concentration of proteins and was performed as 
previously described by Laemmli (1970) using 4% stacking and 10-15% resolving gels. 
Alternatively, 4-12% bis-tris NuPAGE gels (Invitrogen, UK) were used according 
manufacturer’s instructions. Gels were stained with 0.1% (w/v) Coomassie Brilliant Blue, 
10% (v/v) acetic acid, 50% (v/v) methanol for at least 30 minutes before being destained with 
1 0 % (v/v) acetic acid, 1 0 % (v/v) methanol overnight.
3.3.5.2 Non-denaturing PAGE
Non-denaturing PAGE as described by Bollag et al. (1996b) was employed to determine 
protein complex formation and to check for the presence of aggregate species. A 5% stacking 
and 8 % resolving gel were used and gels were run at 10 mA at room temperature for 3-6 
hours. Gels were stained with Coomassie Brilliant Blue as described above.
3.3.6 D eterm ination  o f p rotein  con centration
The protein concentrations of XSBD and XDD were determined using their calculated 
extinction coefficients at 280 nm of 9800 and 11380 M '\ respectively. Similarly, E2DD 
preparations were quantitated using a calculated extinction coefficient at 278 nm of 9800 M '\ 
E3 was quantitated using an experimentally determined extinction coefficient of 22600 M‘‘
,3
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3.3.7 M odification o f p rotein s w ith  mPEG m aleim ide
Monomethoxypoiyethylene glycol (mPEG) 5000 maleimide is a thiol reagent that interacts 
covalently with the reduced forms of cysteine and lipoic acid. Proteins (20-30 |xg) were pre­
incubated under reducing or oxidising conditions for 30 minutes at room temperature, 
followed by the addition of 1 mM mPEG 5000 maleimide and further incubation at 25°C for 
30 minutes. Reactions were stopped by the addition of excess DTT (final concentration 35 
mM) and proteins (ca. 13 pg) resolved by SDS PAGE on 12% (v/v) gels.
3.4 Biophysical methods
for the E3 dimer, exploiting FAD absorbance at 450 nm. Since the amino acid sequence of 
bovine E l is not known, the sequence of human E l was used to calculate an extinction 
coefficient of 140000 M'  ^ at 278 nm. Alternatively, BioRad assays (Bio-Rad, Germany) were 
performed to determine protein concentrations by producing a standard curve for BSA and/or 
IgG according to manufacturer’s instructions.
i
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3.4.1 C alculation o f buffer d en sities and v isco sities
Buffer densities and viscosities were calculated from buffer compositions, using the computer 
program SEDNTERP (Laue et al., 1992) (see Table 3.4).
3.4.2 Sed im entation  velocity  analytical 
u ltracentrifugation
Sedimentation velocity (SV) experiments were conducted at 4°C in a Beckman Coulter 
Optima XL-I analytical ultracentrifuge (Palo Alto, USA) using an An-60 Ti rotor and rotor 
speeds of 45000-49000 rpm. Sample concentrations depended on the specific experiment. 
Samples (380 pi or 90 pi) were loaded into 12 mm or 3 mm path length charcoal-filled epon 
double sector centrepieces, respectively. A series of scans was collected using interference 
optics or a combination of interference and absorbance optics. The data were analysed using
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■tthe computer program SEDFIT (Schuck, 2000; Schuck et a l, 2002) which allows the user to 
subtract radial and time-independent noise, and to directly model the sedimentation boundary 
as a continuous distribution of discrete, non-interacting species (c(s) analysis). Sedimentation 
coefficients of cleaiiy defined systems were further evaluated using finite element analysis in 
SEDFIT which finds the sedimentation coefficients that best fit the Lamm equation. More
details can be found in Section 2.2.1.1.
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Buffer Buffer composition Temperature
GC)
Density
(g/ml)
Viscosity
(Poise)
TEB 2 mM EDTA, 4 1.002 0.0159
50 mM Tris-HCl, pH 7.5 20 1.000 0.0102
TEBS50 2 mM EDTA, 
50 mM NaCl,
4 1.004 0.0160
50 mM Tris-HCl, pH 7.5 20 1.002 0.0102
TEBSlOO 2 mM EDTA, 
100 mM NaCl,
4 1.006 0.0161
50 mM Tris-HCl, pH 7.5 20 1.004 0.0103
FEB 2 mM EDTA, 4 1.005 0.0159
50 mM KPO4, pH 7.4 20 1.003 0.0101
Table 3.4 Density and viscosity of buffers used throughout this project
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3,4.3 Sed im entation  equilibrium  analytica l 
ultracentrifugation
Sedimentation equilibrium (SE) experiments were conducted at 4°C in a Beckman Coulter 
Optima XL-I analytical ultracentrifuge (Palo Alto, USA) using an An-60 Ti rotor and rotor 
speeds of 8500-32000 rpm. Sample concentrations depended on the specific experiment. The 
samples (120 pi or 30 pi) were loaded into 12 mm or 3 mm double sector charcoal-filled epon 
centrepieces, respectively. A series of scans was obtained using interference and/or 
absorbance optics. For absorbance optics 20 replicate data sets were recorded in step mode 
using a step size of 0.001 cm over a radial range of 5.7-7.2 cm. Attainment of equilibrium 
was ascertained with WinMATCH (www.biotech.uconn.edu/auf/) until no net movement of 
protein was observed in scans recorded three hours apart. The optical baseline was 
determined by overspeeding at 49000 rpm. SE data were analysed using global analysis in the 
Beckman XL-A/XL-I software implemented in MicroCal ORIGIN in order to obtain
i
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estimates of the whole cell weight-average protein molar mass. Furthermore, the computer 
program SEDPHAT (Schuck, 2003; Vistica et al., 2004) which allows global fitting of more 
than one species was used for the analysis of more complex systems. Analysis of some data 
sets required the inclusion of non-ideality. The data were analysed in ORIGIN, but fitting 
included the second virial coefficient, B. A starting estimate for B was calculated using the 
program COVOL (Harding et al., 1999) based on molecule dimensions and charge. The 
values of the weight-average moleculai' weight, , and B at infinite dilution B^ were 
determined by plotting l/M .^app against concentration (in g/ml), where is the inverse of 
the y intercept and can be calculated fiom the slope.
3.4.4 Isotherm al titration  calorim etry
Isothermal titration calorimetry (FTC) measurements were canied out in a VP-ITC 
microcalorimeter (MicroCal Inc., USA) at 25°C as described by Jung et al. (2002). Briefly, 
all proteins were dialysed overnight against 2 mM EDTA, 0.01% (w/v) sodium azide, 20 mM 
MOPS, pH 7.4. Syringe contents were injected in 10 pi steps into the reaction cell. Data were 
analysed using non-linear regression in the MicroCal ORIGIN software package, assuming a 
simple binding model. ITC experiments and analyses were done by Mrs. Margaret Nutley in 
the laboratory of Prof. Alan Cooper, University of Glasgow.
3.4,5 Sm all angle x-ray scatterin g
Experiments at beamline X33 of the EMBL Hamburg outstation at the storage ring DORIS 
III of the Deutsches Elektronen Synchrotron (DESY) used beam currents of 80-240 mA, an 
electron energy of 2 GeV and a wavelength of 1.54 Â. Data for several different sample 
concentrations were recorded at 10°C using a detector-to-sample distance of 2.6 m, covering 
a range of momentum transfer of 0.01 < .s < 0.42 Â'‘ {s-An^mOfÀ),  where 2^ is the
scattering angle and X the wavelength of the x-rays. The 2D MAR detector was calibrated 
using wet rat tail collagen. Data were collected in 5 x 60 s frames, integrated, normalised to 
the incident beam and corrected for the detector response using the program PRIMUS
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(Konarev et al, 2003). Signs of radiation induced aggregation were checked for by dividing 
the first frame by the last. Frames unaffected by aggregation were averaged, the scattering of 
the buffer was subtracted and the difference curves scaled for concentration (in PRIMUS). 
The final scattering curve was obtained by merging the low angle region of the low 
concentration curve with the high angle region of the high concentration curve in order to 
eliminate the effects of inteiparticle interference. The maximum dimension, and particle 
distance distribution function p(r) were obtained by indirect Fourier transformation using the 
program GNOM (Semenyuk & Svergun, 1991; Svergun, 1992). The radius of gyration Rg 
was obtained by employing both the Guinier approximation and GNOM.
Experiments at beamline 2.1 at the SRS Daresbury, UK were performed using procedures 
similar to those described above. Due to the smaller detector size two different camera 
lengths were used, namely 4.25 m and 1.0 m covering a range of momentum transfer of 0.01 
< s < 0.74 The data were collected in 30 x 60 s frames and were then integrated, 
normalised to the incident beam, checked for aggregation, averaged and corrected for the 
detector response using the computer programs BSL and XOTOKO (Boulin et a l, 1988). The 
scattering of the buffer was subtracted and the difference curves scaled for concentration in 
PRIMUS (Konarev et a l, 2003). As before, the low angle region of the low concentration 
curve was merged with the high angle region of the high concentration curve in order to 
eliminate the effects of interparticle interference. Furthermore, the low angle region of the 
long camera length data was merged with the high angle region of the short camera length 
data in order to produce the final scattering curve. Further data analysis proceeded as 
described above. S:
3.4.6 Sm all angle neutron  scatterin g
Small angle neutron scattering data (SANS) data were obtained on beamline D ll at the 
Institut Laue-Langevin (ILL, Grenoble, France) using a neutron wavelength, A of 6  À. 
Experiments were performed in 1 mm optical path length quartz cuvettes. Samples were first 
prepared in normal buffer and subsequently dialysed extensively against D2 0 -based buffer. 
Low angle scattering data (s = 4:^sin0/À), where 20 is the scattering angle were obtained 
using a detector distance of 1 0  m, while high angle data were recorded at a detector distance
s
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of 3,3 m. An overall 5 -range of 0,0064 <s < 0.203 Â'  ^ was covered. Data collection times of 
3 hours were used per sample and scattering was recorded on a two-dimensional gas detector. 
The computer program windet was used to determine the position of the beam centie on a 
transmission file. A mask file of the beam was subsequently produced using the program 
rmask. Data integration was performed with mils, while xpolly was used to generate a 
detector response file from a vanadium sample transmission, as well as background and HgO 
scattering data. Buffer and sample data were corrected for the detector response and then the 
buffer subtracted from the sample scattering in xpolly. Further details on data treatment can 
be found in Ghosh et a l (1989). The maximum dimension, and particle distance 
distribution function p{r) were obtained by indirect Fourier transformation using the program 
GNOM (Semenyuk & Svergun, 1991; Svergun, 1992). The radius of gyration was 
obtained by employing both the Guinier approximation and GNOM. SANS experiments were 
done by Dr. Phil Callow, Institut Laue-Langevin, Grenoble, France.
3.4.7 C ircular d ichroism
3.5 Computational methods
3.5.1 Sequence alignm ents
Pairwise sequence alignments were performed using EMBOSS-Align 
('www.ebi.ac.uk/emboss/align/). while alignment of multiple nucleotide or protein sequences 
was done with MULT ALIN (Corpet, 1988) ('prodes.toulouse.inra.fr/imiItalin/multalin.html).
6 6
XSBD was dialysed against 50 mM sodium phosphate, pH 7.4. Circular dichroism (CD) 
experiments of 0.5 mg/ml XSBD were performed at room temperature on a JASCO J-810 
spectropolarimeter covering a range of 260-180 nm at a scan speed of 50 nra/min and a 
bandwidth of 1 nm. Results were analysed with the CONTIN program package (Provencher 
& Glockner, 1981; Sreerama & Woody, 2000) in order to obtain numerical estimates of 
protein secondary structure content. All CD measurements and analyses were performed by 
Dr. Sharon Kelly, University of Glasgow.
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3.5.2 H om ology m odelling
Homology models of human E3, the LD and SBD of human E3BP as well as the SBD of 
human E2 were obtained from SWISS-MODEL (Guex & Peitsch, 1997; Peitsch et al., 2000;
Schwede et al., 2003). The crystal structure solved for S. cerevisiae E3 (Toyoda et aï., 1998b)
(PDB ID IJEH) was used as a template for human E3. The E3BP-LD and SBDs of E2 and 
E3BP were based on the NMR structures determined for the human E2-LD (Howard et al.,
1998) (PDB ID IFYC) and B. stearothermophilus E2-SBD (Kalia et al., 1993; Mande et al.,
1996) (PDB BD 2PDD, lEBD), respectively. The lack of structural information for the E3 
His-tag (aa 1-27) meant that an approach using secondary and tertiary structure prediction 
was used to obtain a model structure. JPRED (Cuff et a l, 1998) was employed to assign
..secondary structure to each individual residue. Twenty runs with the tertiary structure 
prediction package DRAGON (Aszodi & Taylor, 1996) were used to obtain a final model of 
the His-tag which was attached to the N-terminus of the E3 homology model in INSIGHT II 
(Accelrys, USA). Energy minimisation of all homology models was performed with the 
computer program QUANTA (Accelrys, USA). All structures were visualised using VMD
(Humphrey et a l, 1996) or Pymol (DeLano Scientific, USA).
3.5.3 H ydrodynam ic m odelling
The program HYDROPRO (Garcia de la Torre et a l, 2000; Garcia de la Torre, 2001) was
■used to calculate the hydrodynamic parameters of high resolution structures. HYDROPRO 
first produces a bead model representing the high resolution structure, which is then 
converted into a shell model where the surface of the molecule is represented by a collection 
of equally sized minibeads. The hydrodynamic properties, including sedimentation 
coefficient and translational diffusion coefficient, are calculated for shell models with 
different minibead sizes. The apparent hydrodynamic parameters are estimated by 
extrapolation to a minibead radius of zero. The van der Waals radii of the initial bead model 
range between 1 .5-2.0 Â, but represent the molecule in vacuo and therefore do not take 
hydration into account. The atomic element radius (AER) is used to adjust the bead radius of 
the initial bead model in order to account for hydration. For proteins an AER of 
approximately 3.3 Â is usually appropriate, although variations do occur (Garcia de la Torre 
et al, 2000). For all calculations in this project the AER was set to 3.0-3.3 Â. All runs were
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performed using at least five minibead radii resulting in shell models with 300-2000 
minibeads. In order to ensure the accuracy of the models and their calculated hydrodynamic 
parameters, the amount of hydration for each model was checked to be within acceptable 
limits for proteins (0.3-0.4 g water/g protein) (Garcia de la Torre, 2001).
3.5.4 Ah initio  m odelling  from  SAXS data
Ab initio shape reconstruction was done using the computer programs DAMMIN (Svergun,
1999) and GASBOR (Svergun et al., 2001; Petoukhov & Svergun, 2003). DAMMIN restores 
the structure as a collection of densely packed beads in a dummy atom model (DAM) inside a 
search volume (a sphere with a diameter corresponding to the maximum particle dimension, 
Dniax)- The program starts from a random configuration and uses a simulated annealing 
algorithm to explore the landscape of acceptable low resolution structures. GASBOR 
represents particles as collections of dummy residues (DR) using one DR per amino acid 
residue. The DRs are randomly distributed within the search volume and simulated annealing 
is used to obtain a chain-compatible spatial distribution. Ten GASBOR models were 
superimposed, averaged and the resulting pdb file used as the initial search space for a final 
DAMMIN reconstruction (see Section 2.4.2.3).
3.5.5 C alculation  o f sca tterin g  curves from  structural 
m odels
Scattering curves for high resolution structures or models and their fits to experimental 
scattering curves were calculated using the program CRYSOL (Svergun et al., 1995) using 
default parameters.
3.5.6 R igid body m odelling
For the purpose of rigid body modelling with the computer program Rayuela (Noilmann et 
al., 2005) the complex structure was defined by several “domains”. Rayuela allows 
translation and rotation of each individual domain, calculates a SAXS curve as well as 1.
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sedimentation coefficient for each composite structure, compares it to the corresponding 
experimental data and determines the lowest energy conformation. Initially, only a single 
domain was allowed to sample different configurations with respect to the remaining 
molecule. Separate runs were performed for each domain. During final runs, fine-tuning of all 
domain positions was achieved by independent movement of all domains.
3,5.7 Superim position  o f d ifferent m odel structures
Superimposition of different ab initio models was done using the computer program 
SUPCOMB (Kozin & Svergun, 2001). SUPCOMB was developed to superimpose low 
resolution structures with each other as well as with high resolution structures. It maximises 
the volume of the two search models in order to optimise superimposition. This approach 
works very well for the superimposition of several low resolution structures of very similar 
shape. However, for the superimposition of the final ab initio model with a high resolution 3'structure the computer program SITUS (Wriggers & Birmanns, 2001; Wriggers & Chacon, 1
2001) was used instead. SITUS was initially developed for combining multi-resolution data 
from a variety of sources, including cryo electron microscopy (EM), electron tomography,
SAXS, protein crystallography and NMR. It uses a vector quantisation method where 3-9 
vectors are assigned to both the low and the high resolution structures. The program then 
attempts to optimise the superimposition of both sets of vectors. Results were visualised 
using the program VMD (Humphrey et al., 1996).
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4.1 Introduction
Until the advent of recombinant DNA technology, purification of proteins from their original 
source was a laborious and time-consuming step that all too often yielded only very small 
amounts of protein. The expression of somatostatin (Itakura et al., 1977), human growth 
hormone (Goeddel et al., 1979a) and insulin (Goeddel et al., 1979b) in bacterial cell cultures 
in the late 1970s heralded a new era for biochemical studies: today many different bacterial 
expression systems are available commercially and are used in most biochemistry laboratories 
to allow large-scale overexpression of recombinant proteins at very low cost.
Another advantage of recombinant DNA technology is the absolute control over the coding 
sequence given to the researcher. Only this development has made protein engineering a 
reality. Furthermore, it allows all types of gene manipulation, including mutagenesis as well 
as the opportunity to study individual domains of multi-domain proteins in isolation. A large 
number of tags added onto the N- or C-terminus of recombinant proteins have been developed
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that aid protein purification and detection: commonly used tags and fusion proteins include, 
for example, His-tags, glutathione S-transferase (GST)- and maltose binding protein (MBP)- 
fusions. His-tags usually consist of 6-10 histidine residues joined onto a protein’s N~ or C- 
terminus via a short linker region. Histidine residues display an affinity for metal ions which 
is exploited for protein purification in metal chelate chromatography where imidoacetate 
groups linked to the resin are loaded with metal ions such as Ni^’*', Zn^ '*' or Co^  ^which in turn 
interact with the His-tag (Lindner et al., 1992). Protein is eluted using imidazole which 
competes with the protein for the metal ions. Glutathione affinity purification is based on a 
similar principle: glutathione 5-transferase (GST) -  a 26 kDa polypeptide -  is fused to the 
protein of interest. During the purification GST interacts with the glutathione in the resin and 
the protein is eluted with a high concentration of glutathione. GST fusion proteins are often 
used for the overexpression of small or insoluble proteins. Thus, the application of protein 
tags can shorten protein purification protocols significantly, often requiring only one or two 
purification steps.
Overexpression of constituent enzymes of PDC is straightforward and routine as evidenced 
by the large number of research papers published that employ recombinant PDC proteins 
from various organisms, including human (Leung et al., 1990; 1996; Quinn et a l, 1993; 
Ciszak et a l, 2001; 2003), porcine (Toyoda et al, 1998a), S. cerevisiae (Stoops et a l, 1992; 
1997; Toyoda et a l, 1998b), B. stearothermophilus (Kalia et a l, 1993; Lessard et a l, 1998; 
Domingo et a l, 1999; Allen et a l, 2005), E. coli (Allen et a l, 1989; Green et a l, 1995, 
Arjunan et a l, 2002), Streptococcus faecalis (Allen & Perham, 1991), A. vinelandii (Schulze 
et al, 1993; Hengeveld et a l, 1999) and nematodes (Klingbeil et a l, 1996; Harmych et a l,
2002), Ail proteins are non-glycosylated and therefore do not require the eukaryotic post- 
translational modification machinery. The recombinant proteins used throughout this project 
were expressed with an N- or C-terminal His-tag, except for the E3BP lipoyl domain (XLD) 
which contains an N-terminal GST-tag. Overexpression of all proteins works very well 
(Brown, 2002) and, with the exception of E l, they are readily soluble. Therefore, the only 
proteins purified from an original source throughout this project were E l and E2/E3BP core 
which were obtained in large amounts from PDC purified from bovine heart muscle.
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4.2 Materials & methods
4.2.1 Subclon ing o f the E3BP subunit b in d in g  dom ain  
(XSBD)
The cD N A  for E3BP is freely available in the public domain (Harris et al., 1997). Primers 
were designed for the amplification o f residues 166-230 o f the mature protein encompassing 
the subunit binding domain o f  E3BP as well as approximately 15 amino acid residues on 
either side o f the domain that form part o f  the linker regions. The SBD  o f E3BP does not 
contain any aromatic amino acids which complicates quantification o f  the purified protein. 
Protein absorbance between 190-230 nm corresponding to the absorbance o f  the peptide bond 
can be used for concentration determination, but is less accurate than using the absorbance at 
280 nm. Therefore, a tryptophan residue was added onto the C-terminal end o f the sequence 
by incorporation o f the corresponding codon into the reverse primer. As the last few  amino 
acids o f this construct form part o f the linker region, the presence o f  a tryptophan residue was 
not thought to have any detrimental effects on protein structure or its interaction with E3. The 
forward and reverse primers include N del and Xhol restriction sites for site-directed cloning 
into pET30a (Fig. 4.1).
F o rw a r d  p r im e r  X S B D h is l66 - 230£
5 ' CGGC|CATATi^AGATTTCCATCCCTGTCAAG 3 '
R e v e r s e  p r im e r  X S B D h is l66 - 230r
5 • GCCgJI^U^CACTCGGTAATCTTGCCCGTTTG 3 '
Figure 4.1 Primer sequences for the subcloning of XSBD
The Ndel and Xhol restriction sites are shown in yellow and green boxes, respectively. Nucleotide 
sequences corresponding to the methionine start codon (ATG) and C-terminal tryptophan (CCA) are 
shown in bold.
PCR reactions were set up using the Expand High Fidelity PCR System  (Roche, USA). A  
typical 50 pi reaction included 1.5 mM MgCE, 200 pM o f each dNTP, 300 nM o f each 
primer, approximately 100 ng o f  D NA template (pET14-X), 100 pg/ml BSA  and 2.6 U o f  
Expand polymerase in Ix Expand reaction buffer. Negative control reactions without D NA  
template were also set up. PCR cycles are shown in Table 4.1.
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Following PCR, samples were subjected to agarose gel electrophoresis on a 2% (w/v) gel and 
the DNA extracted from the gel. The PCR product and recipient plasmid pET30a were 
digested with restriction enzymes Ndel and Xhol for directional insertion into the vector. 
NdeHXhol double digests were set up in a total volume of 40 jxl containing 25 pi DNA, 5 U 
Ndel and 5 U Xhol in Ix Promega buffer D. Reactions were incubated at 37°C for 4 hours. 
The digested DNA was again gel purified and then ligated. For ligation reactions the amount 
of insert: vector DNA was varied, ranging from a tlree- to ten-fold excess of insert DNA. 
Negative controls contained vector DNA only. Ligations were incubated in Ix Rapid Ligation 
buffer (Promega, USA) with 3 U of T4 ligase at room temperature for 3 hours and then 
immediately transformed.
step Temperature
GC)
Time
1 Dénaturation 94 2 min
2 Dénaturation 94 15 s
3 Annealing 52 30 s
4 Extension 72 45 s
Repeat steps 2-4 for 9 cycles
5 Dénaturation 94 15 s
6 Annealing 52 30 s
7 Extension 72 50 s + 5s/cycle
Repeat steps 5-7 for 17 cycles
8 Extension 72 7 min
2
Table 4,1 PCR cycling reactions
Diagnostic restriction digests of pET30a and pET30-XSBD were performed with Pvul or 
double restriction with Pvul and Nhel (both NEB, USA). Reactions were set up containing ca. 
1 pg DNA, 100 pg/ml BSA and 5 U of enzyme(s) in Ix NEB buffer 3 {Pvul single digest) or 
ix  NEB buffer 2 {PvuVNhel double digest). All digests were incubated at 37*^ C for 4 hours 
and subsequently analysed by agarose gel electrophoresis on a 0.8% (w/v) agarose gel. Both 
strands of thiee pET30-XSBD plasmids were sequenced on both strands (MWG, Germany) in 
order to verify the entire coding sequence.
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4.2.2 P rotein  overexpression
Overexpression plasmids were transformed into different bacterial strains as outlined in Table 
4.2. Protein overexpression of His-tagged E3, E3BP didomain (XDD), E2 didomain (E2DD), 
GST-tagged E3BP lipoyl domain (GST-XLD) and coexpression of E2 and E3BP was 
performed using a standard protocol as outlined in Section 3.3.1. XSBD overexpression was 
attempted at 30°C and 15°C for 4 hours and overnight, respectively, following induction with 
1 mM IPTG and its solubility tested as described in Section 3.3.1.
Plasmid E. coli strain Antibiotic^
pET14-E3 BL21 DE3 pLysS Amp, Chi
pET14-XDD BL21 DE3 pLysS Amp, Chi
pGEX2-XLD BL21 DE3 Star Amp
pET30-XSBD BL21 DE3 pLysS 
BL21 DE3 Star
Kan, Chi 
Kan
pET14-E2DD BL2I DE3 pLysS Amp, Chi
pETll-E2
pET28-X
BL21 DE3 pLys5 Amp, Kan, Chi
Table 4.2 E. coli strains and selection conditions used for protein overexpression
4.2.3 P rotein  purification
E3 was purified by a combination of metal chelate and size exclusion chromatography. Its 
His-tags were removed by thrombin cleavage prior to gel filtration. XDD, E2DD and 
E2/E3BP purifications included metal chelate, anion exchange and gel filtration 
chromatography steps. XSBD purification required a sequence of metal chelate, anion 
exchange, cation exchange and size exclusion chromatography steps. Metal chelate 
chi’omatography of all proteins was performed using 100 mM ZnCh to load the column with 
metal ions, except for the purification of XSBD when 100 mM NiCh was used instead. XLD 
was purified by glutathione affinity chiomatography. E l was obtained by a combination of 
sucrose gradient centrifugation of bovine PDC, followed by anion exchange based on a 
method developed by McCartney (1998) (for modifications see Table 4.3) and gel filtration 
chiomatography. A Sephacryl S-300 column was used for size exclusion chiomatography of
I
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ail polypeptides except for XSBD which requii'ed use of a Sephacryl S-100 column 
(Amersham, USA) due to its low molecular weight.
Bovine E2/E3BP core was a by-product of E l purification by sucrose density centrifugation. 
Pellets containing PDC core were homogenised in 50 mM potassium phosphate, 2 M NaCl, 2 
mM EDTA, 0.01% sodium azide, pH 7.4 (see Section 3.3.2.7) and subjected to a second 
round of sucrose density centrifugation in order to remove any remaining molecules of El 
and E3. E2/E3BP core pellets were again homogenised and extensively dialysed against 50 
mM potassium phosphate, 2 mM EDTA, 0.01% sodium azide, pH 7.4.
Technical details of protein purification are given in Section 3.3.2. Details of the buffers used 
for all chiomatography steps are listed in Table 4.3. Protein quantity and quality were 
assessed by SDS PAGE.
4.3 Results and discussion
4,3.1 Subclon ing o f the subunit b ind ing  dom ain  o f E3BP  
(XSBD)
XSBD had been previously cloned into the pGEX2T vector (Brown, 2002). However, protein 
yields were fairly low because the thrombin cleavage required to remove the GST tag also 
digested XSBD non-specifically, especially when the purification was scaled up. Therefore, 
XSBD was subcloned into pET30a resulting in a C-terminally His-tagged protein. Residues 
166-230 of full-length human E3BP were subcloned, resulting in a smaller construct due to a 
reduction in the length of linker sequence included. Amplification of the DNA sequence 
corresponding to amino acid residues 166-230 was successful and yielded the expected 230 
bp product (Fig. 4.2A). Using a directional cloning strategy with restriction enzymes Ndel 
and Xhol, the PCR product was ligated into pET30a resulting in the creation of plasmid 
pET30-XSBD (Fig. 4.2B). The presence of the XSBD coding sequence was confirmed using 
diagnostic restriction digests (Fig. 4.2C) with Pvul and Nhel. The vector pET30a contains 
only a single Pvul site, the Nhel restriction site is present only within the insert. Therefore, 
digestion of pET30a yields only a single linearised fragment of 5422 bp. Similarly, digestion
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Protein Purification Binding buffer Elution buffer Elution
gradient
E3 Metal
chelate
Gel filtration
20 mM Hepes, 100 mM NaCl,
5 mM Imidazole, pH 8.0
50 mM Tris-HCl, 2 mM EDTA, 
pH 7.5 (TEB)
20 mM Hepes, 100 mM NaCl, 
500 mM Imidazole, pH 7.0
0-100%8CV
XDD Metal
chelate
20 mM Hepes, 100 mM NaCl, 
5 mM Imidazole, pH 8.0
20 mM Hepes, 100 mM NaCl, 
500 mM Imidazole, pH 7.0
0-100%8CV
Anion
exchange
25 mM Tris-HCl, pH 7.5 25 mM Tris-HCl, 1 M NaCl, 
pH 7.5
0-100% 
100 CV
Gel filtration 50 mM Tris-HCl, 100 mM NaCl, 
2 mM EDTA, pH 7.5 (TEBSlOO)
XLD GST affinity PBS (140 mM NaCl, 2.7 mM KCl, 
10 mM Na2HP04,1.8 mM KH2PO4, pH 7.3)
50 mM Tris-HCl,
20 mM glutathione, pH 8.0
N/A
XSBD Metal
chelate
20 mM Hepes, 100 mM NaCl, 
5 mM Imidazole, pH 8.0
20 mM Hepes, 100 mM NaCl, 
500 mM Imidazole, pH 7.0
0-100%8CV
Anion
exchange
25 mM Tris-HCl, pH 7.5 25 mM Tris-HCl, 2 M NaCl, 
pH 7.5
0-100% 
30 CV
Cation
exchange
25 mM Tricine, pH 8.5 25 mM Tricine,
1.2 M NaCl, pH 8.5
0-100% 
15 CV
Gel filtration 50 mM Tris-HCl, 2 mM EDTA, 
pH 7.5 (TEB)
E2DD Metal
chelate
20 mM Hepes, 100 mM NaCl, 
5 mM Imidazole, pH 8.0
20 mM Hepes, 100 mM NaCl, 
500 mM Imidazole, pH 7.0
0-100%8CV
Anion
exchange
25 mM Tris-HCl, pH 7.5 25 mM Tris-HCl, 2 M NaCl, 
pH 7.5
0-50% 
80 CV
Gel filtration 50 mM Tris-HCl, 2 mM EDTA, 
pH 7.5 (TEB)
E l Anion
exchange
Gel filtration
20 mM MOPS, 10 mM NaCl,
2 mM EDTA, 1 mM CHAPS, 
pH 7.4
50 mM KPO4, 2 mM EDTA, 
0.01% sodium azide, pH 7.4 (PEB)
20 mM MOPS, 1 M NaCl, 
2 mM EDTA, pH 7.4
0-75% 
100 CV
E2/
E3BP
Metal
chelate
20 mM Hepes, 100 mM NaCl, 
5 mM Imidazole, pH 8.0
20 mM Hepes, 100 mM NaCl, 
500 mM Imidazole, pH 7.0
0-100%8CV
Anion
exchange
20 mM MOPS, 2 mM EDTA, 
0.01% sodium azide, pH 7.4 
(MEB)
20 mM MOPS, I M NaCl,
2 mM EDTA, 0.01% sodium 
azide, pH 7.4
0-100% 
100 CV
Gel filtration 50 mM KPO4, 2 mM EDTA,
0.01% sodium azide, pH 7.4 (PEB)
I
Î
Ï
,1
Table 4.3 Chromatography buffers used during this project
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of pET30-XSBD with Pvul alone results in the formation of a single fragment of 5439 bp. 
However, double restriction with Pvul and Nhel generates two fragments of 4233 bp and 
1206 bp (Fig. 4.2C). Several bands are visible for the single digests of pET30a and pET30- 
XSBD. This is a result of incomplete restriction of the plasmid DNA and the two additional 
bands correspond to relaxed and supercoiled DNA which exhibit different mobilities with 
respect to linear DNA. DNA sequencing confirmed that no mutations had been introduced by 
PCR.
B
lltb 166-230 
ladder -ve R
182-223 
-ve R
50bp
ladder xa«i-s)6iA%«I-S2<2 
;vdrl-S lS8 
T7 promcxer
PET30-XSBD 
5439 bp
Ikb pET30a 
ladder P+N
Ikb pET30a 166-230a
^Relaxed 
3 “ Linear 
—  Supercoiled
Figure 4.2 Production of pET30-XSBD
(A) PCR products obtained for the amplification of E3BP residues 166-230. A second, even shorter 
construct (aa 182-223) was also designed, but was not used in subsequent experiments. The negative 
controls (-ve) and PCR reactions (R) are shown. (B) A map of plasmid pET30-XSBD containing E3BP 
residues 166-230 is shown, including all restriction sites used. (C) Diagnostic restriction digests of 
pET30a and pET30-XSBD (166-230a) were performed with Pvul (P) or Pvul and Nhel (N-hP). Band 
sizes are indicated in bp.
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4.3.2 P rotein  overexpression  o f XSBD
Overexpression of XSBD at 15°C failed to produce any protein at all (results not shown). 
However, induction at 30°C resulted in good yields (Fig. 4.3A) although the protein seems to 
migrate faster than expected for an 8.5 kDa protein. This may be attributed to the presence of 
several proline and glycine residues at the N- and C-termini of the protein that are part of the 
linker regions on either side of XSBD and could cause abnormal migration. All of the 
overexpressed protein was found in the soluble fraction (Fig. 4.3B).
A B
Mw XSBD XSBD Mw
U ti to Sol IB98
■ - 1
*  =  #
}? •
'■ =  M
Figure 4 3  SDS PAGE analysis of XSBD overexpression and solubility
(A) XSBD was overexpressed at 30°C and samples were taken at the time of induction (to) and after 
three hours (tg). (B) In order to determine protein solubility the cells were lysed and the soluble fraction 
(Sol) and inclusion bodies (IB) resolved by SDS PAGE. Bands corresponding to XSBD are indicated 
by arrows. Molecular weights of marker proteins (Mw) are shown in kDa.
4.3.3 P rotein  purification
4.3.3.1 Purification of E3
Previous purification protocols included an initial heat step, exploiting E3’s stability at 65°C. 
However, yields were significantly improved when the heating step was omitted. Sometimes 
small impurities were still visible on SDS PAGE gels following metal chelate 
chromatography, but these were easily removed using gel filtration (Fig. 4.4).
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Figure 4.4 Purification of E3
(A+B) Metal chelate chromatography of E3. Only the last sample injection is shown in the 
cliromatogram. The imidazole gradient used for elution is shown in cyan. Cell extract (Ex), the flow­
through (FT) and fractions collected during the elution gradient were run on SDS PAGE. (C+D) Size 
exclusion chromatography of E3. Protein absorbance was measured at 280 nm (—) and flavin 
absorbance at 450 nm (—). Peak fractions were checked for protein purity by SDS PAGE, Molecular 
weights of marker proteins (Mw) are shown in kOa,
4.3.3.2 Purification of XDD
After the initial metal chelate step XDD preparations still contained a number of 
contaminating proteins and a substantial amount of DNA (Fig. 4.5A,B)- XDD has a low 
calculated isoelectric point (pi 5.7). Therefore, at the pH used during metal chelate 
purification (pH 7.0-8.0) the molecules were negatively charged and should not interact with 
DNA. However, the protein consists of the lipoyl domain -  which has a very low pi (5.0) -  
and the subunit binding domain with a high pi of 9.7. Therefore, at pH 7-8 the SBD is still 
positively charged overall and can interact non-specific ally with the negatively charged 
phosphate groups in DNA. Anion exchange chromatography was used to remove all DNA 
and protein contaminants. It also resolves the lipoylated and non-Iipoylated forms of the
I
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4.3.S.3 Purification of XSBD
XSBD required an extensive purification protocol. Due to its high isoelectric point (pi 9.9), 
XSBD carries an overall positive charge in buffers used during metal chelate chromatography 
and significant DNA contamination was found in protein preparations (Fig, 4.6A,B). Anion 
exchange chromatography was used to remove the DNA. Some XSBD also bound weakly to 
the anion exchange column, although a significant proportion of the protein was found in the 
flow-through as expected (Fig. 4.6C,D). Since some contaminating proteins were still present 
following anion exchange, a further cation exchange step was necessaiy. Cation exchange 
chromatography removed most remaining contaminants: some proteolytic products of XSBD 
were found in the flow-through and contaminants were present in the first peak fraction which 
contained only little XSBD (Fig. 4.6D,E). Pure peak fractions were pooled and either used 
directly in experiments or subjected to an additional size exclusion step (Fig. 4.6F,G) in order 
to remove potential aggregate as well as to provide a means of buffer exchange.
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protein (Fig. 4.5C) whereby the lipoylated protein is eluted from the column first. The 
different lipoylation states of XDD can be visualised by SDS PAGE; the presence of the 
lipoic acid co-factor covalently linked to Lys97 retards the protein in the gel and results in the 
formation of a double band (Fig. 4.5D). Gel filtration was used as a final purification step in 
order to remove aggregates and minor contaminating species (Fig. 4.5E,F). Only lipoylated 
fractions from anion exchange were used for gel filtration and experimental purposes, 
although a very small amount of non-lipoylated protein sometimes remained following size 
exclusion chromatography.
I
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4.3.3.4 Purification of GST-XLD
The purification of GST-tagged XLD was straightforward and required only a single affinity 
purification step using glutathione affinity cliromatography (Fig. 4.7A). When peak fractions 
were run on SDS PAGE no contaminants could be seen using Coomassie blue staining (Fig. I
4.7B). Purified protein was dialysed and used for subsequent experiments.
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Figure 4.5 Purification of XDD
(A+B) Metal chelate chromatography of XDD. Only the last sample injection is shown in the 
chromatogram. All elution gradients are shown in cyan. Protein absorbance was measured at 280 nm 
(—) and 260 nm (—). Cell extract (Ex), the flow-through (FT) and fractions collected during elution 
were run on SDS PAGE. (C+D) HQ anion exchange chromatography of XDD. Only protein fractions 
(A2go>A26o) collected during elution were run on SDS PAGE. (E+F) Gel filtration chromatography of 
XDD. Peak fractions were checked for protein purity and lipoylation. Molecular weights of marker 
proteins (Mw) are shown in kDa.
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Figure 4,6 Purification of XSBD
(A+B) Metal chelate chromatography of XSBD. Only the last sample Injection Is shown in the 
chromatogram. All elution gradients are shown in cyan. Absorbance was measured at 280 nm (—) and 
260 nm (—). The flow-through (FT) and gradient fractions were loaded on SDS PAGE. (C+D) HQ 
anion exchange chromatography of XSBD. The flow-through (FT) and protein peak were loaded on 
SDS PAGE. (D+E) S cation exchange chromatography of XSBD. FT and peak fractions were analysed 
by SDS PAGE. (F+G) Gel filtration of XSBD. The purity of the final XSBD preparation was assessed 
by SDS PAGE. Molecular weights of marker proteins (Mw) are shown in kDa.
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Figure 4.7 Purification of GST-XLD by GST afllnity chromatography
(A) GST-tagged XLD was purified using glutathione affinity chromatography with a single elution step 
(—). (B) The cell extract (Ex), flow-through (FT) and peak fractions were analysed by SDS PAGE. 
Molecular weights of marker proteins (Mw) are shown in kDa.
4.S.3.5 Purification of Ë2DD
Purification o f E2DD was very similar to X D D  purification. E2DD also has a rather low  
calculated isoelectric point (pi 6.1), and similarly consists o f a negatively charged LD (pi 4.5) 
and a positively charged SBD (pi 9.6) at pH 7.0-8.0. Therefore, follow ing initial metal chelate 
affinity purification (Fig. 4 .8A) an anion exchange chromatography step (Fig. 4.8B ) was 
required to remove non-specifically bound DNA. Furthermore, E2D D  also runs on SDS  
PAGE as a double band due to the presence/absence o f lipoic acid (Fig. 4.8C). As before, 
only fractions containing lipoylated protein were further purified by gel filtration (Fig. 
4.8D ,E) in order to remove aggregated protein. In addition, proteolysis did pose some 
problems despite the presence o f protease inhibitors throughout the entire purification. 
However, the amount o f proteolytic products did not exceed 5-10% o f  the total protein 
purified, as judged by SDS PAGE (Fig. 4.8E).
4.3.3.G Purification of E l
E l was obtained from previously purified bovine PDC (see Section 3.3.2.7) by sucrose 
gradient centrifugation. The E2 core pelleted at the bottom o f the ultracentrifugation tube and 
retained a significant amount o f peripherally bound E l and E3 (Fig. 4 .9A). However, the 
majority o f E l and E3 was found unassociated in the gradient fractions. All fractions lacking
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E2 core were pooled and used for HQ anion exchange chromatography in order to separate E l 
from E3. E3 was only slightly retarded on the anion exchange column at pH 7.4 (Fig. 4.9B), 
presumably due to the proximity of its isoelectric point of 6.5, assuming that bovine and 
human E3 have similar pis. The amino acid sequence of bovine E3 (and E l) is not available, 
but the proteins are thought to be very closely related to the human enzymes. Some 
unassociated E l a subunits also eluted in the flow-through. E l eluted in the first third of the 
salt gradient as a double peak, and SDS PAGE confirmed the high purity of the E l 
preparation (Fig. 4.9C). No difference between E l from either peak was visible on the SDS 
PAGE gel, but may represent non-phosphorylated and phosphorylated protein, respectively. 
E l containing fractions were pooled and used for gel filtration chromatography in order to 
remove small amounts of aggregate (Fig. 4.9D,E).
4.S.3.7 Purification of bovine E2/E3BP
Pure bovine E2/E3BP core was obtained by homogenisation of PDC core pellets obtained 
from sucrose density gradient ultracentrifugation (see Section 3.3.2.8), followed by a second 
round of ultracentrifugation. The resultant E2/E3BP pellets were homogenised again and run 
on SDS PAGE to assess the purity of the PDC preparation (Fig. 4.10).
4.3.3.S Purification of human E2/E3BP
Purification of E2/E3BP was very similar to XDD and E2DD purifications, as protein purified 
by metal chelate chromatography (Fig. 4.11A,B) still contained significant amounts of 
contaminating protein and DNA. Peak fractions were pooled and subjected to anion exchange 
chromatography in order to remove all contaminants (Fig. 4.11C,D). Gel filtration 
chromatography was used as a final purification step in order to separate excess E3BP not 
associated with core particles (Fig. 4.11E,F). SDS PAGE shows that despite supplementation 
of E. coli cultures with lipoic acid, both lipoylated and non-lipoylated protein is present in the 
final preparation.
84
4,3 Results & discussion
A
2&-
-00
-20
00
200 20060 120 100
V olum e (ml)
-100
o.os-
-60
20 40 100 120 140 1600 60 00
V o lu m e (m l)
Ex MCMw Gradient fractions
18598
52
31
I?
11
D  020
8g  0 1 6I
60 00 100 120c 20 40
E
Mw
45.0 '"'M it
33.0
20.1 
14.4
V olum e (ml)
Peak fractions
Figure 4.8 Purification of E2DD
(A) Metal chelate chromatography of E2DD. Absorbance readings were recorded at 280 nm (—) and 
260 nm (—). Ail elution gradients are shown in cyan. (B) Anion exchange chromatography of E2DD. 
(C) SDS PAGE analysis of metal chelate and anion exchange chromatography. Cell extract (Ex), 
pooled metal chelate fractions (MC) and fractions collected during elution from the anion exchange 
column are shown. (D+E) Size exclusion chromatography of E2DD. Molecular weights of marker 
proteins (Mw) are shown in kDa.
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Figure 4,9 Purification of bovine El
(A) SDS PAGE of PDC sucrose gradient ultracentrifugation (UC). E la  (*)and E lp  (♦) subunits are 
indicated. (B+C) UC fractions containing bovine E l and E3 only were used for HQ anion exchange 
chromatography. Absorbance readings were recorded at 280 nm (—) and 260 nm (—). The elution 
gradient is shown in cyan. Separate peaks in the flow-through (FT) and during elution are indicated and 
correspond to fractions loaded onto SDS PAGE. (D+E) Fractions from anion exchange peaks 3 and 4 
were used for gel filtration chromatography of E l. Only fractions corresponding to the main GFC peak 
were analysed by SDS PAGE in (E). Molecular weights of marker proteins (Mw) are shown in kDa. Î
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Figure 4.10 Purification of bovine E2/E3BP core
SDS PAGE of homogenised bovine E2/E3BP pellets (HP) 
obtained from two rounds of sucrose gradient ultracentrifugation 
(UC). The positions of E2 and E3BP (X) are indicated. 
Molecular weights of marker proteins (Mw) are shown in kDa,
8 6
4.3 Results & discussion
100
-8 0
0 .9 -
0 6 -
-200 .3 -
00
80 100 120 140 160 180 200 220 240 260 280
I
!i
Volume (ml)c 0.10 100
0 .0 8 - -8 0
0 .0 6 - - 6 0
0 .0 4 - -4 0<
0.0 2 - -20
0 .0 0 -0 20 40 80 80 100 120 140
mI■s
Volume (ml)
40 60 80
Volume (ml)
100 120
B
97.0
66.0
45.0
33.0
20.1
FT M w Gradient Auctions 
gmi
^  •  e »  —  e2
I
•  ?
D
Mw Gradient fractions
97.0 — -
66.0 —
45.0 —
33.0 —
Mw Peak 1 Peak 2
97 0
66.0
Figure 4.11 Purifîcation of human E2/E3BP core
(A+B) Metal chelate chromatography of E2/E3BP. Only the last sample injection is shown in the 
chromatogram. All elution gradients are shown in cyan. Absorbance was measured at 280 nm (—) and 
260 nm (—). The flow-through (FT) and gradient fractions were loaded on SDS PAGE. The positions 
of E2 and E3BP (X) are indicated. (C+D) Anion exchange chromatography of E2/E3BP. Gradient 
fractions were analysed by SDS PAGE. (E+F) Gel filtration of E2/E3BP. The purity of the final 
E2/E3BP preparation was assessed by SDS PAGE. Molecular weights of marker proteins (Mw) are 
shown in kDa.
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4.3.S.9 Yields
Typical yields obtained for all purified proteins used in this project are summarised in Table 
4.4.
Protein Plasmid Yield
E3 pET14-E3 30-40 mg/1
XDD pET14-XDD 20-25 mg/1
GST-XLD pGEX2-XLD 15-20 mg/1
XSBD pET30-XSBD 5-8 mg/1
E2DD pET14-E2DD 15-20 mg/1
El N/A 25-35 mg/kg bovine heart
Human E2/E3BP pETll-E2 3-5 mg/1
pET28-X
Bovine E2/E3BP N/A 100-150 mg/kg bovine heart
Table 4.4 Summary of protein purification yields
8 8 !
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Characterisation of the human E3BP/E3 
subcomplex and its constituents
5.1 Introduction
In mammals PDC consists of a central icosahedral core assembly comprising 60 E2 
polypeptides and 12 copies of the E2-related polypeptide termed E3 binding protein (E3BF) 
(Sanderson et al., 1996b). Basic trimeric units of E2 form the 20 vertices of the icosahedron
■'"i
Ï
with E3BP thought to be bound in each of the 12 faces (Stoops et al., 1997; Zhou et a l,
.2001b), Both E2 and E3BP have a similar, modular domain structure: human E2 and E3BP 
contain two (E2) or one (E3BP) N-terminal lipoyl domain(s) of approximately 80 amino 
acids. Each LD carries a lipoic acid moiety covalently linked to a lysine residue located 
within a conserved DKA motif situated at the tip of a type I (3-turn (Howard et a l, 1998). The 
LD is followed by a subunit binding domain of about 35 residues and a C-terminal domain 
(CTD) of about 250 residues that is essential for core formation (Izard et a l, 1999). In E2 the 
CTD is also the catalytic domain, while the active site motif is not present in E3BP, thus 
rendering it incapable of catalysing the acetyltransferase reaction (Behai et a l, 1989; Harris et 
a l, 1997). All domains are interconnected by long linker regions rich in alanine, proline and 
charged amino acids of approximately 30 residues (Borges et a l, 1990; Perham, 2000), that
89
5.1 Introduction
solution, similar studies on eukaryotic PDC have not been conducted until now. Intriguingly, 
the reported stoichiometries for each of the constituent enzymes of mammalian PDC suggest 
the possibility of formation of 2:1 stoichiometric subcomplexes in this case. Thus, at maximal 
occupancy, 30 E l enzymes can associate with the 60-meric E2 core while 12 E3BP molecules 
associate with 6 E3 dimers (Sanderson et al., 1996b).
This chapter describes the characterisation of the individual proteins and protein constructs 
involved in the interaction of E3BP with E3 as well as the complex itself. Full-length E3 as 
well as two protein constructs of E3BP (Fig. 5.1) consisting of the lipoyl and/or subunit
'impart the necessary flexibility to the LDs to visit all three active sites during catalysis (Green
et al., 1992). In eukaryotes the E2/E3BP core of PDC provides the structural and mechanistic
framework for the tight but non-covalent association of the heterotetrameric E l and
homodimeric E3 enzymes. The stability and overall subunit organisation of the complex are
governed by specific and tight protein-protein interactions between E2-SBD and E l, and
E3BP-SBD and E3, respectively. However, other organisms with icosahedral cores such as
the Gram positive bacterium B, stearothermophilus do not have the gene for E3BP.
Consequently, E l and E3 have to compete for overlapping binding sites on E2; interaction of 
.E2 with either E l or E3 prevents complex formation with the other. Interestingly, PDC- 
deficient patients who totally lack the E3BP subunit possess partial complex activity (10-20% 
of conti'ols) (Ling et a l, 1998), apparently because the SBD of E2 has retained a limited 
ability to mediate low affinity E3 binding.
In B, stearothermophilus PDC, E l and E3 both bind to the SBD of E2 with 1:1 
stoichiometries (Hipps et a l, 1994; Lessard et a l, 1998; Jung et a l, 2002a; 2003). The crystal 
structures determined for the E3/E2-SBD as well as the E1/E2-SBD subcomplexes from B, 
stearothermophilus show unequivocally that association of a second molecule of E2-SBD to 
either El or E3 is not possible. In the case of El the binding site for E2-SBD is located across 
the two-fold axis (Frank et a l, 2005) whereas the binding site on E3 is close to the two-fold 
axis of symmetry (Mande et a l, 1996). Occupation of both binding sites on E3 would result in 
steric clashes in one of the loop regions. A similar arrangement in the crystal structure of 
human E3 bound to E3BP-SBD has been reported very recently (Ciszak et a l, 2006). While 
the 1:1 stoichiometry of bacterial PDC E2-SBD/E1 and E2-SBD/E3 has been confirmed in
I
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binding domains, termed X D D  and X SBD , respectively, were characterised individually in 
vitro. In addition, the stoichiometry and affinity o f the interaction o f E3 with X D D  and X SBD  
were investigated using a range o f  biochemical and biophysical approaches including native 
polyacrylamide gel electrophoresis (PAGE), analytical ultracentrifugation (AUC) and 
isothermal titration calorimetry (ITC). Low resolution structures o f  E3, X SB D  as well as o f  
the com plex formed between X D D  and E3 were obtained by small angle x-ray scattering 
(SA X S).
E3B P(X p)
E3BP-DD
Figure 5.1 E3BP constructs used in this project
Full-length E3BP -  also termed protein X -  consists of three domains; an N-terminal lipoyl domain 
(LD), a subunit binding domain (SBD) responsible for interaction with E3 and a C-terminal domain 
(CT) that associates with E2 to form the icosahedral core of PDC. Two constructs were derived from 
E3BP: a di-domain construct (XDD) consisting of the LD and SBD, as well as XSBD formed solely by 
the subunit binding domain.
5.2 Materials and methods
5.2.1 Sam ple preparation
Individual proteins were purified as outlined in Section 4.2.3. X D D /E3 complex was 
reconstituted from the purified proteins at a stoichiometric ratio o f  3:1 (XDD:E3) using a final 
size exclusion step on a Sephacryl S-300 column (Amersham, U SA ) in TEB buffer (see 4.2.3) 
to remove unbound XDD.
5.2.2 Gel filtration  analysis
Gel filtration chromatography (GFC) was employed to obtain estimates o f the relative 
molecular weights o f E3, X D D  and purified XDD/E3 com plex. A Sephacryl S-300 column
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(Amersham, USA) was standardised with a range of GFC protein markers (Sigma, USA). 
Blue dextran was used to determine the column’s void volume, Vo. The logarithms of protein 
molecular weights were plotted versus the ratio of elution volume to void volume (Ve/Vo) to 
produce a standard curve.
5.2.3 N on-denaturing PAGE
Stoichiometric mixtures of XSBD:E3 from 4:1 to 1:3, as well as XDD:E3 from 10:1 to 1:3 
were prepared, keeping the amount of E3 used constant at 500 pmol. The samples were 
incubated at 25^C for 15 minutes in 25 mM Tris-HCl, pH 7.0. Protein samples (5-15 pg) were 
loaded onto Tris-glycine gels (5% stacking, 8% resolving gel) and subjected to non­
denaturing PAGE. More details can be found in Section 3.3.5.2. Non-denaturing PAGE 
analysis of the XDD:E3 mixtures was performed by Dr. Alison Prior, University of Glasgow.
5.2.4 Sed im entation  velocity  analytical 
u ltracentrifugation
Sedimentation velocity (SV) experiments were performed as described in Section 3.4.2. 
Purified E3 was dialysed against TEBS100 and sedimentation data recorded at 4°C at a rotor 
speed of 45000 rpm, using both interference and absorbance optics in separate experiments. A 
series of 30 scans, 10 minutes apait with a step size of 0.002 cm in continuous mode and three 
averages was recorded for each sample using absorbance optics. A total of 300 scans, 2 
minutes apart, was recorded using interference optics. Sample concentrations ranged from 1.7 
pM to 17 pM. The samples (380 pi) were loaded into 12 mm double sector centrepieces.
Purified XDD was dialysed against 50 mM Tris-HCl, 2 mM EDTA, pH 8.5 and sedimentation 
data recorded at 4°C at a rotor speed of 45000 rpm, using both interference and absorbance 
optics. A series of 150 scans, 5 minutes apart, was recorded for each sample, using a step size 
of 0.003 cm in continuous mode and three averages. Sample concentrations ranged from 7 
pM to 44 pM. The samples (380 pi) were loaded into 12 mm double sector centrepieces.
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Purified XSBD in 50 mM potassium phosphate, pH 7.1 was used for SV experiments 
conducted at 45000 rpm and 4°C and sedimentation data recorded using both absorbance and 
interference optics. A series of 200 scans, 15 minutes apart with a step size of 0.003 cm in 
continuous mode and five averages were recorded for each sample. Sample concentrations 
ranged from 8 |.lM to 50 pM. The samples (380 pi) were loaded into 12 nam double sector 
centrepieces.
For the analysis of stoichiometric XDD:E3 mixtures, samples were prepared by keeping the 
concentration of E3 fixed at 4.9 pM and varying the XDD concentrations accordingly to 
achieve XDD:E3 ratios of 4:1 to 1:3. Samples were dialysed extensively against TEB prior to 
data acquisition. The samples (380 pi) were loaded into 12 mm double sector centrepieces. A 
rotor speed of 45000 rpm was selected and interference optics scans were collected at 4°C 
every minute until sedimentation was complete. SV analysis of the purified XDD/E3 complex 
was conducted as described above for the XDD:E3 stoichiometric mixtures and covered a 
concentration range of 6-44 pM. Sedimentation profiles were analysed with the computer 
program SEDFIT (Schuck, 2000) (see Sections 2.2.1.1 and 3.4.2 for details). Finite element 
analysis in SEDFIT was also used to determine the true sedimentation coefficients of all 
samples. These were extrapolated to infinite dilution to give a sedimentation coefficient 
independent of concentration, •
5,2.5 Sed im entation  equilibrium  an alytica l u ltra­
centrifugation
Sedimentation equilibrium (SE) data were collected for E3, XDD, XSBD, XDD;E3 
stoichiometric mixtures as well as the purified XDD/E3 complex using interference optics. 
All samples used for the collection of SE data had been subjected to SV analysis first and the 
same buffer conditions were used. Details of the experimental set-up can be found in Table
5.1 and Section 3.4.3. Attainment of all equilibrium experiments was ascertained with 
WinMATCH (www.biotech.uconn.edu/aufA when no net movement of protein was observed 
in scans recorded tliree hours apart. SE data were analysed using single experiment and global 
analysis in the Beckman XL-A/XL-I software implemented in MicroCal ORIGIN.
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Alternatively, multi-speed analysis fitting each sample concentration singly as well as 
globally in SEDPHAT (Vistica et al., 2004) as described in Sections 2.2.2.1 and 3.4.3 was 
also used. In order to determine the weight-average molecular weight of samples independent 
of concentration, the apparent weight-average molecular weights, M,v,app determined for 
each sample concentration were extrapolated to infinite dilution.
SE analysis of purified XDD/E3 complex was carried out and the data analysed as described 
above, but included fitting of the second virial coefficient, B. A  starting estimate for B of 
XDD/E3 was calculated using the program CO VOL (Harding et al., 1999) based on molecule 
dimensions and charge. The values of M" and B at infinite dilution, B° were determined by 
plotting 1/M,^ npp against concentration (in g/ml), where M" is the inverse of the y intercept 
and B^ can be calculated from the slope.
Table 5.1 Summary of parameters used for sedimentation equilibrium experiments
5.2.6 Isotherm al titration  calorim etry
XDD and E3 were dialysed overnight in 25 mM Tris-HCl, pH 7,0. E3 at a concentration of
40.7 pM was injected in 10 pi aliquots into the reaction cell containing 6.2 pM XDD at 25°C. 
Purified GST-XLD was exposed to 50 mM DTT for several hours before dialysing both GST-
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Protein Speed
(rpm)
Centrepiece Path length 
(mm)
Volume
(uD
Replicates Step size 
(cm)
E3 12000
17000
Double sector 
or
12 120 20 0.001
g21000 Six channel 12 80 ■ï
XDD 25000 Double sector 3 30 15 0.001 i;29000 or
35000 Six channel 12 80 g:XSBD 25000
35000
45000
Double sector 12 120 15 0.001 •g
XDD:E3 8500 Double sector 3 30 20 0.001
stoichiometric 12000 *mixtures 16000
XDD/E3 10500
15000
18000
Double sector 3 30 20 0.001
'
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XLD and E3 overnight in 50 inM Tris-HCl, 2 mM EDTA, pH 7.5. GST-XLD at a
concentration of 43.6 pM was injected in 10 pi aliquots into the reaction cell containing 4,1 
pM E3. This experiment was done at 10°C and 25"^ C. Data were analysed using non-linear 
regression in the MicroCal ORIGIN software package, assuming a simple binding model (see 
Section 3.4.4). All ITC experiments were performed by Mrs. Margaret Nutley in the 
laboratory of Prof. Alan Cooper, University of Glasgow. The XDD/E3 ITC experiment was 
prepared by Dr. Alison Prior, University of Glasgow.
3
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5.2.7 Sm all angle x-ray scatterin g  and ab initio  
m odelling
SAXS data for E3, XDD and XDD/E3 were collected on beamline X33 of the EMBL
Outstation Hamburg at the storage ring DORIS III of the Deutsches Elektronen Synchi'oton 
(DESY) using a camera length of 2.6 m. Protein concentrations of 1.8, 5.6, 10.8 and 17.5 
mg/ml were used for E3 data collection. XDD scattering curves were obtained for
concentrations of 0.4, 4.8 and 11.1 mg/ml, while XDD/E3 data were recorded for
concentrations of 1.5, 6.3, 9.6 and 22.6 mg/ml. Scattering data for XSBD were obtained on 
beamline 2.1 at the SRS Daresbury, UK using a concentration of 7 mg/ml at a single camera 
length of 1 m. More details can be found in section 3.4.5.
The programs GASBOR (Svergun et al., 2001; Petoukhov & Svergun, 2003) and DAMMIN 
(Svergun, 1999) were used for ab initio reconstruction of E3, XSBD as well as the XDD/E3 
subcomplex. Since E3 is known to be a homodimer with a two-fold symmetry axis, P2
symmetry enabled in GASBOR and DAMMIN was used for reconstructions, while no
symmetry was imposed during the modelling process of XSBD and the XDD/E3 complex. 
More details on ab initio modelling can be found in Sections 2.4.2.3 and 3.5.4.
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5.2,8 H om ology, hydrodynam ic and rig id  body  
m odelling
Homology models of individual proteins and domains were obtained as described in Section 
3.5.2 and superimposed onto ab initio models obtained from small angle x-ray scattering 
where appropriate using the program SITUS (Wriggers & Birmanns, 2001; Wriggers & 
Chacon, 2001). In order to obtain a homology model of the human XDD/B3 complex the 
crystal structure obtained for the E2-SBD/E3 complex (Mande et al., 1996) (PDB ID lEBD) 
was used as a template. Models of XDD/E3 with lipoyl domains in different positions were 
generated (see Section 5.3.3.6) and their sedimentation coefficients, s calculated using the 
program HYDROPRO (Garcia de la Torre et al., 2000; Garcia de la Toire, 2001). For the 
purpose of rigid body modelling with the program Rayuela (Nollmann et al, 2005), the 
complex was defined by five “domains”: E3, XSBDl, XSBD2, XLDl and XLD2. Rayuela 
was used to determine the lowest energy conformation for all five domains as judged by 
comparison to the corresponding experimental data. The best model obtained with Rayuela 
was used for superimposition onto the ab initio model using the program SITUS (Wriggers & 
Birmanns, 2001; Wriggers & Chacon, 2001).
5.2.9 D eterm ination  o f the XDD redox sta te
XDD (30 pg) was pre-incubated with and without 3 mM DTT (reactions 4, 5)’' for 30 minutes 
at room temperature. Control reactions were set up for XDD with 25 pg E3 (reaction 3), 25 
pg E3 and 10 mM NAD^ (reaction 1) or 10 mM NADH (reaction 2). E3BP-LD (XLD) was 
used as a further control: XLD (20 pg) was incubated with 25 pg E3 and 10 mM NAD"  ^or 10 
mM NADH (reactions 6,7). Monomethoxypolyethylene glycol (mPEG) 5000 maleimide was 
added to a final concentration of 1 mM and reactions were incubated at 25°C for 30 minutes. 
Reactions were stopped by the addition of excess DTT and proteins were resolved by SDS 
PAGE. Further information can be found in Section 3,3.7.
Reactions were numbered as they appear on SDS PAGE (Section 5.3.3.8).
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5.3.1 C haracterisation  o f E3
5.3.1.1 Homology modelling
Residues 18-496 of human E3 were successfully modelled using SWISS-MODEL (Guex & 
Peitsch, 1997; Schwede et al., 2003; Kopp & Schwede, 2004) based on the three-dimensional 
structure available for the S. cerevisiae enzyme (Toyoda et al., 1998b). The two sequences are 
very closely related, displaying 58% sequence identity and 75% sequence similarity overall 
(Fig. 5.2A). The interface domain is the most highly conserved domain of E3 with 75%
superimposition of these coordinates with those for the homology model gave a very low ims 
deviation of 0.6 Â: the two structures are almost identical, differing primarily in the NAD 
domain.
5.3.1.2 Analytical ultracentrifugation and hydrodynamic 
modelling
E3 is an obligate homodimer which requires its FAD cofactor for correct folding (Lindsay et 
al,, 2000) and enzymatic function (Klyachko et al., 2005). Sedimentation velocity data (Fig. 
5.3) confirmed the presence of a single main species present in E3 samples, corresponding to 
the E3 homodimer (Fig. 5.3A). A very small amount of a second, larger species with an 
apparent sedimentation coefficient of approximately 8 S can be seen at the highest 
concentration only. The second peak may conespond to a very low concentration of E3 
tetramer or contaminant species. E3 tetramer formation only occurs at high concentrations 
and has been observed before (Klyachko et al., 2005).
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identity and 86% sequence similarity, while the FAD, the NAD and the central domains are
slightly less well conserved with 53%, 50% and 48% sequence identity, respectively. A 
superimposition of the human model with the yeast template shows only relatively small 
differences in backbone positions (Fig. 5.2B).
Very recently, the crystal structures of human E3 complexed both with NAD and NADH 
(PDB ID IZMC, IZMD) have been published (Brautigam et al., 2005). However,
J
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E 3 .  A . a t .  CSRPIELPH FKFS-H RILDSTGA LM LGBVPK SLW IGeGX ICIELGTA yARrG TKV TXLE
2 5 0  2 6 0  2 7 0  2 8 0  2 9 0  3 0 0
E 3 ,  h u m a n  FLOHVBeVGIONBISKllPORILgKOGFKFBLHTKVTOATKKSDORl-PVSIEAASBOKAE 
B 3 .  y a a a t  FgpgiD A -SM D OEV AK ATO KFLK KgoLPFKLSTKV ISAKlUiBPKllW EX W BPTK niK gE 
E 3 ,  A . a t .  0 AGE XL E -  GFEK#* AAXIKKRL KKKGVEWT HALAK6AEBBBD G VTVTXEAEOETK
3 1 0  3 2 0  3 3 0  3 4 0  3 5 0  3 6 0
E 3 ,  h u m a n  VlTCBVLLVCIORRPFTUILOLEELOXELOPRGRIPVETRFOTKXPHnrAIGDVVAGPlIL 
E 3 .  y a a a t  ELEAEV1.LVAVGRRPEXA G IOAEKIOLEVDKRGRtVXX»AgfEEKFPM IKW GDVTFGPM L 
E3 , A . a t . TIPAAIVLVTVORHPETPBLOLEqiGllO iTA HG LIEVPQ QCRTEV PM IFA IOPIVPO PAL
3 7 0 3 8 0 3 9 0 4 0 0 4 1 0
E 3 ,  h u m a n  AHKAEPEGIICVEGHABGAD H I P n  CVPSVXYTHPEVRWVGKSEEgLKEEGIE 
E 3 ,  y a a a t  AKKAEBE6IAAVEMLKT6NC HVHXE EXPSVMySHPEVAVVGKTF.BQLKEAGIP' 
E 3 .  A . a t .  AHKASrECKVAAEAXAPHPi AVPM hlPAW FSDPECAEVGYFEOOAKPEGIP
4 3 0  4 4 0  4 5 0  4 6 0  4 7 0
B 3 , h u m a n  FAAHSRAXTMADrPGMVKIL6«KSTPRVLGAHILGP6AGEMVHEAALJl07 
B 3 .  y a a a t  FAAHSRAKTMgDTEGFVKXLIPSICTERXI.GAMX I6PMAGD11AEAGLR LEY 
E 3 ,  A . a t .  FAAMORALALEPTPOFLKLW RKEPQVIIGAgXIGPW ASPM IAELCLlttEAl
E 3 ,  h u m a n  
E 3 ,  y a a a t  
E 3 ,  A . a t .
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Figure 5.2 Sequence alignment and homology modelling of human E3
(A) The amino acid sequences of human, yeast and B. stearothermophilus E3 were aligned. The FAD 
( ), NADH ( ), central (—), and interface (—) domains are indicated. Residues known or thought to be 
involved in binding of the subunit binding domain of E3BP are boxed. Residues identical in all three 
sequences are shown in purple, amino acids identical in two of three sequences are shown in green, and 
residues whose charge has been conserved are depicted in blue. (B) Front view of superimposed yeast 
and human E3. Yeast E3 is coloured according to secondary structure in purple (helix), yellow (sheet), 
and cyan (turns), while the human homology model is shown in grey.
98
5.3 Results and analysis
Finite element analysis with a single-species model yields the true sedimentation coefficients 
for E3 at all experimental concentrations. These were then extrapolated to infinite dilution to 
give a sedimentation coefficient for E3 independent of concentration of jfo.iv-- 5.83 ± 0.02 S
and 5.81 ± 0.03 S determined from absorbance and interference data, respectively (Fig. 5.3B). 
The sedimentation coefficient is lower than that of a hydrated sphere of the same mass and 
partial specific volume as E3 (s -  6.7 S), indicating an increase in its hydrodynamic radius 
and thus elongation in shape.
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Figure 5.3 Sedimentation velocity analysis of E3
(A) c(j) distribution from SV absorbance data collected for a range of E3 concentrations (— 1.7 pM, — 
2.4 pM, — 5.1 pM, — 6.7 pM, — 8.7 pM, — 12 pM, — 17 pM). (B) Determination of concentration 
independent jfo.w foi' E3 data recorded using absorbance (-*-) and interference optics (□, dashed line).
The high resolution structures determined for E3 from other organisms, such as yeast and B. 
stearothermophilus all show butterfly-shaped molecules. Hence, this increase in the 
hydrodynamic radius of E3 was expected. HYDROPRO was used to obtain a calculated 
sedimentation coefficient of 5.7 S for the homology model of the human E3 dimer. The result 
agrees very well with the experimentally determined value of 5 of 5.8 S. The slight difference 
in the calculated and experimental values of s are presumably due to slight differences in the 
structure of human E3 when compared to the model.
The dimeric nature of E3 was also confirmed by sedimentation equilibrium experiments 
where the molecular weight of E3 was determined to be 101 ± 3 kDa, in good agreement with
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the value predicted from the E3 amino acid sequence of 106 kDa (Fig. 5.4). Analysis of the 
individual SE data sets using a single species model in SEDPHAT shows an increase in the 
apparent molecular weight, Mn,,app with increasing E3 concentration, indicative of the presence 
of a second, higher molecular weight species, in agreement with observations from SV.
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Figure 5.4 Sedimentation equilibrium analysis of E3
^w.app was determined for each sample and extrapolated to zero concentration. Data from the same cell 
but recorded at different speeds were analysed simultaneously using the multi-speed equilibrium 
routine in SEDPHAT with a single species model. The calculated molecular weight of dimeric E3 is 
indicated by an aiTow.
Using global analysis and fitting of a second component, the of the main species was 
102 ± 4 kDa while the M^ .app of the second species was determined to be 182 ± 4 kDa which 
is somewhat lower than the calculated molecular weight of the E3 tetramer of 212 kDa. The 
data could not be fitted satisfactorily with a self-association model, possibly due to the small 
amount of tetramer present. Alternatively, the second species may represent a contaminant 
protein not visible in SDS PAGE gels. Presence of a contaminant protein seems more likely 
as E3 was purified using gel filtration chromatography prior to AUC experiments which 
should separate the E3 dimer and tetramer species. Furthermore, the use of gel filtration is 
supposed to prevent more tetramer formation (Klyachko et al., 2005). A higher molecular 
weight contaminant would be expected to co-elute with E3 assuming it is more globular in 
shape than E3 itself.
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5.3.1.3 Small angle x-ray scattering and ah in itio  modelling
The scattering curve obtained for E3 (Fig. 5 .5A ) also confirms its status as a homodimer 
using a molecular weight estimate obtained by extrapolation o f  the scattering intensity to zero 
angle, 1(0) o f 112 kDa. The slightly elevated value is due to experimental error. Guinier 
analysis and the program GNOM (Semenyuk & Svergun, 1991; Svergun, 1992) were used to 
determine the radius o f  gyration, /?g to be 38 ±  1 Â and 37 ±  1 Â, respectively. The distance 
distribution function, p{r) (Fig. 5.5B ) shows the slightly elongated shape o f  E3 and was used 
to estimate the maximum particle dimension, D^ax, o f  130 Â. The Rg and D^ax determined for 
the E3 hom ology model with the program CRYSOL (Svergun et al., 1995) were 32 Â and 
129 Â, respectively and therefore agree very well with the experimental values. This clearly 
indicates that the hom ology model -  and by implication the yeast structure -  adequately 
describes the molecular shape o f  human E3.
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Figure 5.5 Small angle x-ray scattering of E3
The scattering curve for E3 (—) and the shape scattering curve from GNOM (—) are shown in (A). The 
distance distribution p{r) (B) was calculated using GNOM. Error bars are shown but not visible due 
their small size.
Crystallisation o f E3 was attempted in order to determine its structure at high resolution, but 
all protein crystals obtained were unsuitable for structure determination; similar observations 
have been made previously for the crystallisation and structure determination o f porcine E3 
(Toyoda et al., 1998a). Instead, the SA X S data were used to obtain a three-dimensional 
structure o f E3. Recently, the high resolution structure o f human E3 has been solved 
(Brautigam et al., 2005).
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Ab initio modelling of E3 scattering data with GASBOR and DAMMIN produced an 
elongated particle, which superimposes well onto the E3 homology model (Fig. 5.6) despite 
being somewhat more anisotropic than the homology model. Only the NAD domain of E3 is 
not satisfactorily positioned within the electron density of the model, presumably because of 
differences between the solution and crystal structures. Superimposition of the atomic 
structures determined for human and yeast E3 revealed only relatively minor differences in 
backbone positions. However, possible rearrangements in the E3 solution structure with 
respect to the crystal structure can be accommodated within the model density. A theoretical 
sedimentation coefficient of 5.82 S assuming a hydration of 0.36 g/g was calculated for the ab 
initio model using HYDROPRO, in excellent agreement with the sedimentation velocity data 
obtained for E3 ( = 5.8 S).
Figure 5.6 Superimposition of the homology and ab initio models of E3
Front and side views of a superimposition of the ab initio model (blue wiremesh) and the homology 
model of human E3 (cartoon).
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5.3.2 C haracterisation  o f XDD and XSBD
Full-length E3BP is difficult to work with owing to its tendency to aggregate and precipitate. 
In order to circumvent these problems two shorter constructs consisting of the E3BP lipoyl 
and/or subunit binding domains, termed XDD and XSBD, respectively, were used instead.
5.3.2.1 Homology modelling of XDD and XSBD
The LD and SBD are reasonably well conserved, exhibiting 36% and 34% sequence identity 
with the corresponding E2 domains from B, stearothermophilus, respectively (Fig. 5.7). Due 
to a lack of structural information on the linker region connecting the lipoyl and subunit 
binding domains, a complete homology model of the E3BP didomain (XDD) could not be 
constructed.
The LD and SBD were therefore modelled independently using human and Bacillus E2 
domains as templates, respectively (see Section 3.5.2). The structure of the E2-SBD used for 
modelling comprises only the minimum number of amino acid residues required for binding 
of E2 to E l and E3 in Bacillus. Therefore, not all residues of the E3BP subunit binding 
domain (XSBD) construct used are accounted for in the homology model. In order to produce 
a model structure for the didomain construct, both domains were placed approximately 65 Â 
apart, based on previous EM data (Zhou et al., 2001a; 2001b) and overall PDC dimensions.
5.3.2.2 Analytical ultracentrifugation of XDD
SV data show that XDD is monodisperse at low concentrations, although formation of dimers 
can be observed at concentrations higher than approximately 0.4 mg/ml (22 pM) (Fig. 5.8A), 
while fonnation of high-order oligomers and aggregate occurs at concentrations above 3 
mg/ml (data not shown).
Finite element analysis of the SV data, assuming the presence of two species, yields the true 
sedimentation coefficients for XDD at all experimental concentiations. These were then
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10 20 30 40 50 60
E 2, human SLPPHQKVFLPSLSPTMQAGTlAiarEKKEGDKINEGDLlAEVETDKATVGFESLEECYHA
E3BP, human ------------------------------------------------------------------------------------------------------------
E 2 ,  B . a r t .  ---------------------------------------------------------------------------------------------------------------------------------------------
70 80 90 100 110 120
E 2 , human KILVAEGTRDVPIGAIICITVGKPEDIEAFKNYTLDSSAAPTPQAAPAPTPAATASPPTP
E3BP, human ------------------------------------------------------------------------------------------------------------
E 2 , B . s t .  ----------------------------------------------------------- ------------------------------------------------
130 140 150 160 170 180
E2,  human SAQAPGSSYPPHMQVLLPALSPTMTMGTVQRWEKKVGEKL SEGDLLAE IE TDKATIGFEV
E3BP, human ---------------- GDPIKILMPSLSPTMEEGHIVKWLKKEGEAVSAGDALCEIETDKAVVTLDA
E 2 ,  B . s t .  ---------------- -MAFEFKLPPIGEGIHEGEIVKWPVKPGDEVHEDDVLCEVqHPKAWEIPS
190 200 210 220 230 240
E2/  human QEEGYLAKILVPEGTRDVPLGTPLCIIVEKEAD ISAFABYRPTEVTDLKPQVPPPTP
E3BP, human SDDGILAKIWEEGSKHIRLGSLIGLIVEEBEDtlKHVElPKDVGPPPFVS-KFSEPRPSP 
E 2 , B . s t .  PVKGKVLEILVPEGIVAIVGOTLITLDAPGYEH------------------------------------------------ -MTFKGQEQEEAKKE
250 260 270 280 290 300
E 2 , human PPVAAVPPTPgPLAPTPSTPCPATPAGPKGRVFVDPLAKKLAVEKGl------------ DLTQVK
E3BP, human EPQISIPVKKEHXPGTLRFRLSPAAJRNILEKHSLDASQGTATGPRGIFTKEDALKLVQLK 
E 2, B . s t .  EKTETVSKEEKVDAVRPMAPAAEAEAGPHRRVIAMPSVRKmREKGV------------ DIRLVQ
310 320 330 340 350 360
E2 , human GTGPDGRITKKDIDSFVPSKVAPA--------------PAAWPPTGPGUAPVPTGVFTDIPISMI
E3BP, human QTGKITESRPTPAPXftTPTAPSPLQATAGPSYPRPVIPPVSTPGQPHAVGTFTEIPASNl 
E 2 , B . s t .  GTGKHGKVLKEDIDAFLA6GAKPAPAAA EEKAAPAAAKPATTEGEFPETREKMSGI
370 380 390 400 410 420
E 2, human RRVIAQRLHQSKQTIPlfïïLLS-CKYGEVLLVRKELHKILEGR-SKISVNDFIlKASALA
E3BP, human RRVIAKRLTESKSTVPHAYATADCDLGAVLIWRQDLVK DD-IKVSVITDFIIKAAAVT
E 2, B . s t .  RRAIAKAMVHSKHTAPHVTLMDEADVTKLVAHRKKFKAIAAEKQIKLTFLPXWKALVSA
430 440 450 460 470 480
E2 , human CLKVPEAIISSWMDTVIR— QHHWDVSVAVSTPAGLITPIVFHAHIKGVETIAHDVVSLA
E3BP, human LKQHPDVHVSWPGEGPK— QLPFIDISVAVATDKGLLTPIIKDAAAKGIQEIADSVKALS 
E 2, B . s t .  LREYPVLMTSIDDETEEIIOKHYYHIGIAADTDRGLLVPVIKHAPRKPIFALAQEIHELA
490 500 510 520 530 540
E 2, human TKAREGKLQPHEFQGGTFTISNLGMFGIKHFSAIIHPPQACILAIGASEDKLVPADHEKG
E3BP, human KKARDGKLLPEEYQGGSFSISHLGMFGIDEFTAVIMPPOACILAVGRFHPVI.KLTEDEEG 
E 2, B . s t .  EKARDGKLTPGEMKGASCTITHIGSAGGqwrTPVIMHPEVAILGIGRIAEKPIVRDGE—
550 560 570 580
E2 , human  FDVASMMSVTLSCDHRWDGAVGAQIW1JUEFRKÏI.EKPITMLL —
E3BP, human HAKLQQRQLITVTHSSDSRWDDELATRFLKSFKAHLEHFIRLA-----
E 2 , B . s t .   IVAAPMLAl. SL SFPHRMID GATAQKAI HHIKRU ■ SPPELLLMEA
Figure 5.7 Sequence alignment of E2 and E3BP
The amino acid sequences of human E2 and E3BP and B. stearothermophilus E2 were aligned. The 
lipoyl domains (—), subunit binding domain (—) and C-terminal acetyltransferase domain (—) are 
indicated. Residues identical in all three sequences are shown in red, amino acids identical in two of 
three sequences are shown in green, and residues whose charge has been conserved are depicted in 
blue.
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extrapolated to infinite dilution to give s for XDD independent of concentration of =
1.87 ± 0.03 S and 1.91 ± 0.02 S determined from absorbance and interference data, 
respectively (Fig. 5.SB). Again, the value obtained for the XDD sedimentation coefficient is 
lower than that calculated for a hydrated sphere (s = 2.3 S) in accordance with previous 
observations in which the linker region has been described as a flexible, yet extended 
structure (Green et al., 1992). The elongated sti’ucture of XDD was therefore expected and 
confirms observations from size exclusion chromatography (see Section 5.3.3.2).
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Figure 5.8 Sedimentation velocity analysis of XDD
(A) c(s) distribution of SV absorbance data collected for a range of XDD concentrations (— 7.3 pM, — 
14.7 pM, — 22.0 pM, — 29.3 pM, — 32.9 pM, — 36,6 pM, — 43.9 pM). (B) Determination of 
concentration independent for XDD data recorded using absorbance (-*-) and interference optics 
(□, dashed line).
SE data obtained for XDD show a rise in the apparent whole cell, weight-average molecular 
weight, with increasing sample concentration, indicative of self-association and/or
aggregate formation (Fig. 5.9). The molecular weight of XDD independent of concentration, 
M" was determined to be 27.1 ± 1.8 kDa, which is considerably higher than the molecular' 
weight predicted from its amino acid composition of 19.7 kDa. Similarly, M,y,app of XDD 
obtained from global analysis with a single species was 25.2 ± 4.0 kDa. However, data fits 
improved considerably when two species were used for global analysis of the SE data with 
molecular weights of 20.5 ± 3.8 kDa and 35.5 ± 3.8 kDa, respectively. The molecular weight 
of the second species is a little lower than expected for an XDD dimer (39.4 kDa), but within
J
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the limits of experimental error. However, the data could not be fitted satisfactorily with a 
self-association model.
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Figure 5.9 Sedimentation equilibrium analysis of XDD
was determined for each sample and extrapolated to zero concentration. Data from the same cell 
but recorded at different speeds were analysed simultaneously using the multi-speed equilibrium 
routine in SEDPHAT with a single species model. The calculated molecular weight of XDD is 
indicated by an arrow.
The existence of E3BP dimers has been suggested before (Sanderson et ah, 1996b; Hiromasa 
et ah, 2004), but was unexpected in this experiment because the authors described the C- 
terminal domain of E3BP as responsible for self- as well as E2 association. The C-terminal 
domain is absent from the XDD construct, while both the lipoyl and subunit binding domains 
seem unlikely candidates for dimer formation -  certainly such an interaction has never been 
reported. Lastly, the N-terminal His-tag could be responsible for dimérisation, however, due 
to the presence of a metal chelator, EDTA, in the buffer this seems unlikely. His-tag induced 
dimer formation is commonly caused by leaching of metal ions from the column during metal 
chelate purification. Most probably, the results represent the initial stages of aggregate 
formation which has been observed before, especially for XDD concentrations above 0.4 
mg/ml.
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Data were also analysed taking into account non-ideality arising from the elongated shape and 
charge of XDD by fitting of the second virial coefficient, B. Agreement of M,„,app from global 
analysis (20.2 ± 2 .5  kDa) with the expected molecular weight of XDD was substantially 
improved, although a small concentration-dependent increase in from analysis of
individual cells was still apparent. The values obtained experimentally for the second virial 
coefficient, B of 10.3 x 10"^  ml mol g^, 8.6. x 10'  ^ml mol g'^ and 9.1 x 10'  ^ ml mol g'  ^ (for 
rotor speeds 25000, 29000 and 35000 rpm, respectively) correspond well to B calculated with 
COVOL (Harding et ah, 1999) of 8.4 x 10'  ^ml mol g' .^
5.3.2.3 Small angle x-ray scattering of XDD
SAXS analysis of XDD was problematic, as the protein has a tendency to aggregate at the 
concentrations required for SAXS experiments. In order to circumvent this problem XDD was 
kept at low concentrations (< 0.4 mg/ml) and only concenfrated immediately prior to SAXS 
experiments. However, even this approach could not prevent protein aggregation as evidenced 
by the molecular weight values estimated from the scattering intensity to zero angle, 1(0): Mw 
increased from 25 kDa to 33 kDa and 80 kDa for sample concentrations of 0.4 mg/ml, 4.8 
mg/ml and 11.1 mg/ml with a concomitant increase in R^. The scattering data obtained for the 
lowest concentration sample seem to be alone in not containing a significant amount of 
aggregate as the difference in molecular weight compared to the calculated value of 19.7 kDa 
is within the experimental eiTor -  molecular weight estimation using SAXS is not particularly
S"
accurate. However, due to the low sample concentration the data are noisy and could not be 
used for ab initio modelling. The elongated structure of XDD is still apparent from the 
scattering curve (Fig. 5.10A), as expected from previous cryo-EM data of PDC (Zhou et al., 
2001b). In contrast, the of 25 Â determined from the XDD distance distribution function, 
p{r) (Fig. 5.10B) is much shorter than the anticipated length of 80-100 Â. The reason for this 
large discrepancy is probably the poor statistics of the data. Since the LD and SBD are 
interconnected by an extended polypeptide chain, scattering from the two domains -  due to 
their larger size -  is thought to dominate the scattering pattern, while scattering from the 
linker is very weak. The two domains aie similar in size and their longest dimension is 
approximately 25 Â, corresponding to the observed in the distance distribution function 
shown in Fig. 5.10B, Usually this problem would be overcome by increasing the sample
5.3 Results and analysis
concentration and thus acquiring data with improved statistics, but this was not possible for 
XDD.
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Figure 5.10 Small angle x-ray scattering of XDD
The scattering curve for XDD at 0.4 mg/ml (—) and the shape scattering curve from GNOM (—) are 
shown in (A). The distance distribution p{r) (B) was calculated using GNOM.
5.3.2.4 Circular diehrolsm of XSBD
Western blotting with antibodies raised against bovine full-length E3BP was employed 
initially to confirm XSBD identity (data not shown). In addition, circular dichroism (CD) was 
used to determine correct protein folding (see Section 3.3.7). From the CD spectrum and 
comparison against typical proteins, XSBD was found to consist of 35% a-helix, 7% P-sheet, 
23% turns with 35% of residues left disordered, consistent with a folded subunit binding 
domain surrounded by linker residues present in an extended conformation.
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5.3.2.5 Analytical ultracentrifugation of XSBD
SV experiments confirm that XSBD is monodisperse over a wide concenti’ation range (Fig. 
5.11 A). Using finite element analysis of the data in SEDFIT the true sedimentation 
coefficients of XSBD were determined for each sample and extrapolated to infinite dilution to 
determine “  1.06 ± 0.02 S and 1.08 ± 0.02 S for absorbance and interference data,
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respectively (Fig. 5.1 IB), The sedimentation coefficient calculated for an equivalent hydrated 
sphere was 1.26 S, indicating that XSBD is somewhat elongated in shape as part of the linker 
regions are present on either side of the domain proper.
A
i:
B 1.4
1.3-
1.2-
&
i
0.8-
0.7
20 30 40
Concentration (f<M)
Figure 5.11 Sedimentation velocity analysis of XSBD
(A) c(j') distribution of SV interference data collected for XSBD (— 8.5 pM, — 25.5 pM, — 50.2 pM).
(B) Determination of concentration independent for XSBD data recorded using absorbance (-*-) 
and interference optics (□, dashed line).
SE data confirm the monodisperse nature of XSBD, Only a very slight rise in the apparent 
whole cell molecular weight, M,^ ,app with increasing sample concentration is apparent in Fig, 
5.12. The molecular weight independent of concentration, M" was determined to be 9.6 ± 
2.0 kDa, in good agreement with the calculated molecular weight of 8.5 kDa.
Similarly, using global analysis with a single species the molecular weight of XSBD was 
determined to be 9.9 ± 4.4 kDa. The fit to the data was improved further by using global 
analysis with two species, resulting in molecular weights of 8.8 ± 3.7 kDa and 13.2 ± 3.7 kDa, 
respectively. The second species presumably represents a small amount of XSBD dimers 
and/or contaminating protein. However, as shown in Fig. 5.12, the effect of the second 
species on the XSBD equilibrium data is negligible over a large concentration range.
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Figure 5,12 Sedimentation equilibrium analysis of XSBD
Mw,app was determined for each sample and extrapolated to zero concentration. Data from the same cell 
but recorded at different speeds were analysed simultaneously using the multi-speed equilibrium 
routine in SEDPHAT with a single species model. The calculated molecular weight of XSBD is 
indicated by an arrow.
5.3.2.6 Small angle x-ray scattering and ab in itio  modelling of 
XSBD
Due to a lack of protein, scattering data for XSBD were recorded only for a single 
concentration. However, inspection of the low angle region of the scattering curve (Fig. 
5.13A) did not reveal any indication of inter-particle interference. The radius of gyration, /?g, 
as determined using the Guinier approximation is 20 ± 1 Â. The distance distribution 
function, p{r) is shown in Fig. 5.13B. The is 69 ± 2 Â and the calculated from thep{r) 
function is 21 ± 1 À, in good agreement with the value obtained from the Guinier 
approximation. The Rg and determined for the XSBD homology model with the program 
CRYSOL were 10 Â and 24 Â, respectively, and thus considerably lower than the values 
determined for Rg and D^ a^x experimentally. This discrepancy can be explained by the absence 
of a total of 37 residues from the N- and C-terminal linker regions of XSBD due to a lack of 
structural information.
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Figure 5.13 Small angle x-ray scattering of XSBD
The scattering curve of XSBD (—) and the shape scattering curve from GNOM (—) are shown in (A). 
The distance distribution p{r) (B) was calculated using GNOM. Error bars are shown, but not visible 
due to their small size.
The ab initio model of XSBD (Fig. 5.14) clearly shows this increase in size with respect to 
the homology model. The central domain of the ab initio model was superimposed separately 
with the XSBD homology model in SITUS and the fit works very well. However, the regions 
thought to accommodate the XSBD N- and C-terminal linker regions are considerably larger 
than expected. A SAXS curve contains time-averaged as well as radially averaged structural 
information. As both linkers are thought to be reasonably flexible they will adopt a large 
variety of slightly different conformations over the time-scale of the experiment. This is 
reflected in the ab initio model where both termini resemble separate domains rather than 
extended polypeptide chains.
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5.3.3 Cross-bridge form ation  b etw een  E3BP and E3 
5.3.3.1 Preparation of the XDD/E3 subcomplex
The XDD/E3 subcomplex was reconstituted from purified proteins at a ratio of 3:1 
(XDD:E3). Due to the large difference in molecular weight between the XDD/E3 complex 
and XDD, the two species were easily separated by size exclusion chi'omatography (Fig. 
5.15A) where the complex elutes from the column first, followed by uncomplexed XDD (Fig. 
5.15B). The XDD/E3 complex is very stable; E3 is extremely protease resistant (Lindsay et
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Figure 5.14 Superimposition of the homology and ab initio models of XSBD
Top (A) and side (B) views of the XSBD homology model (cartoon) superimposed onto the ab initio 
model (blue wiremesh).
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Figure 5.15 Purifîcation of the XDD/E3 suhcomplex
Gel filtration chromatography (GFC) of XDD/E3 (A). The peaks corresponding to XDD/E3 (1) and 
XDD (2) are indicated. Protein absorbance was recorded at 280 nm (—) and 260 nm (—). The protein 
peaks obtained from GFC were analysed by SDS PAGE (B). The positions of E3 and XDD are 
indicated. Molecular weights (Mw) are shown in kDa.
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al, 2000) and also protects XDD from proteolytic cleavage, while uncomplexed XDD is very 
sensitive to the presence of proteases (Fig. 5.15B).
d.3.3.2 Gel filtration analysis of XDD/E3 and its constituent 
proteins
When compared to the standard curve (Fig. 5.16) only the molecular weight of E3 is 
consistent with the molecular weight calculated from its amino acid composition of 106 kDa. 
Estimates for the apparent molecular weights, Mwapp, of XDD and the XDD/E3 complex of 
approximately 60 kDa and 300 kDa fai’ exceed their predicted molecular weights of 19.7 kDa 
and 144 kDa, respectively. This is indicative of the anisotropic shapes of the molecules and in 
consequence of their enlarged hydrodynamic radii when compared to other globular proteins 
of similar molecular weights. This result confirms the data obtained for XDD (see Section 
5.3.2), E3 (see Section 5.3.1) and XDD/E3 (see below) by AUC and SAXS.
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Figure 5.16 Molecular weight determination using gel filtration chromatography
A Sephacryl S-300 gel filtration column was standardised using globular proteins of known molecular 
weights. The logarithm of the molecular weights was plotted versus the ratio of elution to void volume 
(Ve/Vo) in order to obtain a standard curve. The elution positions of XDD, E3 and the XDD/E3 
complex are indicated.
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5.3 3.3 Non-denaturing PAGE
Initial binding studies were carried out by mixing either X SB D  or X D D  with E3 at different 
molar ratios and subjecting them to non-denaturing PAGE. The addition o f  X SBD  or X D D  to 
E3 results in a noticeable bandshift which increases as more X SB D  or X D D  is added. At a 
stoichiometry o f  2:1 all o f  the E3 present is shifted into the lower mobility band 
corresponding to the XSBD/E3 (Fig. 5.17A ) or XDD/E3 (Fig. 5.17B ) complex. At 
stoichiometries lower than 2:1, excess E3 is seen (Fig. 5.17), while at stoichiometries higher 
than 2:1, excess X D D  remains (Fig. 5.17B). At the pH used to conduct non-denaturing PAGE 
(pH 8.8), X SB D  m oves towards the cathode and thereby out o f  the gel due to its high pi o f  
9.9. N o intermediates in com plex formation have been observed.
XSBD:E3
4:1 3:1 2:1 1:1 1:2 1:3 1:4 E3
B XDD:E3 E3 XDD
10:1 8:1 6:1 5:1 4:1 3:1 2:1 1:1 1:2
Figure 5.17 Non-denaturing PAGE of different XSBD:E3 and XDD:E3 stoichiometries
Stoichiometric mixtures of E3 and XSBD (A) or XDD (B) were pre-incubated at 25°C for 15 minutes. 
As the amount of XSBD/XDD increases a shift from the position corresponding to E3 into that for the 
complex is observed, indicating the formation of a tight complex. The positions of the complex band 
are shown by arrows. At stoichiometries above 2:1 free XDD is seen in addition to the complex band. 
Free XSBD migrates towards the cathode and thereby out of the gel due to its high pi of 9.9.
5 3.3.4 Analytical ultracentrifugation of XDD/E3
SV experiments were conducted for uncomplexed E3 and X D D  as well as for different 
XDD:E3 stoichiometries and the sedimentation profiles fitted using c (j ) analysis in SEDFIT 
(Schuck, 2000). The c(^) profiles o f free X D D  and E3 show single peaks with apparent 
sedimentation coefficients o f 2.0 S and 5.9 S, respectively (Fig. 5.18A ). Fig. 5.18B clearly 
shows the complete disappearance o f  the X D D  peak at a stoichiometry o f 2:1. The E3 and
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XDD/E3 peaks overlap completely, although the peak position is slightly shifted to an 
apparent sedimentation coefficient of 5.7 S for XDD/E3. A globular protein of higher 
molecular weight is expected to sediment faster (and therefore have a higher sedimentation 
coefficient) than a protein of lower molecular weight. Therefore, it can be inferred that the 
complex has an extended shape which offsets the gain in moleculai’ weight with respect to 
free E3, and causes it to sediment at the same speed as E3, confirming previous observations 
from gel filtration chromatography (see Section 5.3.3.2).
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Figure 5.18 Sedimentation velocity analysis of XDD;E3 stoichiometric mixtures and 
purified XDD/E3 complex
c(5> analysis of SV data for uncomplexed E3 and XDD (A) as well as different XDD:E3 stoichiometric 
mixtures (B). c(s) analysis for a range of concentrations of purified XDD/E3 complex (C) and
determination of for XDD/E3 (D).
115
5.3 Results and analysis
The small broad peak around 7.5-8 S observed at all stoichiometries corresponds to aggregate 
species and is greatly reduced if the complex is purified to uniformity by gel filtration prior to 
AUC analysis (Fig. 5.18C). c(s) analysis of SV profiles from the purified complex also show 
that a single species is present in solution bar a small amount of aggregate that is present at 
high concentrations only, a result substantiated by non-denaturing PAGE (data not shown). 
No free protein or intennediates are observed at any concentration, in accordance with the 
expected tight interaction between XDD and E3. Finite element analysis with a single-species 
model yields the true sedimentation coefficients for XDD/E3 at all experimental 
concentrations. These were then extrapolated to infinite dilution to give a sedimentation 
coefficient for XDD/E3 independent of concentration of = 5.68 ± 0.05 S (Fig. 5.18D).
The apparent whole cell, weight-average molecular weight, M,v.app, was determined for each 
XDD:E3 stoichiometric mixture using SE. The M,v,app peaks, as expected, at a stoichiometry of 
2:1 (Fig. 5.19) when all protein present is associated into complex, owing to the tight 
interaction between XDD and E3. At all other molar ratios, free XDD or E3 is observed, thus 
depressing M,v,app. The value of M,v,app at a molar ratio of 2:1 (XDD:E3) of 137 kDa is lower 
than expected when compared to the calculated molecular weight of 144 kDa. This is 
attributable to the non-ideal behaviour of the complex, SE data for XDD/E3 complex purified 
by gel filtration were also analysed: agreement with the expected molecular weight was 
substantially improved when non-ideality arising from molecular shape and charge was taken 
into account. The values obtained experimentally for the second virial coefficient B of 7.2 x 
lO"'^  ml mol g '^  1.7 X lO""^  ml mol g'^ and 2.9 x lO''^  ml mol g'^ (for rotor speeds 10500, 15000 
and 18000 rpm, respectively) correspond very well to B calculated with COVOL (Harding et
al., 1999) of 1.7 X 10'  ^ml mol g '\
When non-ideality is accounted for the molecular weight estimates for XDD/E3 are 151 kDa, 
142 kDa and 141 kDa for rotor speeds 10500, 15000 and 18000 rpm, respectively. These 
values compare very well to the calculated Mw of 144 kDa for a 2:1 complex of XDD:E3. 
When non-ideality is included in the data analysis for the 2:1 stoichiometric mixture of 
XDD:E3, M,y,app is increased to 147 kDa, 142 kDa and 141 kDa for rotor speeds 8500, 12000 
and 16000 rpm, respectively, in excellent agreement with the results for the purified complex 
and the calculated molecular weight. For all other stoichiometric mixtures of XDD:E3, Mw,app
J
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decreases with increasing rotor speed which is indicative of the presence/formation of high 
molecular weight aggregate, as shown also by the SV results in Fig, 5.18B. Only for the 1:1 
stoichiometric mixture are all estimates consistently lower than the calculated
molecular weight. This is due to the choice of fitting limits. Aggregate would be steeply 
distributed and is thus effectively excluded from the subsequent analysis, resulting in an 
underestimate of M,v,app- Because stoichiometric mixtures other than 2:1 contain more than 
one species (plus aggregate), when the data aie trimmed to exclude aggregate, the exponential 
describing the heavier component is disproportionately affected, resulting in a corresponding
reduction in M,vv .app*
150
1 4 5 -
1 3 5 -
1 3 0 -
1 2 5 - XDD-E3
120 -
1 1 5 -
110 -
1 0 5 - E3
4:1 3:1 2:1 1:1
XDD:E3 stoichiometries
1:2
Figure 5.19 Sedimentation equilibrium analysis of XDD;E3 stoichiometries
SE experiments of stoichiometric mixtures of XDD:E3 were done at 8500 (■), 12000 (®) and 16000 
rpm (A) in order to determine M,^ ,app for each stoichiometry. values calculated on the basis of a 
very strong interaction between XDD and E3 are also shown (□). The molecular weights of E3, XDD- 
E3 and (XDD)2-E3 calculated from the amino acid sequence are indicated.
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5.3.S.5 Isothermal titration calorimetry
The heats of interaction of XDD with E3 were determined using TTC. Complex formation is 
exothermic (i.e. negative peaks in the ITC output) (Fig. 5.20A). Differential thermal binding 
curves were obtained by integration of the data and analysed using standard non-linear 
regression in order to obtain estimates of the binding stoichiometry, equilibrium association 
constant and enthalpy of binding (Fig. 5.20B). The data confirm the tight binding of XDD to 
E3 (Xa -  2.8 X 10’ M'*) with a stoichiometry of 2:1. Binding is characterised by a large, 
favourable enthalpy change (Ai7 = -12.1 kcal/moi) and a small negative entropy change (TAS 
= -1.7 kcal/mol). This experiment confirms similar ITC results of the interaction of full-length 
E3BP with E3 (Brown, 2002) which show that full-length E3BP binds E3 with similar affinity 
and identical stoichiometry.
5.S.3.6 Homology and hydrodynamic modelling of XDD/E3
Homology modelling was used in combination with AUC and SAXS (see below) to gain 
more insight into the XDD/E3 structure. A model of the human XDD/E3 complex was built 
from homology models (generated with SWISS-MODEL) for E3, E3BP-LD and SBD (see 
Section 5.3.2.1). The structure of the B. stearothermophilus E2-SBD/E3 complex (Mande et 
al., 1996) was used to position the human E3 and XSBD homology models with respect to 
each other. The second XSBD molecule was positioned exploiting the two-fold symmetry 
axis of E3. Several models with different positioning of the two lipoyl domains LDl and LD2 
were generated (Fig. 5.21), while taking into account available biochemical and structural 
data. In an extended conformation, both LDl and LD2 were located approximately 65 Â from 
the SBDs, in accordance with previous EM data (Zhou et al., 2001a; Zhou et al., 2001b; 
Milne et al., 2002) and overall PDC dimensions. The resulting model XDD/E3e.«„ (Fig. 5.21C) 
has a maximum dimension, D^ ax» of 227 Â. The lack of structural information for the linker 
region and the paucity of related sequences meant that it was not it was not possible to model 
part of the linker using either homology or secondary structure modelling. A second complex 
model with both LDs docked in the E3 active sites and a of 134 Â, XDDfE3dock (Fig. 
5.21 A) was also generated. In the process Lys97 was positioned 14 Â from E3 residues Cys45 
and Cys50, allowing accommodation of the lipoic acid cofactor linked to Lys97 (Howard et
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Figure 5.20 Isothermal titration calorimetry of XDD and E3
(A) Raw data obtained from a series of 10 [.il injections of E3 into XDD at 25°C and plotted as heat 
versus time. (B) Binding isotherms created by plotting the areas under the peaks in (A) against the 
molar ratio of E3 injected. The best fit shown was obtained by least-squares fitting using a simple 
binding model and gives a stoichiometry of 0.5 (E3:XDD) which is equivalent to 2:1 (XDD:E3).
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al., 1998), in agreement with data from mutation studies on the E3 enzyme mechanism 
(Leung et al,, 1990; Kim et al., 1992). Although other E3 residues involved in the binding of 
the LD are not known, access to the E3 active site is only possible from one side of the 
molecule. The presence of the FAD and NAD^ cofactors otherwise obstructs the interaction 
between the lipoate and the cysteine pair (Toyoda et al., 1998b). An intermediate model with 
one LD present in the extended conformation and the second docked in the active site, and a 
Dmax of 156 Â, XDD/E3,»,, (Fig. 5.21B) was also produced. Sedimentation coefficients of 5.3 
S, 5.9 S and 6.5 S were calculated for XDD/E3<. ,^„, XDD/E3,„, and XDD/E3^oct, respectively, 
using the program HYDROPRO (Garcia de la Torre et al., 2000; Garcia de la Torre, 2(X)1). 
Accordingly, the XDD/E3^, model with one docked and one extended LD gave the best 
agreement with the experimentally determined s of 5.68 S and also agrees best with the 
experimentally determined Dmax of 158 Â (see below).
Figure 5.21 Homology models generated for the XDD/E3 complex
Front views are shown of XDD/E3do<.* (A) with both lipoyl domains docked in the E3 active sites, 
XDD/E3,„, (B) with one docked and one extended LD, and XDD/E3„,„ (C) with both LDs extended 
away from E3. E3 is shown in orange, the SBDs in lime and green, and the two LDs in blue and cyan.
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5,3.3.7 Small angle x-ray scattering and rigid body modelling
Small angle x-ray scattering (SAXS) curves for purified XDD/E3 complex were acquired at 
three different protein concentrations to account for the effects of interparticle interference 
(Fig. 5.22A). The radius of gyration determined using the Guinier approximation, is 38 ± 1 
Â. The particle distiibution function, p(r) is shown in Fig. 5.22B. The is 158 ± 5 Â and 
the Rg calculated from the p(r) function is 41 ± 1 Â (Fig. 5.22B) which agrees well with the 
value obtained using the Guinier approximation.
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Figure 5.22 Small angle x-ray scattering of XDD/E3
The scattering curve for XDD/E3 (—) is shown in (A). The shape scattering curve from GNOM (—) and 
the calculated scattering curves determined for the models obtained from ab initio (—) and rigid body 
modelling (—) are also shown, The distance distribution p{r) (B) was calculated using GNOM. Error 
bars are shown but not visible due their small size.
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Ab initio shape restoration produced an elongated, asymmetric structure (Fig. 5.23). Direct 
rigid body modelling was used in combination with ab initio modelling to analyse the 
structure of the XDD/E3 complex: using translations and rotations, the lowest energy ":Aconformation of each “domain” (E3, XSBDl, XSBD2, XLDl, XLD2) within the complex 
was determined using the program Rayuela (Nollmann et al., 2005) as judged by fits to the 
SAXS data. This model was superimposed upon the ab initio model (Fig. 5.23). While most 
of the complex model fits very well into the SAXS envelope, it was not possible to fit 
residues 265-297 which form part of the E3 NAD domain. The same range of residues also 
could not be accommodated by the E3 ab initio model when superimposed onto the homology ;:7model (see Section 5.3.1.3), indicating structural differences between the solution and atomic 
structures of E3, presumably due to the effects of crystal packing. Binding of XDD to E3 is 
unlikely to cause conformational changes within E3, as the high resolution structures 
determined for human E3BP/E3 (Ciszak et al., 2006) as well as E2/E3 and E2/E1 complexes 
from B. stearothermophilus (Mande et al., 1996; Frank et al., 2005) suggest a lock-and-key 
rather than an induced fit mechanism.
5.3.3.8 Redox states of lipoyl domains within the XDD/Ë3 complex
In order for B3BP lipoyl domains (XLD) to interact with the E3 active site the lipoate needs 
to be present in its reduced form. As NADH was not present in the buffer of protein 
prepaiations or at any stage during the purification process, the lipoate cofactor of XDD was 
reduced by the addition of DTT during protein purification and immediately prior to SAXS 
experiments. DTT is often added to SAXS samples to prevent x-ray induced protein 
aggregation due to radical formation.
Monomethoxypolyethylene glycol (raPEG) 5000 maleimide was used to covalently modify 
reduced cysteine and lipoate thiol groups, thus increasing the apparent molecular weight of 
XDD and retarding its progress during SDS PAGE (Fig. 5.24, lane 4). Control reactions for 
XDD were set up as well, containing E3 and either NAD^ (lane 1) or NADH (lane 2). NADH 
and E3 cause complete reduction of the lipoate cofactor and bandshift of XDD, while NAD'*' 
and E3 provide a negative control by reoxidation of the lipoate. Some
I-
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Figure 5.23 Superimposition of XDD/E3 models from ab initio and rigid body 
modelling
The ab initio model is shown as a blue wire mesh. Homology models of the five “domains” used for 
rigid body modelling are shown as follows; E3, orange; XSBD 1 & 2, green; XLDl, purple; XLD2, 
yellow. Two orthogonal views are shown.
123
5.3 Results and analysis
mPEG maleimide modification can still be seen in the presence o f NAD^; as X D D  will form a 
tight com plex with E3 in solution, steric hindrance may be responsible for this behaviour. A  
further control experiment looking at the modification o f  purified E3BP lipoyl domain (XLD) 
in the presence o f E3 and NAD^ and/or NADH  was conducted under the same reaction 
conditions. The LD on its own is not able to associate tightly with E3 and is completely re­
oxidised in the presence o f  E3 and N A D \ High molecular weight bands are caused by mPEG 
maleimide modification o f E3.
Mw XDDreactiotM XLDr«action( XDD E3
98 «■
1 2 3 4 5 6 7
i l
E3
mPEG
Figure 5.24 SDS PAGE analysis of mPEG maleimide treated XDD
XDD (reactions 1-5) and XLD (reactions 6-7) were treated with mPEG maleimide. XDD was 
incubated with E3 and NAD^ (1), E3 and NADH (2), E3 and DTT (3), DTT only (4) or on its own (5) 
before exposure to mPEG maleimide. Control XLD reactions were incubated with E3 and NAD^ (6), 
and E3 and NADH (7). Untreated XDD and E3 were used as additional controls. Bands of unmodified 
XDD (#) and mPEG maleimide modified XDD (O) as well as unmodified XLD (★) and mPEG 
maleimide modified XLD (☆) are indicated. Bands resulting from mPEG maleimide binding to E3 are 
also shown. Molecular weights (Mw) are shown in kDa.
5.3.3.9 Interaction of Ë3 with the E3BP lipoyl domain
ITC was employed to determine whether the E3BP-LD in its reduced form is able to interact 
with E3 on its own. Experiments were done at two temperatures, 10°C and 25°C (data not 
shown) in order to ensure that equivalence in the enthalpy and entropy terms at one particular 
temperature could not mask a possible interaction. However, no binding was observed at
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either temperature, leading to the conclusion that the lipoyl domain probably requires pre­
orientation from the subunit binding domain in order to form a stable complex.
5.4 Discussion
The evidence presented here demonstrates that two E3BP-derived molecules interact with a 
single E3 homodimer, thus enabling the formation of 2:1 stoichiometric “cross-bridges” in 
human PDC. These findings are in direct contrast to the crystal structures obtained for the B. 
stearothermophilus E3/E2SBD (Mande et al., 1996) and human E3/E3BP-SBD complexes 
(Ciszak et al., 2006) where only one SBD is associated with E3 due to steric hindrance by a 
loop in E3BP which prevents binding of a second SBD. Comparison of the crystal structures 
determined for unbound (Brautigam et al., 2005) and bound human E3 (Ciszak et a l, 2006) as 
well as yeast E3 (Toyoda et a l, 1998b) yields only very small differences in coordinates. The 
highly homologous (54% identical) human and yeast E3 may crystallise similarly. As the 
results presented in this chapter were determined in solution it is thought that either crystal 
packing and/or crystallisation buffer compositions affect the structures determined for 
eukaryotic E3 and the E3/E3BP-SBD complex. Unfortunately, E3 is too large for structure 
determination via NMR spectroscopy. However, SAXS data suggest that the solution 
conformation of free human E3 is slightly more elongated and flattened than that in the 
crystal structure. The solution conformations of other proteins, including yeast pyruvate 
decarboxylase (Svergun et a l, 2000) can differ significantly from their crystal structures 
(Trewhella et a l, 1988; Vigh et a l, 1989; Svergun et al, 1997a; Nakasako et a l, 2001; Kozak 
& Jurga, 2002). While the 1:1 stoichiometry of bacterial PDC E2-SBD/E1 and B2-SBD/E3 
has been confirmed via surface plasmon resonance (Lessard et a l, 1996) and ITC (Jung et al, 
2002a; 2003), the stoichiometry of eukaryotic PDC has remained undetermined, until now.
The binding surfaces involved in the association of human E3 with E3BP-SBD are thought to 
be different to those in the B. stearothermophilus PDC: in the prokaryotic complex E3 and 
E2-SBD interact via an electrostatic zipper (Mande et a l, 1996). However, the amino acid 
sequence of E3BP-SBD has undergone significant changes and is more hydrophobic in 
character, including a number of surface residues. It is therefore thought to interact with a
I
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complementary hydrophobic patch on E3, adjacent to the known binding site of prokaryotic 
E2 and further away from the two-fold axis of E3. Thermodynamics seem to support this 
hypothesis: a detailed analysis of the interactions of B. stearothermophilus E2 didomain (DD; 
consisting of the E2 lipoyl and subunit binding domains) with E l and E3 (Jung & Perham,
2003; Jung et al., 2003) carefully characterised the thermodynamic differences in the 
formation of the E2-DD/E1 and E2-DD/E3 complexes, respectively. The authors used a 
number of point mutants of both E l and E3 as well as the wild-type enzymes to dissect the 
thermodynamic contribution of different residues to complex formation. While the Gibbs free 
energy, AG“ of both interactions is very similar, the E2-DD/E1 association is characterised by 
a large, favourable enthalpy change and a small, negative entropy change. In contrast, the 
interaction of E2-DD with E3 is described by an unfavourable enthalpy change and large, 
positive entropy change (Jung et al., 2002a). Electrostatic interactions are present in both 
complexes, however E2-DD/E1 formation in Bacillus seems to involve additional 
hydrophobic contacts when compared to the E2-DD/E3 complex. As evidenced by 
microcalorimetry in Section 5.3.3.5 the interaction of the human XDD with E3 is also defined 
by a large, favourable enthalpy change and a small, negative entropy change, very similai* to 
the E2-DD/E1 association in Bacillus, thus signalling the possible importance of hydrophobic 
interactions in human XDD/E3 complex formation. However, further experiments using point 
mutants analogous to those used by Jung et al. (2002b; 2003) are required to obtain more 
conclusive data.
Comparison of eukaryotic E3 crystal structures with those of prokaryotes also shows that 
even though the overall structure is highly conserved, the amino acid sequence identity of E3 i
is rather low. The region of E3 associated with E2 interaction in prokaryotes has undergone 
significant changes in human and S. cerevisiae E3 that result in a more neutral surface i
potential (Toyoda et al., 1998b). Thus, a slight shift in the location of the E3BP binding site 
away from the two-fold axis on E3 may be sufficient to allow binding of two E3BP molecules 
simultaneously.
The low resolution x-ray scattering structure determined for the human XDD/E3 subcomplex 
conclusively verifies its 2:1 stoichiometric relationship and high stability. Unexpectedly, the 
subcomplex proved to be highly asymmetric. These data are compatible with a model in
126
5.4 Discussion
127
s
which one LD is peripherally extended away from the E3 dimer whereas the second LD is 
docked into one of the E3 active sites that are located at the monomer-monomer interface. 
During XDD puiification, the lipoyl group was maintained in its dithiol fonn by the presence 
of DTT. Reduced lipoate is the true substrate for E3 and its reoxidation by E3 is prevented by 
the absence of NAD'*'. The redox state of the lipoamide cofactor was confirmed by 
modification with PEG 5000 maleimide, a thiol group reagent that leads to a dramatic 
increase in the apparent Mw of XDD, provided it is present in its reduced form. That only one 
of the two LDs is found near the E3 active site, suggests E3 may operate by a flip-flop 
mechanism; only one E3 active site in turn can accept a LD, house its reduced lipoamide 
cofactor and catalyse its re-oxidation. This would be similar to the mechanism proposed 
previously for E l, where different steps of the reaction are performed in each of the active 
sites at any given moment (Khailova & Korochkina, 1985; Ciszak et al., 2003). However, 
more experiments are required to substantiate this hypothesis and, in addition, it will be of 
interest to determine the SAXS solution structure of the XDD/E3 complex with its lipoamide 
cofactors in their oxidised states as this would be predicted to form a more extended and 
symmetrical structure when compared to its reduced counterpait.
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C hapter 6
Characterisation of the E2/E1 
subcomplex and its constituents I
a
6.1 Introduction
E2 is central to eukaryotic PDC core formation due to its self-association into a 60-meric 
pentagonal dodecahedron via its C-terminal domain, while the N-terminal “swinging arms” 
project outwards. As described in Chapter 1, in Bacillus and other Gram-positive bacteria E2 
provides the framework for its interaction with both E l and E3 at a stoichiometry of 1:1, as 
determined using surface plasmon resonance (SPR), microcalorimetry and protein 
crystallography (Lessai'd et al., 1996; Jung et al., 2002a; 2003; Frank et al., 2005). In contrast, 
subunit interactions in eukaiyotic PDC are more differentiated due to the presence of an 
additional protein, E3BP. Consequently, E2 interacts specifically with E l and has largely lost 
the ability to bind E3 -  residual PDC activity is observed only if E3 is present in large excess 
(McCartney et al., 1997). Similarly, patients with E3BP deficiency display only 10-20% of 
normal levels of PDC activity (Robinson et al., 1990; Marsac et a l, 1993; Ling et al. 1998;
Brown et a l, 2002).
,
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6.1 Introduction
This chapter presents preliminary data for the characterisation of the subcomplex formed 
between native bovine E l and a didomain construct of E2 (E2DD) analogous to XDD (Fig.
While the Bacillus PDC core is capable of binding up to 60 E l or 60 E3 molecules during 
reconstitution experiments (Lessard et a l, 1995; 1998; Domingo et a l, 1999), the maximum 
number of E l molecules able to associate with the eukaryotic PDC core is 30 (Roche et al, 
1993). However, the PDC core is not necessarily always fully occupied: when PDC was 
isolated from bovine heart muscle and kidney, differential E l occupation was observed 
(Roche et a l, 1993), reflecting the different metabolic requirements of the two tissues. 
Analogous to subcomplex formation between E3BP and E3, the reported stoichiometries for 
E2 and E l within eukaryotic PDC suggest the possibility of formation of 2:1 stoichiometric 
subcomplexes. Thus, at maximal occupancy, 30 E l molecules could associate with the 60- 
meric E2 core.
The crystal structure determined for the E1/E2-SBD subcomplex from B. stearothermophilus 
shows unequivocally that association of a second molecule of E2-SBD to E l is not possible as 
the binding site for E2-SBD is located across the two-fold axis. Occupation of both binding 
sites on E l would result in steric clashes in one of the loop regions (Frank et al, 2005). The 
association of two molecules of E2 with one heterotetramer of E l therefore requires either a 
change in the location of E2-SBD binding and/or a structural change in the confomiation of
E2-SBD and/or EL
E2 also provides binding sites for PDC kinase (PDK) and PDC phosphatase (PDP). While E l 
associates with the E2 via its subunit binding domain (E2-SBD), both PDK and PDP interact 
with the inner lipoyl domain (ILD). This results in the juxtaposition of E l and PDK/PDP in a 
manner ideal for the regulation of PDC activity which is controlled by the phosphorylation 
state of E l.
5.1) consisting of the inner LD and the SBD. Both proteins were also analysed individually in 
vitro. In addition, the stoichiometry and affinity of the interaction of E l with E2DD was 
investigated using AUC and ITC. A low resolution structure of the E2DD/E1 complex was 
obtained from SAXS.
I'I
129
6.2 Materials & methods
6.2 Materials and methods
6 .2.1 Sam ple preparation
Individual proteins were purified as outlined in Section 4.2.3, E2DD/E1 complex was 
reconstituted from the purified proteins at a stoichiometric ratio of 3:1 (E2DD;E1) using a 
final size exclusion step on a Sephacryl S-300 column (Amersham, USA) in MEB buffer to 
remove unbound E2DD. For details of all buffers used refer to Section 4.2.3.
6 .2.2 Gel filtration  analysis
Gel filtration chiomatography (GFC) was employed to obtain estimates of the relative 
molecular weights of El, E2DD and purified E2DD/E1 complex. A Sephacryl S-300 column 
(Amersham, USA) was standardised with a range of GFC protein markers (Sigma, USA). 
Blue dextran was used to determine the void volume, Vo. The logarithms of protein 
molecular weights were plotted versus the ratio of elution volume to void volume (VeWo) to 
produce a standard curve.
6.2.3 S ed im entation  v elocity  analytical 
u ltracentrifugation
SV experiments were perfoimed as described in Section 3.4.2. Purified E2DD was dialysed 
against TEB and sedimentation data recorded at 4°C at a rotor speed of 49000 rpm, using both 
interference and absorbance optics in separate experiments. A series of 150 scans, 15 minutes 
apart with a step size of 0.001 cm in continuous mode was recorded at 278 nm for each 
sample using absorbance optics. A total of 400 scans, 1 minute apart, was recorded using 
interference optics. Sample concentrations ranged from 8.5 pM to 84.9 pM. The samples (380 
pi) were loaded into 12 mm double sector centrepieces.
Purified bovine E l was dialysed against PEB and sedimentation data recorded at 4*^ C at a 
rotor speed of 45000 rpm, using both interference and absorbance optics in separate 
experiments. A series of 100 scans, 11 minutes apait, was recorded for each sample at 278 nm 
with a step size of 0.002 cm in continuous mode using absorbance optics. A total of 500
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scans, 1 minute apart, was recorded using interference optics. Sample concentrations ranged 
from 1.2 pM to 5.9 pM. The samples (380 pi) were loaded into 12 mm double sector 
centrepieces.
For the analysis of stoichiometric E2DD:E1 mixtures, samples were prepared by keeping the 
concentration of E l fixed at 2.3 pM and varying the E2DD concentrations accordingly to 
achieve E2DD:E1 ratios of 4:1 to 1:3. Samples were dialysed extensively against PEB prior to 
data acquisition. A rotor speed of 45000 rpm was selected and absorbance and interference 
optics scans were collected at 4°C in separate experiments. A series of 100 scans, 11 minutes 
apart, was recorded for each sample at 278 nm with a step size of 0.002 cm in continuous 
mode using absorbance optics. A total of 500 scans, 1 minute apart, was recorded using 
interference optics. The samples (380 pi) were loaded into 12 mm double sector centrepieces.
SV analysis of the purified E2DD/E1 complex was conducted as described above for the
Î
E2DD:E1 stoichiometric mixtures and covered a concentration range of 1-5 pM.
Sedimentation profiles were analysed with the computer program SEDFIT (Schuck, 2000)
(see Sections 2.2.1.1 and 3,4.2 for details). Finite element analysis in SEDFIT was also used 
to determine the true sedimentation coefficients of all samples. These were extrapolated to 
infinite dilution to give a sedimentation coefficient independent of concentration,
I
6.2,4 Sed im entation  equilibrium  analytical 
u ltracentrifugation
SE data were collected for E2DD and purified E2DD/E1 complex using interference optics.
All samples used for the collection of SE data had been subjected to SV analysis first and the 
same buffer conditions were used. Details of the experimental set-up can be found in Table
6.1 and Section 3.4.3. Attainment of equilibrium was ascertained with WinMATCH 
(www.biotech.uconn.edu/auf/). SE data were analysed using single experiment and global 
analysis in the Beckman XL-A/XL-1 software implemented in MicroCal ORIGIN. 
Alternatively, multi-speed analysis (fitting each sample concentration singly as well as 
globally) in SEDPHAT (Vistica et al., 2004) as described in Sections 2.2.2.1 and 3.4.3 was 
used. In order to determine the molecular weight of samples independent of concentration.
Ï
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M ^, the whole cell, weight-average molecular weights, Mw,app, determined for each sample 
concentration were extrapolated to infinite dilution.
Protein Speed
(rpm)
Centrepiece Thickness
(mm)
Volume
(pl)
Replicates Step size 
(cm)
E2DD 26500
32000
Double sector 12 120 15 0.001
E2DD/E1 9000
12500
15000
Double sector 12 120 20 0.001
Table 6.1 Summary of parameters used for sedimentation equilibrium experiments
6.2.5 Isotherm al titra tion  calorim etry
E2DD and E l were dialysed overnight in MEB. E2DD at a concentration of 386 pM was 
injected in 10 pi aliquots into the reaction cell containing 22 pM E l at 25°C. Data were 
analysed using non-linear regression in the MicroCal ORIGIN software package, assuming a 
simple binding model (see Section 3.4.4). ITC experiments were performed by Mrs. Margaret 
Nutley in the laboratory of Prof. Alan Cooper, University of Glasgow.
6.2.6 Sm all angle x-ray scatterin g  and ab initio  
m odelling
SAXS data for E l, E2DD and E2DD/E1 were collected at beamline 2.1 of the SRS 
Daresbury, UK. A protein concentration of 1.0 mg/ml was used for E l data collection. E2DD 
scattering curves were obtained for concentrations of 2.7, 12.0 and 16.8 mg/ml, while 
E2DD/E1 data were recorded for concentrations of 3.4, 7.0 and 13.8 mg/ml. Two camera 
lengths (4.25 m and 1 m) were used; only the highest concentration sample of each protein 
was recorded at the shorter sample-to-detector distance of 1 m. More details can be found in 
section 3.4.5.
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The program DAMMIN (Svergun et al., 1999) was used for ab initio reconstruction of the 
E2DD/E1 subcomplex. No symmetry was imposed during the modelling process. More 
details on ab initio modelling can be found in Section 2.4.2.3.
6.8 Results and analysis
6.3.1 C haracterisation  o f E l
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6.2.7 H om ology and hydrodynam ic m odelling
A homology model of human E2-SBD was obtained as described in Section 3.5.2. In order to I
obtain a model of the human E2DD/E1 complex the crystal structure obtained for the E2- 
SBD/El complex from B. stearothermophilus (Frank et al., 2005) (PDB ID 1W85) was used 
as a template. Models of E2DD/EI with lipoyl domains in different positions were generated 
(see Section 6.3.3.5) and superimposed onto the ab initio model using the program SITUS 
(Wriggers & Chacon, 2001; Wriggers & Birmanns, 2001).
1
6.3.1.1 Analytical ultracentrifugation and hydrodynamic 
modelling of E l
Sedimentation velocity experiments (Fig. 6.1) show that the preparation of E l used in this 
project was not monodisperse. E l was purified using gel filtration (Section 4.3.3.6) in order to 
remove any aggregate present. SDS PAGE analysis of the purification (Section 4.3.3.6) did 
not reveal any contamination of the sample visible by staining with Copmassie. The minor 
peaks shown in the E l c{s) distribution (Fig. 6.1 A) therefore must correspond to dissociation 
and possibly degradation products as well as protein aggregate of E l formed over time. The 
main species is E l with an apparent sedimentation coefficient, a^pp of 7.8 S. The two smaller 
peaks may correspond to separate E la  and |3 subunits and a(3 heterodimers, respectively. The 
difference in molecular weight of the two subunits is only 4.3 kDa and they are therefore 
expected to form overlapping peaks.
3
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Finite element analysis was used to determine the true sedimentation coefficient for E l. Each 
data set was fitted with a model o f 3-4 non-interacting species depending on E l concentration 
and the c{s) distribution. These were then extrapolated to infinite dilution to give = 7.88
± 0 .1 1  S (Fig. 6 . IB). As the crystal structure for human E l has been solved (Ciszak et al., 
2003), its sedimentation coefficient was calculated using the program HYDROPRO (Garcia 
de la Torre et al., 2000; 2001) to be 8.3 S. This value is somewhat higher than that determined 
experimentally for bovine E l. As the bovine and human enzym es are thought to be very 
closely related -  no amino acid sequence is available for bovine E l -  it seems likely that the 
overall structure is conserved. Thus E l must be more elongated in solution than it is in the 
crystal structure, which could be a consequence o f crystal packing effects. Both the 
experimental and calculated sedimentation coefficient for human E l are lower than that o f a 
hydrated sphere o f equivalent mass (s = 8.6 S), also indicating an increase in the 
hydrodynamic radius.
Due to the heterogeneity o f the E l preparation sedimentation equilibrium experiments were 
not conducted. Despite recent advances in SE data analysis that allow fitting o f more than one 
component, most programs cannot satisfactorily model an experimental system consisting o f  
more than three or four species. Similarly, SA X S data obtained for E l could not be analysed 
due to sample heterogeneity.
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Figure 6.1 Sedimentation velocity analysis of bovine El
(A) c(s) distribution derived from SV interference data collected for a range of E l concentrations (—
1.2 pM, — 1.8 pM, — 2.4 pM, — 3.0 pM, — 3.6 pM, — 4.2 pM, — 5.9 pM). (B) Determination of  ^
from El data recorded using interference optics.
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6.3.2 C haracterisation  o f E2DD
6.3.2.1 Analytical ultracentrifugation of E2DD
SV data show that E2DD is monodisperse over a large range of concentiations (Fig. 6.2A). 
Finite element analysis of the SV data with a single species yields the true sedimentation 
coefficients for E2DD at all experimental concentrations. These were then extrapolated to 
infinite dilution to give = 1.77 ± 0.01 S (Fig. 6.2B). Again, the value obtained for the
E2DD sedimentation coefficient is lower than that calculated for a hydrated sphere of 
equivalent mass (  ^= 2.4 S). This result agi'ees well with previous observations for XDD (see 
Section 5.3.2) and reports in which the linker region has been described as a flexible, yet 
extended structure (Green et al., 1992). The elongated structure of E2DD was therefore 
expected and confirms observations from size exclusion chromatography (see Section 
6.3.3.2).
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Figure 6.2 Sedimentation velocity analysis of E2DD
(A) c( )^ distribution derived from SV interference data collected for a range of E2DD concentrations 
(— 8.5 pM, — 17.0 pM, — 25.5 pM, — 34.0 pM, — 50.9 pM). (B) Determination of E2DD
data recorded using interference optics.
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SE data obtained for E2DD show a small decrease in its apparent whole cell, weight-average 
molecular weight, Mw,^ ,p with increasing sample concentration, possibly indicative of non- 
ideality due to the elongated shape of the molecule (Fig. 6.3). The molecular weight of E2DD 
independent of concentration, M" was determined to be 27.5 ± 1.4 kDa, which is somewhat 
higher than the molecular weight predicted from its amino acid composition of 23,9 kDa.
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SiiTiilarly, the apparent molecular weight of E2DD obtained from global analysis with a single 
species was 27.3 ± 4.0 kDa. Fitting including a second species was unsuccessful and does not 
seem warranted given the monodispersity of E2DD determined by sedimentation velocity.
i
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Figure 6.3 Sedimentation equilibrium analysis of E2DD
Afiv,app was determined for each sample and extrapolated to zero concentiation. Data from the same cell 
but recorded at different rotor speeds were analysed simultaneously using the multi-speed equilibrium 
routine in SEDPHAT with a single species model.
G.3.2.2 Small angle x-ray scattering of E2DD
SAXS analysis of E2DD was problematic, due to the formation of aggi'egate species as can be 
seen from the steep slope of the scattering curve at very low angles (Fig. 6.4). Individual 
frames were always checked for x-ray induced aggregate formation (see Section 3.4.5), but no 
such process could be detected. Therefore, it seems reasonable to suppose that aggregates 
formed prior to x-ray exposure as a consequence of protein concentration, even though no 
aggregation was observed in AUC experiments.
:
The data could not be fitted satisfactorily with GNOM (Semenyuk & Svergun, 1991; 
Svergun, 1992), especially at low angles, which is another indication that the sample was not
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monodisperse. Using Guinier analysis, the radius of gyration, Rg was determined to be 84 ± 
11 À and 97 ± 6 Â for sample concentrations of 2.7 mg/ml and 12 mg/ml, respectively. This 
value is much larger than expected for E2DD and another indicator of aggregate formation; in 
comparison, monodisperse XDD, a molecule of similar molecular weight and shape has an i?g 
of only 27 Â. Due to these problems ab initio modelling of E2DD was not possible.
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Figure 6,4 Small angle x-ray scattering curve of E2DD
The region of the scattering curve indicative of the presence of aggregate species is circled (—).
6.3.3 Cross-bridge form ation b etw een  E2DD and E l
6.3.3.1 Generation of the E2DD/EX complex
The E2DD/E1 complex was reconstituted from purified proteins at a ratio of 3:1 (E2DD:E1). 
Due to the large difference in molecular weight between the E2DD/E1 complex and E2DD, 
the two species were easily separated by size exclusion chromatography (Fig. 6.5A) where 
aggregated material eluted from the column first, followed by the E2DD/E1 complex and 
uncomplexed E2DD. The E2DD/E1 complex is more stable than either protein on its own. 
However, both proteins are prone to degradation.
137
6.3 Results & analysis
^  0.14
0 .1 2 -
0.10-I 0.08-
^  0.06-
0.0 2 -
0,00
20 00 1200 80 100
V olum e (ml)
B
Mw Peak ! Pcak2 Peak 3
97.0
66.0
45.0
33.0
20.1
mm mm nia
«  'gg  ||6 d
Figure 6.5 Generation of the E2DD/E1 complex
(A) Gel filti'ation chromatography (GFC) of E2DD/E1. The peaks corresponding to aggregate (1), 
E2DD/E1 (2) and E2DD (3) are indicated. Protein absorbance was recorded at 280 nm (—) and 260 nm 
(—). (B) The protein peaks obtained from GFC were analysed by SDS PAGE. The positions of the El 
subunits and E2DD ai'e indicated. Molecular weights (Mw) are shown in kDa.
G.3.3.2 Gel filtration analysis of E2DD/E1 and its constituents
When compared to the standard curve (Fig. 6.6) the molecular weights of all proteins exceed 
their molecular weights predicted from their amino acid sequences. The apparent molecular 
weights, M,v,app, of E2DD, E l and the E2DD/E1 complex (~ 62 kDa, 250 kDa and 320 kDa, 
respectively) far exceed their predicted molecular weights (24 kDa, 152 kDa and 200 kDa, 
respectively). This is indicative of their anisotropic shapes and consequently enlarged 
hydrodynamic radii when compared to globular proteins of similar molecular weights. This 
result is in agreement with data obtained for E2DD (see Section 6.3.2), E l (see Section 6.3.1) 
and E2DD/E1 (see below) by AUC and SAXS.
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Figure 6.6 Molecular weight estimation using gel filtration chromatography
A Sephacryl S-300 gel filtration column was standardised using globular proteins of known molecular 
weights. The logarithm of the molecular weights was plotted versus the ratio of elution to void volume 
(Ve/Vo) in order to obtain a standard curve. The elution positions of E2DD, El and the E2DD/E1 
complex are indicated.
6.3.3.3 Analytical ultracentrifugation of E2DD/E1
Sedimentation velocity (SV) experiments were conducted for uncomplexed El and E2DD and 
different E2DD:E1 stoichiometries and the sedimentation profiles fitted using c(s) analysis in 
SEDFIT (Schuck, 2000). The c(s) profiles of free E2DD and El show one main peak with an 
apparent sedimentation coefficient of 2.0 S and 7.8 S, respectively (Fig. 6.7A,C). However, 
several minor peaks are apparent for both proteins in the c{s) profile derived from interference 
data (Fig. 6.7D), while a second peak for E l is observed in the analysis of the absorbance data 
(Fig. 6.7B). The absorbance data in Fig. 6.7B clearly show the complete disappearance of the 
E2DD peak at a stoichiometry of 2:1, analogous to the results obtained for XDD/E3. The El 
and E2DD/E1 peaks overlap completely, although the peak position is slightly shifted to an 
apparent sedimentation coefficient of 7.3 S for E2DD/E1. The interference data present a
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more complex picture: a small E2DD peak remains at a stoichiometry of 2:1 (E2DD;E1) (Fig. 
6.7D) and only disappears at a ratio of 1:1 (E2DD:E1). However, this discrepancy is due to
Inot all of the E l being binding competent as evidenced by the existence of two minor peaks and one large peak. Therefore, not all of the E2DD can participate in complex formation. 
E2DD has a comparatively low molar extinction coefficient at 278 nm (e = 9800 M’^ ) and its 
residual signal is too low for detection with absorbance optics at the concentrations used in 
these AUC studies. In addition, the main peak in the 1:1 (E2DD:E1) sample is shifted slightly 
to the right with respect to samples containing excess E2DD, indicative of the presence of
both E2DD/E1 complex and uncomplexed El. A globular protein of higher molecular weight 
is expected to sediment faster (and therefore have a higher sedimentation coefficient) than a 
protein of lower molecular weight. Therefore, it can be inferred that the complex has an 
extended shape which offsets the gain in molecular weight with respect to free E l, and causes 
it to sediment at roughly the same speed as E l, confirming previous observations from gel 
filtration chromatography (see Section 6.3.3.2). The same conclusion can be drawn from 
comparison of the apparent sedimentation coefficient of E2DD/E1 (7.3 S) with s calculated 
for a hydrated sphere of the same moleculai' weight and partial specific volume as the 
complex (s = 10.3 S).
Several minor species that do not correspond to either uncomplexed E2DD or E l were 
observed at all stoichiometries. They correspond to a complex mixture of dissociated and 
aggregate species, but can be significantly reduced if the complex is purified to uniformity by 
gel filtration prior to AUC analysis (Fig. 6.8A). c(s) analysis of SV profiles from the purified 
complex also show that a single species is present in solution bar small amounts of 
dissociation products and aggregate which are, however, negligible when compared to the 
total amount of protein. No free protein or intermediates are observed at any concentration, in 
accordance with the expected tight interaction between E2DD and E l. Finite element analysis 
with three discrete species yields the true sedimentation coefficients for E2DD/E1 at all 
experimental concentrations. These were then extrapolated to infinite dilution to give a 
sedimentation coefficient for E2DD/E1 independent of concentration, ^2o.w of 7.36 ± 0.06 S
(Fig. 6.8B).
'
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Figure 6.8 Sedimentation velocity analysis of purified E2DD/E1 complex
(A) c( )^ distiibution derived from SV interference data collected for a range of E2DD/E1 complex 
concentrations (— 1.0 pM, — 1.6 pM, — 2.1 pM, — 2.4 pM, — 3.1 pM, — 3.6 pM). (B) Determination of
concentration independent Aom the E2DD/E1 complex data recorded using interference optics.
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Figure 6.9 Sedimentation equilibrium analysis of purified E2DD/E1 complex
^w.app was determined for each sample and exh apolated to zero concentration. Data from the same cell 
but recorded at different rotor speeds were analysed simultaneously using the multi-speed equilibrium 
routine in SEDPHAT with a single species model.
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Due to the presence of several other species apart from E2DD/E1 and uncomplexed E2DD or 
E l, sedimentation equilibrium (SE) experiments of the stoichiometric E2DD:E1 mixtures 
were not performed as the data analysis was deemed too unreliable. Instead, the purified 
E2DD/E1 complex was subjected to SB analysis which confirmed the 2:1 stoichiometric 
complex formation as its molecular weight was determined to be 190 ±11 kDa (Fig. 6.9), in 
good agreement with the value predicted from the El and E2DD amino acid sequences (200 
kDa). Analysis of the individual SE data sets using a single species model in SEDPHAT 
(Schuck, 2003; Vistica et ah, 2004) shows an increase in the apparent whole cell, weight- 
average molecular weight, M,„,app with increasing E2DD/E1 concentration, indicative of 
aggregate formation. Indeed, using global analysis and fitting of a second component, the 
molecular weight of the main species was 199 ± 4 kDa while the second species was 
determined to be 676 ± 9 kDa. Aggregate probably formed during SE data acquisition due to 
the long experimental times required, as no appreciable amount of aggregate was formed 
during sedimentation velocity studies (Fig. 6.8A).
6.3.3.4 Isothermal titration calorimetry
An initial attempt to determine the strength of the E2DD/E1 interaction was made using ITC. 
Measuring the heats of interaction of E2DD with E l, complex formation was found to be 
exothermic, i.e. the peaks in the ITC output are negative (Fig. 6.10A). A differential thermal 
binding curve was obtained by integration of the data and analysed using standard non-linear 
regression (Fig. 6.1 OB) in order to obtain estimates of the binding stoichiometry, equilibrium 
association constant (Ka) and enthalpy of binding (AH). The data confirm the tight binding of 
E2DD to El (TCa = 9.88 x lO’ M '‘), although the analysis relies on too few data points and is 
near the limit > 10^  M"') of accurate determination. Binding is characterised by a large, 
favourable enthalpy change (AH = -10.2 kcal/mol) and a small positive entropy change (TAS 
= 0.72 kcal/mol). The stoichiometry of binding of 0.3 (E2DD;E1), i.e. 3 molecules of E2DD 
are bound per 10 molecules of E l, is much lower than expected. This result was completely 
unexpected and probably caused by the non-specific aggregation of E l prior to and during 
TTC. Aggregation was obvious from visual inspection of the sample at the end of the 
experiment. Since the affinity of E2DD for E l is extremely high it should be possible to use
143
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much lower concentrations of E l in a repeat experiment which will hopefully substantially 
reduce, if not eliminate, E l aggregation.
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Figure 6.10 Isothermal titration calorimetry of E2DD and El
(A) Raw data obtained from a series of 10 gl injections of El into E2DD at 25°C, (B) Binding 
isotherms created by plotting the areas under the peaks in (A) against the molai* ratio of E2DD injected. 
The best fit shown was obtained by least-squai'es fitting using a simple binding model and gives a 
stoichiometry of 0.3 (E2DD:E1).
6.3.S.5 Homology modelling of E2DD/E1
Homology modelling was used in combination with AUC and SAXS (see below) to gain 
more insight into the E2DD/E1 structure. A model of the E2DD/E1 complex was built from
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atomic structures solved for human E l (Ciszak et al., 2003), the human E2-ILD (Howard et 
ah, 1998) and a hom ology model o f  the E2-SBD. The structure o f  the B. stearothermophilus 
E2-SBD/E1 com plex (Frank et ah, 2(X)5) was used to position E l and E2-SBD  with respect to 
each other. The second E2-SBD m olecule was positioned exploiting the two-fold symmetry 
axis o f  E l. Several models with different positioning o f  L D l and LD 2 were generated (Fig. 
6.11), while taking into account known overall dimensions o f  the PDC; all lipoyl domains 
were located approximately 60 Â from the SBD s, sampling three different orientations with 
respect to E2-SBD/E1. Two models have similar values o f ca. 200 Â, but E 2D D /E ly is 
somewhat smaller with a D^ax o f ca. 185 Â.
Figure 6.11 Models of the human E2DD/E1 complex
E2DD/Elz (A), E2DD/Ely (B) and E2DD/E1% (C). Only the LDs (orange) are present in different 
positions. The other subunits shown are E la  (blue), El(3 (red) and the E2-SBD (green). Due to a lack 
of structural information, the linker regions could not be fully modelled.
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6.3,3.6 Small angle x-ray scattering of E2DD/E1
SAXS curves for purified E2DD/E1 complex were acquired at thi'ee protein concentrations to 
account for the effects of interparticle interference (Fig. 6.12A). The radius of gyration, i?g 
determined using the Guinier approximation, is 56 ± 2 Â. The paiticle distribution function, 
p{r) is shown in Fig. 6.12B. The D^ax is 175 ± 5 Â and calculated from the p{r) function is 
53 ± 1 Â which agrees well with the value obtained using the Guinier approximation.
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Figure 6.12 Small angle x-ray scattering of E2DD/E1
(A) The scattering curve recorded for E2DD/E1 (—). The shape scattering curve from GNOM (—) and 
CRYSOL scattering curves calculated for E2DD/E1% (—), E2DD/Ely (—) and E2DD/Elz (~) are also 
shown. (B) The distance distribution function p{r) was calculated using GNOM. Error bars are shown 
but are too small to be visible.
Ab initio shape restoration produced an elongated, asymmetric structure (Fig. 6.13). Of three 
rough initial models (Fig. 6.11) with LDs in different positions with respect to E l, only one 
(E2DD/Ely) can be superimposed satisfactorily onto the ab initio model (Fig. 6.13). 
However, even this superimposition leaves considerable parts of the model outwith the 
recorded electron density (Fig. 6.13A-C). The model can only be fully covered if the density 
corresponding to all 12 ab initio reconstructions is shown (Fig. 6.13D,E). The reason why the 
models are essentially too small is unclear. It is interesting to note, however, that the 
scattering intensity at zero angle, 1(0) of the three E2DD/E1 models calculated with CRYSOL 
is somewhat lower than that obtained from a GNOM fit of the experimental data (Fig. 6.12A). 
Even though the E2DD/E1 models lack a number of residues from the E2DD linker region
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and His-tag, these residues are not thought to contribute significantly to the scattering curve. 
Further experiments are required to fully elucidate the solution structure o f E2DD/E1.
Li
Figure 6.13 Superimposition of E2DD/E1 and ab initio models
Front (A,D), side (B,E) and top views (C) of the E2DD/E1 model superimposed onto the DAMMIN ab 
initio model (blue wiremesh). Density corresponding to all superimposed DAMMIN models (outer 
wiremesh) is shown in (D) and (E). Ela (cyan), Eip (red), E2SBD (green) and E2-LD (orange) are 
depicted.
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The results presented in this chapter indicate that 30 E l heterotetramers are capable of 
interacting with up to 60 E2-derived constructs, forming 2:1 (E2DD:E1) stoichiometric 
complexes, although more experiments are required for a definitive answer. The main 
problem with the experimental set-up and data interpretation is the tendency of both 
uncomplexed E l and E2DD to form non-specific aggregates, although the complex -  
especially at lower concentrations -  seems to be more stable as observed by a combination of 
sedimentation velocity and equilibrium AUC studies.
The formation of 2:1 stoichiometric cross-bridges is in direct contrast to results obtained for 
the interaction of B. stearothermophilus E l and E2-SBD as determined by surface plasmon 
resonance (Lessard et al., 1996) and microcalorimetry (Jung et al., 2002a; 2003). 
Furthermore, the crystal structure determined for the B. stearothermophilus E1/E2-SBD 
complex (Frank et ak, 2005) shows that the SBD is bound across the two-fold axis of E l thus 
preventing association of a second SBD molecule due to steric hindrance. If E2/E1 cross­
bridges do indeed exist in eukaryotic PDCs, this indicates that either the nature of the 
interaction is different and/or a change in the local structure of the E2-SBD and/or its binding 
site on El. A crystal structure of human E l is available (Ciszak et al., 2003) and it 
superimposes reasonably well onto B, stearothermophilus E l complexed with E2-SBD with 
an rmsd of 1.4 Â. Most differences in the backbone structuie can be observed in the E la  
subunits, not the E lp  subunits involved in E2 binding. However, a SAXS study conducted on 
a number of metabolic enzymes from various sources, including yeast pyruvate decarboxylase 
has shown that considerable differences can be observed between the solution structures of 
proteins when compared to their cognate crystal structures (Svergun et al., 2000). In 
particulai*, presumably due to the absence of crystal packing forces, the solution structure of 
yeast pyruvate decarboxylase was less compact (Svergun et al., 2000) -  an effect that has 
been observed for a number of other proteins as well (Trewhella et al., 1988; Katakoka et al., 
1996; Svergun et al., 1997a; Nakasako et al., 2001; Kozak et al., 2002). If human E l behaves 
in a similar fashion, inter-subunit contacts are likely to be affected and a looser association of 
the two E ip subunits could result in the availability of both E2 binding sites. Obviously, more 
experiments are required to elucidate this question; SAXS may provide part of the answer, 
while NMR studies of labelled E2-SBD interacting with unlabelled E l should be more
148
6.4 Discussion
S
definitive due to the presence of an additional set of dipolar couplings arising from the 
interaction of the two subunit binding domains.
Interestingly, preliminary analysis of the thennodynamics involved in the interaction of 
human E2DD with bovine E l is characterised by a large, favourable enthalpy change and a 
small, positive entropy change, and is thus remarkably similar to bacterial E1/E2-SBD 
complex formation (Jung et al., 2002a). Association of human XDD and E3 is also 
comparable, albeit resulting in a small negative entropy change (see Section 5.3.3.5).
However, the ITC experiments concerning E2DD/E1 interaction clearly need to be repeated 
in order to obtain reliable results. Furthermore, experiments using point mutants analogous to 
those used by Jung et al. (2002b; 2003) could be used to chaiacterise the association of E2DD 
with E l with respect to hydrophobic and electrostatic contributions.
Current concepts of PDC subunit architecture envisage the E2/E3BP core forming the 
structural and mechanistic framework for the assembly to which the E l and E3 enzymes bind 
tightly but non-covalently. With respect to the results presented in chapters 5 and 6, the 
peripherally bound E l and E3 enzymes are precisely positioned and oriented around its 
surface to facilitate optimal interaction of their active sites with the lipoyl ‘swinging arms’ of 
E2/E3BP during the catalytic cycle. In this model, E l and E3 interactions with the ‘core’ 
assembly are passive in nature in the sense that they are not predicted to have a direct 
influence on the operation of the E2/E3BP core. However, the existence of a previously 
unrecognised level of ultrastructure resulting from the presence of a network of E3 and El 
cross-bridges around the surface of the E2/E3BP oligomer is predicted to introduce a 
considerable degree of restraint into the movement of the N-terminal ‘swinging arms’ of 
E3BP and E2, limiting in particular the degree of freedom enjoyed by E3BP and E2 lipoyl 
domains (Fig. 6.14). Since LDs are, in effect, substrates for all thiee active sites within the 
PDC, this more restrictive environment highlights some interesting questions concerning PDC 'mechanism and efficiency. In particular, it suggests that E l may interact exclusively or 
preferentially with E2 lipoyl domains while E3 may interact similarly with E3BP-LDs as 
substrate, so it would appear unlikely that individual E2 or E3BP LDs are able to visit all 
three types of active site. This new structural feature is also compatible with the idea that 
specific subsets of LDs visit the various active sites of the constituent enzymes and defined
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routes of migration may be involved in mediating the transfer of acetyl groups and reducing 
equivalents between E2 and E3BP lipoyl domains during the catalytic cycle.
Figure 6.14 Cross-bridge formation in human PDC
Representative cross-bridges formed between B2 (green) and El (blue), and E3BP (X; magenta) and 
E3 (cyan) are shown. PDC kinase (PDK) and phosphatase (PDP, PRP) are also depicted. Molecules are 
not drawn to scale.
Another important aspect of PDC function that is influenced by its subunit organisation is 
regulation of its activity state by PDK and PDP. It has been reported that only 1-3 molecules 
of PDC kinase (PDK) are bound per complex (Yeaman et al., 1989). Both regulatory enzymes 
associate with the E2-ILD whereby the lipoate cofactor provides an important part of the 
recognition site. PDP and PDK act by de-/phosphorylation of El on any of three specific E la  
serine residues. Phosphorylation of El renders the complex inactive. Since only a few
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molecules of PDK are present per complex, the enzyme has to migrate around the surface of 
the complex in order to act on the entire population of bound E l molecules. A hand-over- 
hand mechanism has been proposed where the dimeric PDK molecule migrates from one 
inner lipoyl domain to its nearest neighbour. Its high-affinity for dimeric ILD glutathione S- 
transferase constructs suggests that PDK may transiently form cross-links with pairs of 
adjacent E2s as part of the molecular mechanism of migration (Liu et al., 1995a). Regular 
spacing of the E2 lipoyl domains linked by a system of E l cross-bridges could greatly 
facilitate this type of movement and provide convenient access to the full repertoire of E l 
substrate molecules.
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PDC core structure
form the 20 vertices of the icosahedron and are interconnected by 30 bridges (Stoops et al, 
1992; Izard et al., 1999).
7.1 Introduction
The PDC core of E2 (and E3BP) constitutes the central framework for interaction with the 
remaining PDC enzymes, E l and E3. In Gram-negative bacteria, e.g. E. coli, the core adopts 
an octahedral conformation consisting of 24 E2 molecules. In contrast, in Gram-positive 
bacteria such as B. stearothermophilus and eukaryotes, the core is much larger, forming an 
icosahedron with 532 symmetry for the arrangement of its 60 E2 molecules (Reed & Oliver, 
1968; Oliver & Reed, 1982; Wagenknecht et al., 1991). The crystal structure of the cores 
from B. stearothermophilus and Enterococcus faecalis at 4.4 Â and 4.2 Â resolution, 
respectively (PDB ID 1B5S) (Izard et al., 1999), provide clear insights into the structural 
organisation of E2 within the pentagonal dodecahedron (Fig. 1.3) where basic E2 trimers
Eukaryotes contain an additional core protein: E3 binding protein (E3BP), also termed protein
Ï
à
X (De Marcucci & Lindsay, 1985; Jilka et al., 1986; Rahmatullah et al., 1989b), enabling the 
formation of specific subcomplexes between E3BP and E3, and E2 and E l. Using
1
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densitometry Sanderson and colleagues (1996b) determined the stoichiometry of E2:E3BP 
within the bovine PDC core as 60:12. Similar results (12-15 E3BP molecules per core) were 
also obtained for the PDC core of S. cerevisiae (Maeng et al., 1994). Since an icosahedron has 
12 pentagonal faces, it was proposed that one copy of E3BP was located in each face. Cryo- 
EM studies of yeast PDC core confirmed localisation of E3BP to each of its pentagonal faces, 
although it was suggested that E3BP actually bound on the inside of the PDC core near the tip 
of the E2 trimers, resulting in a close association of E3 with the pentagonal faces (Stoops et 
al., 1997).
An alternative model of mammalian PDC core formation has been proposed recently by 
Hiromasa and co-workers (2004) based on ultracentrifugation and SAXS studies on 
recombinant human E2 and E2/E3BP cores: instead of a 60:12 (E2:E3BP) “addition model” 
of PDC core formation the authors suggest that 12 E3BP molecules replace an equivalent 
number of E2 molecules, resulting in a stoichiometry of E2:E3BP of 48:12 (“substitution 
model”).
The work described in this chapter sets out to identify experimental approaches that will 
enable us to define PDC core organisation. Several experimental techniques including 
analytical ultracentrifugation (AUC), small angle x-ray and neutron scattering (SAXS/SANS) 
were used for an initial characterisation of recombinant human PDC core. Where possible, the 
behaviour of recombinant human E2/E3BP core was compared to results obtained for native 
bovine core and intact bovine PDC.
7.2 Materials and methods
7.2,1 Sam ple preparation
Recombinant human E2/E3BP (E2/E3BP) core was purified as outlined in Section 4.2.3.
Bovine PDC was obtained from heart muscle tissue as described in Section 3.3.2.7 and was 
also used to purify bovine E2/E3BP core (Sections 4.2.3). Purification procedures for E3 are 
also detailed in Sections 3.3.2 and 4.2.3.
"I
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7.2.2 Sed im entation  velocity
Sedimentation velocity (SV) experiments were performed as described in Section 3.4.2. 
Purified recombinant human E2/E3BP core was dialysed against 50 mM Tris-HCl, 10 mM 
NaCl, pH 7.5 and sedimentation data recorded at 4°C at a rotor speed of 40000 rpm using 
interference optics only. A series of 450 scans, 30 seconds apart was recorded for each 
sample. Sample concentrations ranged from 52 nM to 194 nM. The samples (380 pi) were 
loaded into 12 mm double sector centrepieces. Sedimentation profiles were analysed with the 
c{s) routine in the computer program SEDFIT (Schuck, 2000). Weight-average sedimentation 
coefficients, were determined by peak integration of the c(a) profile. True sedimentation 
coefficients were obtained from finite element analysis (see Sections 2.2.2.1 and 3.4.2 for 
details).
7.2.3 Sm all angle scatterin g
7.2.3.1 Small angle x-ray scattering
Scattering data for human E2/E3BP core, bovine E2/E3BP core and bovine PDC were 
recorded at beamline 2.1 of the SRS Daresbury, UK. A protein concentration of 1.8 mg/ml 
was used for the collection of human E2/E3BP data. Scattering curves of bovine E2/E3BP 
core were obtained from concentrations of 0.8 and 1.6 mg/ml, while data for bovine PDC 
were recorded for concentrations of 0.8, 2.3 and 4,2 mg/ml. A single sample-to-detector 
distance of 4.25 m was used for the collection of human and bovine E2/E3BP core data, while 
an additional camera length of 1 m was employed to obtain scattering data from bovine PDC.
The program DAMMIN (Svergun, 1999) was used for ab initio reconstructions of human 
E2/E3BP, bovine E2/B3BP and bovine PDC. Since the icosahedral symmetry of eukaryotic 
PDC is well documented, DAMMIN reconstructions were done using icosahedral symmetry 
restraints. More details on ab initio modelling can be found in Section 2.4.2.3.
7.2.3.2 Small angle neutron scattering
Deuterated, recombinant human E2/E3BP core was provided by Dr. Phil Callow, Institut 
Laue-Langevin (ILL), Grenoble, France. Both protonated and deuterated human core were
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purified as described in Section 4.2.3. E2/E3BP was reconstituted at a molar ratio of 12:1
I
with protonated E3 and extensively dialysed against buffer containing 50 mM potassium 
phosphate, pH 7.4. Deuterated core samples (0.75 mg/ml) were dialysed against buffer 
containing 40, 60 and 100% D2O. Samples containing protonated core (1.25 mg/ml) were 
dialysed against buffer containing 25, 40, 60 and 100% D2O. SANS datasets were collected 
on beamline D ll  station at the ILL by Dr. Phil Callow. All experiments were performed at 
4®C. Details of data collection and analysis can be found in Section 3.4.6.
7.3 Results and discussion
7.3.1 Sed im entation  velocity  o f recom binant E2/E3BP 
core
Sedimentation velocity data fi'om human E2/E3BP core clearly show the heterogeneous 
composition of the protein sample (Fig. 7.1 A). Weight-average sedimentation coefficients, 
were determined to be 5, 11, 27 and 35 S by integration of each peak in the c{s) analysis. 
Finite element analysis was used to obtain the true sedimentation coefficients of the two 
major peaks which were corrected for concentration (Fig. 7. IB) to yield values for of
26.3 ± 0.4 S and 33.6 ± 0.1 S. The sample seems to have undergone a certain amount of 
proteolysis, resulting in two major peaks: the peak around 35 S is thought to couespond to the 
intact human E2/E3BP core as its s^ , compares favourably to the published values of 32 S for 
human (Hiromasa et al., 2004) and 35 S for bovine E2/E3BP core (Roche et al., 1993). The 
second major peak around 27 S probably corresponds to E2/E3BP core where some of the N- 
terminal arms of E2 and E3BP have been proteolytically cleaved. In particular, the extended 
linker sequences connecting the various lipoyl domains and subunit binding domains are 
prone to proteolysis, resulting in the two smaller peaks around 5 and 11 S. Proteolysis is not 
apparent from SDS PAGE (data not shown). However, the core has a much larger molecular 
weight and thus a higher capacity to bind Coomassie stain when compared to the significantly 
lower amounts of proteolysis products. The accuracy in the determination of is also thought 
to be lower for the two smaller peaks. The sedimentation process of the two large species was 
fully recorded and used in the analysis. In contrast, sedimentation data of the two minor 
species is incomplete resulting in a more complicated and less accurate data analysis.
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Figure 7.1 Sedimentation velocity analysis of human E2/E3BP core
(A) c(j) distribution from SV interference data collected for 52 nM (—), 103 nM (—) and 194 nM (—) 
human E2/E3BP core. (B) Determination of concentration independent for the two major peaks in 
the E2/E3BP c(s) analysis.
The average sedimentation coefficient of human E2/E3BP core is also considerably lower 
than that calculated for a solid sphere of the same molecular weight and partial specific 
volume: values of 76 S for the addition model and 67 S for the substitution model of PDC 
core, respectively were calculated. Without further information on the sedimentation 
behaviour of core composed solely from E2 it was not possible to distinguish between the two 
different models. The large discrepancy between calculated and experimental sedimentation 
coefficients for human E2/E3BP is due to the large internal cavity of the E2/E3BP core and 
highly solvated external “shell” of E2 and E3BP N-terminal arms resulting in a “drag effect” 
during sedimentation. The fact that human E2/E3BP core has a lower sedimentation 
coefficient than 60-meric E2 as reported by Hiromasa et al. (2004) does not necessarily 
indicate a lower molecular weight. The presence of 12 additional molecules of E3BP in each 
of the pentagonal faces would result in more solvent exposed surface, thus increasing 
hydration and non-ideality. Whether this effect is large enough to cause a decrease in the 
sedimentation coefficient as observed by the authors cannot be answered by SV alone.
A detailed study of human E2 and E2/E3BP core, including sedimentation equilibrium 
experiments, was not possible due to time and sample constraints, but should establish 
whether the E2 or the E2/E3BP core has the larger molecular weight, thus supporting either
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the addition or the substitution model of human E2/E3BP core formation. The analysis of SE 
data for PDC core will be difficult: due to its enormous size (3.5/4.3 MDa for the 
substitution/addition model) SE runs have to be conducted at very low speeds (approximately 
1900-3300 rpm) to cover an appropriate macromolecular distribution within the concentration 
gradients. Data acquisition at such low speeds is problematic although accuracy can be 
improved by using long solution columns. However, long columns take a very long time to
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reach equilibrium during which the core may undergo further degradation. The data published 
by Hiromasa and colleagues (2004) is based on very short columns (50 pi). Furthermore, their 
analysis was done using the Beckman XL-A/XL-I software implemented in MicroCal 
ORIGIN which allows fitting of only a single species. Their SV data show, however, the 
presence of a small amount of aggregate in at least one of their samples which may have a 
profound effect on the final result if not fitted satisfactorily. Programs that allow the fitting of 
more than a single species are available (see Section 2.2.2.1). Also, the authors fail to mention 
how they arrived at initial estimates of the second virial coefficient, B, in order to account for 
non-ideality, exactly how B was implemented during data fitting and its consistency with its 
experimentally determined counterpait.
T
7.3.2 Sm all angle scatterin g  o f PDC and PDC core
7,3.2.1 Small angle x-ray scattering
Due to sample constraints scattering data for human E2/E3BP core were obtained at only one 
concentration. However, inter-particle interference is not apparent in the recorded data and 
was unlikely to occur at the relatively low sample concentration used. Furthermore, the 
human and bovine scattering curves are almost identical (Fig. 7.2A), as expected for the PDC 
core particles from two mammalian species. An attempt to estimate the molecular weights of 
human and bovine core by extrapolation of the scattering intensity to zero angle, 7(0), did not 
provide satisfactory results. Scattering intensity is directly proportional to the total number of 
electrons within a particle and thus relates to its molecular weight. However, this 
extrapolation is more problematic to apply to very small and very large particles due to large 
differences in size when compared to the molecular weight standard -  in this case E3 -  as 
well as a 100 to 10000-fold increase in the experimental error when determining 7(0).
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Figure 7.2 Small angle x-ray scattering from PDC and PDC cores
(A) Scattering curves of human (—) and bovine (—) E2/E3BP core. (B) Scattering curve of bovine PDC 
(—). Shape scattering curves obtained using GNOM are shown (—). (C) p(r) distributions of human (■) 
and bovine (■) E2/E3BP core, and bovine PDC (□).
Guinier analysis and the program GNOM (Semenyuk & Svergun, 1991; Svergun, 1992) were 
used to determine the radius of gyration, R ,^ of human E2/B3BP core (140 ± 2 Â and 138 ± 1 
Â, respectively). These values compare favourably with those obtained for bovine E2/E3BP 
of 135 ± 4 À and 132 ± 1 À from Guinier and GNOM analyses, respectively. In addition, the 
distance distribution functions, p(r), of human and bovine E2/E3BP (Fig. 7.2C) clearly 
confirm the similarity of the scattering curves, and accordingly, the molecular shapes of the 
core particles. It also indicates that recombinantly expressed core seems to assemble into the 
same structure as native core. The maximum particle dimensions, Dmax were determined from 
the p(r) distribution as 400 ± 3 Â and 395 ± 5 Â for human and bovine E2/E3BP,
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respectively, in excellent agreement with the particle diameter of 401 Â determined for 
bovine core using quasi-elastic light scattering (Roche et al., 1993). However, values of of 
human E2/E3BP determined in this study are somewhat lower than those reported by 
Hiromasa et al. (2004) (150 ± 2 À), while their of 390 Â corresponds well to our own 
data.
Assuming that the core of human E2/E3BP has similar dimensions to that of B. 
stearothermophilus (Izard et al., 1999), the subtraction of the D,„ax determined using 
CRYSOL (Svergun et al., 1995) for B, stearothermophilus of 240 Â leaves approximately 80 
Â for the N-terminal arms of E2. A length of approximately 80-90 Â for the swinging arms 
represents a sensible estimate and agrees with data obtained previously from quasi-elastic 
light scattering and cryo-EM (Roche et al., 1993; Milne et al., 2002; 2005).
Analysis of the scattering curve of bovine PDC (Fig. 7.2B,C) shows that PDC is larger and 
more spherical than the E2/E3BP cores, presumably due to the outer shell formed by the 
binding of E l and E3. Guinier and GNOM analyses yielded Rg values of 199 ± 4 A and 167 ± 
1 Â, respectively. Using the Guinier approximation to estimate Rg is problematic in this case 
as it relies on only very few data points in the low angle region. Including data acquired at a 
longer sample-to-detector distance would remedy this, but there was not enough beamtime 
available to do this experiment. The D„u,x of 450 ± 4 Â determined for bovine PDC from the
Ab initio models of human and bovine E2/E3BP core as well as bovine PDC were produced 
with the computer program DAMMIN (Svergun, 1999) (Fig. 7.3) employing icosahedral
distance distribution function (Fig. 7.2C) agrees well with data obtained previously using 
cryo-EM (Milne et al., 2002), although it is somewhat smaller than the diameters of 480 Â 
and 500 Â determined by quasi-elastic light scattering in solution and negative stain electron 
microscopy, respectively (Bleile et al., 1981; Roche et al., 1993). The differences in value 
probably reflect the different experimental approaches used, but may in part also be due to the 
effects of “breathing” of the PDC core, i.e. its thermally driven contraction and expansion 
(Zhou et al., 2001a). However, solution techniques such as SAXS and light scattering should 
yield time-average results, while cryo-EM is able to provide snap-shots of core molecules at 
different “breathing” stages.
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symmetry constraints during the modelling process in accordance with data available for 
eukaryotic PDC core formation (Stoops et al., 1992; 1997; Zhou et al., 2001b). Most models 
incorporate the same symmetry axes as the models obtained from cryo-EM, although some 
reconstructions used a different distribution of symmetry axes and were excluded from further 
analysis.
éB
400Â
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Figure 7.3 Ab initio models of PDC and PDC cores
Ab initio models were obtained using DAMMIN in reconstructions of human E2/E3BP (A), bovine 
E2/E3BP (B) and bovine PDC (C).
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The position of E3BP within the PDC core cannot be determined from the SAXS ab initio 
models: reconsti'uctions result in some models with “empty” pentagonal faces, in line with the 
48:12 substitution model, while others do show electron density in the pentagonal faces of the 
core, thus supporting the 60:12 addition model. However, DAMMIN reconstructions were 
nevertheless successful considering that hollow structures can sometimes pose considerable 
problems for the algorithm (Volkov & Svergun, 2003).
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T.3.2.2 Small angle neutron scattering
Small angle neutron scattering (SANS) has two major advantages over SAXS: neutrons do 
not cause radiation damage to samples, thus preventing radiation-induced aggregation. 
Secondly, the different interactions of neutrons with hydrogen and deuterium enable “contrast 
matching” (Section 2.5.1). Ideally, E3BP would be selectively deuterated and reconstituted 
with protonated E2 to form the PDC core. Unfortunately, mammalian E2 and E3BP have to 
be co-expressed for correct core formation (see Section 1.4.3) (McCartney et al., 1997). 
Instead, deuterated E2/E3BP core (dE2/E3BP) was reconstituted with protonated E3 (pB3) in 
order to exploit E3 positioning to determine the localisation of E3BP within the PDC core.
Recording the scattering of pE3 and dE2/E3BP dialysed against buffers with different 
percentages of D2 O allowed accurate determination of their respective matchpoints of 46% 
and 130%, respectively (Fig. 7.4). A matchpoint of 130% indicates efficient incorporation of 
the deuterium label into the overexpressed protein. With a matchpoint of 46%, the scattering 
contribution of pE3 in reconstituted dE2/E3BP*pE3 can be matched out completely. 
However, when recording the scattering of dE2/E3BP«pE3 in 100% D2O, the E2/E3BP core 
cannot be completely matched and still accounts for 30% of the overall sample scattering and 
thus influences subsequent data analysis. In order to obtain accurate data for future 
experiments the E2/E3BP core will have to be overexpressed in 65% rather than 100% 
deuterated media, so that its matchpoint is less than 100% D2O and the deuterated E2/E3BP 
core can be effectively matched by the solvent.
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The scattering curves obtained for dE2/E3BP and dE2/E3BP*pE3 are shown in Fig. 7.5A,C. 
For dE2/E3BP in buffers containing 40% and 100% D2O respectively, Rg values of 142 ± 2 Â 
and 142 ± 6 Â were determined using GNOM. These values compare favourably to the 7?g of 
145 Â determined by SAXS. The was determined as 425 ± 5 Â for dE2/E3BP in both 
40% and 100% D%0 buffer (Fig. 7.5B) which is somewhat larger than the value obtained by 
SAXS (400 Â).
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Figure 7.4 Matchpoint determination for E3 and E2/E3BP core
Scattering experiments for protonated E3 (□) and deuterated E2/E3BP core (■) were done in buffers 
containing 40, 60 and 100% D2O. Additional data were recorded for pE3 in buffers containing 20% 
D2O.
GNOM analysis of the scattering curves recorded for dE2/E3BP*pE3 in buffers containing 
40% and 100% D2 O, respectively (Fig. 7.5C), yielded Rg values of 143 ± 2 Â and 136 ± 8 Â. 
The decrease in Rg for dE2/E3BP*pE3 in 100% D2O (i.e. with the E2/E3BP core partially 
matched out) was unexpected, but lies within the experimental error. Furthermore, incomplete 
matching of one component has been known to affect data analysis in this way (P. Callow, 
personal communication). The D^ax for dE2/E3BP*pE3 was determined as 425 Â for samples 
in buffers containing 40% and 100% D2O (Fig. 7.5D).
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Figure 7.5 Small angle neutron scattering of E2/E3BP core and E2/E3BP«E3
(A) Scattering curves of deuterated E2/E3BP core in 40% (■) and 100% D2O (□). The shape scattering 
curves obtained from GNOM (—) are shown. (B ) p{r) distributions of deuterated E2/E3BP core in 40% 
(■) and 100% D2O (□). (C) Scattering curves of deuterated E2/E3BP«E3 in 40% (•)  and 100% D2O 
(o). (D ) p(r) distributions of deuterated E2/E3BP core in 40% (• )  and 100% D2O (o).
Reconstructions of dE2/E3BP core in 40% D2O and partially matched out dE2/E3BP*E3 in 
100% D2O were obtained separately with DAMMIN and superimposed onto each other (Fig. 
7.6). The reconstruction of the dE2/E3BP core yielded an unexpected shape, as it seems 
shortened in one direction and with overall dimensions of 425 x 425 x 210 Â. The model 
consists of two parts: an inner core with a diameter of 270 Â and an outer shell with a 
thickness of 80 Â, presumably representing the C-terminal domains and N-terminal arms, 
respectively. In fact, with respect to its short axis the DAMMIN reconstruction is reminiscent 
of cryo-EM micrographs of the breathing PDC core (Zhou et al., 2001a). However, in contrast
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to cryo-EM where pictures of individual molecules are taken (and later averaged), SANS is an 
inherently time-average technique and the resultant structure is expected to represent a time- 
average ensemble (i.e. a more spherical shape), not an extreme conformation.
Most probably the models obtained reflect the fact that more data (with better statistics) need 
to be collected: ideally, scattering data would be recorded using an additional camera length 
and more concentrated protein samples. Furthermore, at 3 hours, data collection times for 
each sample were very short when compared to published SANS experiments. However, due 
to time and sample constraints it was not possible to implement any of the above measures. 
The model shown in Fig. 7.6 was reconstructed using P52 instead of icosahedral (532) 
symmetry, as the introduction of an additional 3-fold axis introduced a minimum in the fit 
that was not observed in the experimental data (not shown). Possibly, this minimum is 
obscured due to the low scattering intensity and statistics of the data, resulting in a flattened 
particle, since using icosahedral symmetry for ab initio modelling of SAXS data did not 
present any problems at all. Possible sample heterogeneities due to limited proteolytic 
cleavage as observed by AUC (see Section 7.3.1) are not thought to influence SANS 
reconstructions significantly, since ab initio models obtained from SAXS seem unaffected.
425 A
210 A270 A
Figure 7.6 Reconstructions of E2/E3BP and matched E2/E3BP*E3 from SANS data
Top (A) and side views rotated by 45“ (B) and 90“ (C). E2/E3BP core (blue) and partially matched 
dE2/E3BP*pE3 (red) were reconstructed from separate data sets.
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Reconstructions of E3 from paitially matched dE2/E3BP*pE3 show that this approach for 
locating E3 positioning with respect to the E2/E3BP core is indeed possible. Modelling of 
dE2/E3BP*pE3 using no symmetry constraints (not shown) as well as P2 (not shown) and P5 
symmetry (Fig. 7.6) all produced comparable results as the density conesponding to E3 was 
distributed in a plane with respect to the dE2/E3BP core. However, as a consequence of the 
incomplete matching out of the dE2/E3BP core, the models obtained for E3 in this experiment 
may be misleading, since it is unclear how DAMMIN reconstructions will be affected by the 
residual scattering from the dE2/E3BP core. Therefore, no clear conclusion as to the core 
formation by E2 and E3BP can be drawn from the experiments described above, nor indeed 
from published material. However, a very strong point in favour of the substitution model is 
the ease of E3BP integration into the core when compared to the addition model: the C- 
terminal domains of E2 and E3BP are highly homologous. Therefore, E3BP should easily be 
able to interact with E2 molecules. In contrast, when integrating into a pentagonal face the 
interaction of E3BP with E2 is likely to be of a completely different nature, although the 
pentagonal opening within the core has a diameter of approximately 60-70 Â which is big 
enough for the accommodation of the E3BP C-terminal domain, assuming similar domain 
dimensions when compared to E2.
While neither AUC nor SAXS can provide a definitive description of PDC organisation, 
completion of SANS experiments employing contrast matching will provide unique insights 
into E2/E3BP core structure. In addition to the SANS experiment discussed above, contrast 
matching with deuterated E2 and protonated protein E3BP may also prove useful: even 
though E2 and protein E3BP have to be co-expressed for the formation of wild-type core, 
dénaturation of bovine E2/E3BP and the subsequent slow removal of guanidine hydrochloride 
by dialysis resulted in the reformation of E2/E3BP particles, although integration of E3BP 
into the core was reduced to only 35% of wild-type levels (McCartney et al., 1997). 
Exploiting the availability of recombinant proteins, however, it may be possible to improve 
incorporation of E3BP into the core using excess E3BP during reconstitution experiments. 
Constructs containing the C-terminal, core forming domains of both E2 and E3BP only would 
be particularly suited to such a SANS experiment as removal of the mobile, N-terminal arm 
should considerably facilitate ab initio modelling. A completely different approach using 
labelled E3BP in fluorescence resonance energy transfer (FRET) studies may also yield
165
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useful complementary results by estimating the intermolecular distance between neighbouring 
E3BP molecules. Clearly, more experiments are needed for the resolution of PDC core 
organisation. However, the work presented in this chapter helps to define feasible 
experimental strategies.
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Conclusions
Multi-enzyme assemblies and in particular the 2-oxoacid dehydrogenase complexes have 
been intensely studied in order to characterise the influence of protein-protein interactions on 
complex efficiency, cooperativity and regulation. While many aspects of function and 
structure of the 2-oxoacid dehydrogenase complexes (2-0ADC) and their constituent 
enzymes are well understood, many questions remain. Hundreds of different mutations have 
been identified in PDC alone, and the links between clinical disease and complex dysfunction 
at a molecular level are often only poorly understood. Similarly, while the atomic structures 
of many 2-0ADC constituent enzymes have been solved over the last 20 years, our 
understanding of how these individual components form into giant and highly complex 
assemblies is more tenuous. With paiticular reference to PDC, a large body of work has been 
dedicated to the detailed characterisation of PDC from B. stearothermophilus and certain 
other Gram-positive bacteria. Analysis of eukaryotic PDC, however, has been slower to 
progress, but is just as interesting and important given the significant differences between 
prokaryotic and eukaryotic PDC. With the discovery of E3BP as an additional component of 
eukaryotic PDC (De Marcucci & Lindsay, 1985; Jilka et al., 1986) and the concomitant 
specialisation of protein-protein interactions within the complex, determining the nature and 
effects of the specific E2/E1 and E3BP/E3 subcomplex formation on overall PDC 
organisation, function and regulation has been at the forefront of eukaryotic PDC research.
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The work described in this thesis concerns the large-scale purification of individual PDC 
proteins from recombinant or native sources (Chapter 4) for use in a variety of subsequent 
biochemical and biophysical experiments. All proteins with the exception of bovine E l and 
bovine E2/E3BP core were expressed as His-tag or GST fusion products in order to aid 
purification. Nevertheless, several chromatography steps were required for all proteins in 
order to obtain >95% pure preparations as judged by SDS PAGE and Coomassie blue 
staining.
Purified proteins were initially characterised individually and then used for the subsequent 
analysis of the stoichiometry of binding between human recombinant constructs of E3BP and 
E3 (Chapter 5), as well as human E2 and bovine E l (Chapter 6). As expected, AUC and 
SAXS data confirmed E3 as a homodimer, while the E3BP-derived construct XDD was found 
by AUC to be monomeric in solution. The E3 solution structure determined by ab initio 
modelling of SAXS data is significantly different to the crystal structures solved for the 
human and yeast enzymes. In solution E3 seems less compact and more anisometric than in 
the crystal, possibly reflecting crystal packing forces.
In the case of the XDD/E3 subcomplex, data obtained from non-denaturing PAGE, AUC and 
ITC all confirmed a 2:1 stoichiometric interaction of XDD with E3. Similarly, analysis of 
data recorded for the purified XDD/E3 subcomplex by AUC and SAXS was in complete 
agreement and even allowed for the determination of a model for the subcomplex using 
SAXS ab initio modelling. Using hydrodynamic and rigid body modelling a molecular model 
was defined, based on homology models of both E3 and XDD. hi the final model of the 
XDD/E3 subcomplex, E3 seems to adopt the same structural configuration as on its own. This 
may be why crystallisation studies of the XDD/E3 subcomplex failed to detect two XDD 
molecules bound per E3 homodimer (Ciszak et al., 2006). Intriguingly, the two XDD 
molecules were found to be non-equivalent: while one lipoyl domain was present in a 
conformation laterally extended away from the SBD, the other LD was found docked into the 
E3 active site, possibly indicating an El-like flip-flop mechanism (Ciszak et al., 2003). 
However, further detailed enzymatic studies are required before drawing any further 
inferences from the solution structure.
■it
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swinging arms of E2 and E3BP with the active sites during catalysis and directly affect the 
operation of the E2/E3BP core. A further consequence of cross-bridge formation would be the 
introduction of considerable constraints upon the mobility of the N-terminal E2 and E3BP 
arms, with particular emphasis on the lipoyl domains.
In comparison to the organisation of peripheral E l and E3 with respect to the PDC core, a 
number of papers had been published on eukaryotic PDC core organisation. However, only 
over the last ten years have researchers begun to try to pinpoint the location of E3BP within 
the core. Two very different models were proposed based on various experimental techniques. 
Chapter 7 represents an effort to develop an experimental approach that will distinguish 
between the two core representations. Neither AUC nor SAXS are suitable on their own due 
to uncertainties in the data collection or interpretation inherent in both techniques and are 
further impeded by the enormous size of the PDC core itself. SANS, however, with its unique
169
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Bovine E l, the E2~derived construct E2DD and their subcomplex were studied in a fashion 
analogous to E3 and E3BP. Lower yields from protein purification and decreased protein 
stability, in particular for E l, meant that characterisation of the E2DD/E1 subcomplex was 
fraught with difficulties. Analysis of stoichiometric mixtures of E2DD and E l by 
sedimentation velocity AUC indicates the formation of 2:1 (E2DD/E1) subcomplexes. Further
- ■ ' iAUC and SAXS studies on the purified E2DD/E1 subcomplex confirmed this result, although 
subsequent ab initio and rigid body modelling of the SAXS data proved problematic.
The E2DD/EI data do favour a 2:1 stoichiometric arrangement, resulting in the formation of 
“cross-bridges” on the PDC surface that precisely position and orient the peripherally bound 
E l and E3. Presumably, such an arrangement would facilitate interaction of the lipoyl
This new level of PDC ultrastructure is also thought to have profound effects on PDC
regulation by PDK and PDP, as only a few molecules of the regulatory proteins are bound per 
complex (Yeaman, 1989). Both enzymes associate with PDC via the E2-DLD which in turn 
would be regularly spaced on the complex surface as a direct consequence of cross-bridge 
formation, ideal for the hand-over-hand mechanism of movement suggested for the dimeric
i
K;
PDK molecules (Liu et al., 1995a).
8 Conclusions
ability to distinguish between different components of the same complex (in this case E3 and 
E2/E3BP) presents a viable alternative for future experiments.
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